data_2lzx_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lzx _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.149 0 N-CA-C 112.602 -0.199 . . . . 0.0 112.602 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.72 113.14 9.99 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 120.803 0.335 . . . . 0.0 110.398 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.628 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . . . -117.8 148.93 41.61 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.918 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -93.19 172.48 8.27 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.981 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.505 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 24.5 tt0 -65.35 136.81 56.99 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.813 0.34 . . . . 0.0 111.01 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.04 -5.36 79.96 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.941 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -93.54 156.79 16.53 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 122.721 0.409 . . . . 0.0 110.647 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.548 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 51.7 m -96.88 116.23 28.81 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.199 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.26 154.17 33.88 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.646 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.516 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.0 m-80 -100.85 138.27 38.13 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.773 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.686 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -91.98 20.45 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.997 0.427 . . . . 0.0 111.051 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.78 -30.13 7.17 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.823 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.72 -45.02 0.15 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -115.56 74.2 4.43 Favored Pre-proline 0 CA--C 1.547 0.852 0 O-C-N 123.19 0.306 . . . . 0.0 111.367 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.59 -172.18 0.88 Allowed 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 122.762 2.308 . . . . 0.0 112.831 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 92.8 m -70.16 -177.69 1.45 Allowed 'General case' 0 CA--C 1.543 0.686 0 O-C-N 123.107 0.255 . . . . 0.0 111.137 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.6 m -84.11 118.6 71.68 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 122.271 0.228 . . . . 0.0 111.334 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.49 157.62 28.87 Favored 'Trans proline' 0 C--N 1.369 1.629 0 C-N-CA 122.676 2.251 . . . . 0.0 113.065 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.72 -32.27 5.67 Favored Glycine 0 C--N 1.338 0.661 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.862 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.4 mt -84.15 -60.46 2.09 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 122.643 0.377 . . . . 0.0 111.02 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.28 36.36 0.3 Allowed Glycine 0 C--N 1.341 0.837 0 O-C-N 123.459 0.475 . . . . 0.0 113.286 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.58 155.59 18.76 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.8 0.333 . . . . 0.0 111.381 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.63 129.39 20.45 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.333 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.11 123.69 30.92 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 123.265 0.353 . . . . 0.0 110.818 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.8 mm -123.26 120.45 27.23 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.127 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.37 -31.64 5.07 Favored 'Cis proline' 0 C--N 1.372 1.773 0 C-N-CA 124.192 -1.17 . . . . 0.0 113.169 -0.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.686 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.59 -24.74 30.91 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-N 115.766 -0.652 . . . . 0.0 113.868 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -113.66 112.18 48.45 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 117.205 0.502 . . . . 0.0 111.009 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -69.96 -25.12 8.3 Favored 'Cis proline' 0 C--N 1.378 2.111 0 C-N-CA 124.978 -0.842 . . . . 0.0 113.321 -0.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.516 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.1 p-10 -153.25 150.98 29.54 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.79 179.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -139.91 -168.54 11.36 Favored Glycine 0 C--N 1.335 0.521 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.473 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.5 134.62 41.21 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.729 0.299 . . . . 0.0 111.459 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.628 ' SG ' ' HB2' ' A' ' 4' ' ' ALA . 77.4 m -80.35 107.73 13.38 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.355 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -112.51 147.51 36.42 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.691 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.441 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.5 m-85 -78.65 129.41 34.7 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.281 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.1 mt . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.473 -0.775 . . . . 0.0 111.475 -179.554 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.153 0 N-CA-C 112.602 -0.199 . . . . 0.0 112.602 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.87 113.26 9.99 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 122.427 0.291 . . . . 0.0 110.462 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.619 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . . . -117.73 148.16 42.28 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.851 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -92.47 172.2 8.54 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.079 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.5 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.5 tt0 -65.17 137.05 57.38 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.51 0.324 . . . . 0.0 111.015 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.93 -5.41 79.4 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.978 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -93.61 156.81 16.5 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 122.772 0.429 . . . . 0.0 110.682 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.548 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 52.9 m -96.8 116.23 28.79 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.18 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.29 154.06 34.08 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.591 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.515 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.0 m-80 -100.75 138.2 38.11 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.801 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.685 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.6 m -91.83 20.34 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 120.945 0.402 . . . . 0.0 111.071 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.71 -30.05 7.22 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.8 -178.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.91 -44.97 0.14 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -115.61 74.16 4.5 Favored Pre-proline 0 CA--C 1.548 0.888 0 O-C-N 123.2 0.312 . . . . 0.0 111.408 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.58 -172.05 0.86 Allowed 'Trans proline' 0 C--N 1.366 1.472 0 C-N-CA 122.768 2.312 . . . . 0.0 112.86 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 93.7 m -70.21 -177.62 1.45 Allowed 'General case' 0 CA--C 1.542 0.663 0 O-C-N 123.155 0.284 . . . . 0.0 111.16 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.7 m -84.15 118.46 71.3 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 122.33 0.252 . . . . 0.0 111.325 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -78.49 157.55 28.87 Favored 'Trans proline' 0 C--N 1.369 1.639 0 C-N-CA 122.64 2.227 . . . . 0.0 113.121 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.77 -32.28 5.68 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.845 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.7 mt -84.14 -60.71 2.01 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 122.617 0.367 . . . . 0.0 110.99 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.66 36.4 0.29 Allowed Glycine 0 C--N 1.341 0.848 0 O-C-N 123.442 0.464 . . . . 0.0 113.312 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.71 155.65 18.66 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.866 0.365 . . . . 0.0 111.389 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.73 129.48 20.43 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.305 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.22 123.74 31.06 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.293 0.37 . . . . 0.0 110.796 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.2 mm -123.18 120.4 27.33 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.132 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -73.45 -31.7 5.04 Favored 'Cis proline' 0 C--N 1.372 1.764 0 C-N-CA 124.217 -1.16 . . . . 0.0 113.136 -0.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.685 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.67 -24.84 30.53 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-O 119.432 -0.649 . . . . 0.0 113.79 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.58 112.17 48.67 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 117.22 0.51 . . . . 0.0 111.001 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -69.85 -25.25 8.17 Favored 'Cis proline' 0 C--N 1.378 2.088 0 CA-C-N 119.386 0.817 . . . . 0.0 113.299 -0.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.515 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.27 151.03 29.57 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.832 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.06 -168.58 11.39 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 115.811 -0.632 . . . . 0.0 112.458 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.4 134.6 41.17 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.723 0.296 . . . . 0.0 111.46 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.619 ' SG ' ' HB2' ' A' ' 4' ' ' ALA . 78.9 m -80.32 107.73 13.36 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.329 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -112.51 147.68 36.06 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.727 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.442 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.5 m-85 -78.83 129.43 34.58 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.311 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.156 -0.926 . . . . 0.0 111.44 -179.496 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.134 0 N-CA-C 112.558 -0.217 . . . . 0.0 112.558 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.86 112.98 9.75 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 120.843 0.354 . . . . 0.0 110.382 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.632 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -117.66 148.6 41.82 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.843 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -92.81 172.13 8.54 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.983 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.502 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.9 tt0 -65.16 137.0 57.35 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.796 0.331 . . . . 0.0 110.975 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.88 -5.31 79.69 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.987 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -93.7 156.84 16.47 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 122.648 0.379 . . . . 0.0 110.635 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.548 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 52.3 m -96.86 116.45 29.19 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.185 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.57 154.16 34.32 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.588 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.515 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.0 m-80 -100.84 138.2 38.2 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.782 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.685 HG21 ' O ' ' A' ' 28' ' ' GLY . 33.6 m -91.87 20.3 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 120.983 0.421 . . . . 0.0 111.064 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -112.68 -30.03 7.23 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.802 -178.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.8 -45.01 0.15 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -115.58 74.21 4.46 Favored Pre-proline 0 CA--C 1.548 0.891 0 O-C-N 123.091 0.244 . . . . 0.0 111.334 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.65 -172.12 0.88 Allowed 'Trans proline' 0 C--N 1.367 1.545 0 C-N-CA 122.704 2.269 . . . . 0.0 112.824 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 91.9 m -70.18 -177.54 1.42 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 122.427 0.291 . . . . 0.0 111.145 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 15.1 m -84.22 118.55 71.51 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 122.272 0.229 . . . . 0.0 111.408 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -78.55 157.69 28.66 Favored 'Trans proline' 0 C--N 1.368 1.563 0 C-N-CA 122.73 2.287 . . . . 0.0 113.04 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.64 -32.21 5.69 Favored Glycine 0 C--N 1.337 0.632 0 O-C-N 123.717 0.636 . . . . 0.0 112.916 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.9 mt -84.22 -60.79 1.98 Allowed 'General case' 0 C--O 1.236 0.385 0 C-N-CA 122.645 0.378 . . . . 0.0 110.962 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.78 36.26 0.29 Allowed Glycine 0 C--N 1.341 0.813 0 O-C-N 123.447 0.467 . . . . 0.0 113.279 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.63 155.77 18.61 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.921 0.361 . . . . 0.0 111.413 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.86 129.4 20.19 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.36 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.17 123.68 30.96 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.299 0.374 . . . . 0.0 110.801 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.4 mm -123.22 120.47 27.28 Favored Pre-proline 0 CA--C 1.542 0.649 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.099 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.39 -31.59 5.1 Favored 'Cis proline' 0 C--N 1.371 1.746 0 C-N-CA 124.192 -1.17 . . . . 0.0 113.19 -0.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.685 ' O ' HG21 ' A' ' 12' ' ' VAL . . . 100.51 -24.77 30.83 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 115.747 -0.66 . . . . 0.0 113.891 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.67 112.17 48.44 Favored Pre-proline 0 CA--C 1.542 0.673 0 CA-C-N 117.199 0.499 . . . . 0.0 111.025 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -69.87 -25.25 8.18 Favored 'Cis proline' 0 C--N 1.378 2.088 0 C-N-CA 125.069 -0.804 . . . . 0.0 113.298 -0.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.515 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.24 150.98 29.55 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.782 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.05 -168.43 11.34 Favored Glycine 0 C--N 1.336 0.533 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.461 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.53 134.64 41.21 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.77 0.319 . . . . 0.0 111.436 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.632 ' SG ' ' HB3' ' A' ' 4' ' ' ALA . 79.9 m -80.28 107.76 13.34 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.334 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -112.59 147.76 36.0 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.654 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.441 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.5 m-85 -78.81 129.36 34.52 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.279 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.134 -0.936 . . . . 0.0 111.45 -179.603 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.169 0 N-CA-C 112.587 -0.205 . . . . 0.0 112.587 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.23 113.69 10.85 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.832 0.349 . . . . 0.0 110.45 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.642 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . . . -119.14 146.71 44.91 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.776 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -92.18 173.67 7.7 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.985 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.511 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.5 tt0 -65.22 137.42 57.58 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.792 0.33 . . . . 0.0 111.204 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.84 -5.74 77.57 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 115.254 -0.885 . . . . 0.0 113.085 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -93.47 156.36 16.8 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 122.625 0.37 . . . . 0.0 110.778 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.544 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 53.3 m -96.88 116.2 28.76 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.127 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.17 154.32 33.5 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.673 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.52 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 5.9 m-80 -101.09 138.33 38.28 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.749 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.687 HG21 ' O ' ' A' ' 28' ' ' GLY . 33.6 m -91.9 20.37 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 120.954 0.407 . . . . 0.0 110.99 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -112.58 -29.92 7.3 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.825 -178.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -149.03 -45.2 0.14 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -115.49 74.16 4.3 Favored Pre-proline 0 CA--C 1.548 0.891 0 O-C-N 123.185 0.303 . . . . 0.0 111.369 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.63 -172.03 0.86 Allowed 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 122.73 2.287 . . . . 0.0 112.798 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 95.4 m -70.26 -177.92 1.55 Allowed 'General case' 0 CA--C 1.543 0.701 0 O-C-N 123.128 0.268 . . . . 0.0 111.13 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.6 m -83.94 118.35 71.11 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 122.237 0.215 . . . . 0.0 111.28 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -78.44 157.87 29.11 Favored 'Trans proline' 0 C--N 1.368 1.604 0 C-N-CA 122.679 2.253 . . . . 0.0 113.128 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.49 -32.03 5.75 Favored Glycine 0 C--N 1.338 0.664 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.858 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.2 mt -84.51 -60.59 2.02 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.63 0.372 . . . . 0.0 111.002 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.72 36.04 0.3 Allowed Glycine 0 C--N 1.341 0.813 0 O-C-N 123.425 0.453 . . . . 0.0 113.327 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.67 155.34 18.91 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.866 0.365 . . . . 0.0 111.361 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.9 t -142.29 129.75 21.28 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.357 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.42 123.72 31.19 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.3 0.375 . . . . 0.0 110.808 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.1 mm -123.07 120.48 27.43 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.092 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.5 -31.39 5.24 Favored 'Cis proline' 0 C--N 1.37 1.688 0 C-N-CA 124.166 -1.181 . . . . 0.0 113.175 -0.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.687 ' O ' HG21 ' A' ' 12' ' ' VAL . . . 100.36 -24.59 31.49 Favored Glycine 0 C--N 1.338 0.656 0 CA-C-N 115.75 -0.659 . . . . 0.0 113.891 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -113.7 112.06 48.42 Favored Pre-proline 0 CA--C 1.543 0.673 0 CA-C-N 117.218 0.509 . . . . 0.0 111.079 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -69.77 -25.35 8.07 Favored 'Cis proline' 0 C--N 1.378 2.106 0 CA-C-N 119.404 0.823 . . . . 0.0 113.313 -0.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.52 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.13 151.18 29.86 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.744 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.544 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.22 -168.67 11.43 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.429 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.33 134.67 41.02 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 120.769 0.319 . . . . 0.0 111.489 -179.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.642 ' SG ' ' HB2' ' A' ' 4' ' ' ALA . 77.9 m -80.24 107.98 13.47 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.3 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -112.82 147.42 36.98 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.769 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.442 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.5 m-85 -78.68 129.75 35.07 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.286 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.137 -0.935 . . . . 0.0 111.429 -179.508 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 0.118 0 N-CA-C 112.578 -0.209 . . . . 0.0 112.578 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.67 113.36 10.23 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 120.77 0.319 . . . . 0.0 110.414 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.615 ' HB1' ' SG ' ' A' ' 34' ' ' CYS . . . -117.99 148.32 42.33 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.887 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -92.4 172.32 8.47 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.971 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.9 tt0 -65.36 137.07 57.26 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.767 0.318 . . . . 0.0 111.056 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.92 -5.3 79.84 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 115.311 -0.859 . . . . 0.0 113.038 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -93.46 156.97 16.45 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 122.66 0.384 . . . . 0.0 110.656 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.55 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.1 t -96.94 115.91 28.27 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.085 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.507 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.04 154.02 33.78 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.629 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.516 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.1 m-80 -100.8 138.25 38.11 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.784 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.686 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -91.99 20.5 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.032 0.444 . . . . 0.0 111.072 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -112.82 -30.0 7.2 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.796 -178.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -148.9 -45.07 0.14 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -178.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -115.57 74.2 4.44 Favored Pre-proline 0 CA--C 1.547 0.852 0 O-C-N 123.053 0.22 . . . . 0.0 111.37 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.67 -172.03 0.86 Allowed 'Trans proline' 0 C--N 1.367 1.535 0 C-N-CA 122.758 2.305 . . . . 0.0 112.8 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.507 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 93.2 m -70.22 -177.62 1.46 Allowed 'General case' 0 CA--C 1.542 0.663 0 O-C-N 123.152 0.282 . . . . 0.0 111.126 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.9 m -84.26 118.56 71.5 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 122.29 0.236 . . . . 0.0 111.379 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.51 157.85 28.85 Favored 'Trans proline' 0 C--N 1.37 1.658 0 C-N-CA 122.606 2.204 . . . . 0.0 113.073 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.53 -32.22 5.65 Favored Glycine 0 C--N 1.338 0.659 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.897 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.5 mt -84.19 -60.42 2.1 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 122.693 0.397 . . . . 0.0 111.023 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.19 36.42 0.3 Allowed Glycine 0 C--N 1.341 0.831 0 O-C-N 123.413 0.445 . . . . 0.0 113.248 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.51 155.72 18.69 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.891 0.345 . . . . 0.0 111.455 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.74 129.39 20.32 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.32 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.21 123.74 31.06 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.253 0.346 . . . . 0.0 110.843 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.2 mm -123.26 120.39 27.25 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.087 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.34 -31.74 5.01 Favored 'Cis proline' 0 C--N 1.371 1.75 0 C-N-CA 124.188 -1.172 . . . . 0.0 113.201 -0.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.686 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.66 -24.85 30.49 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-N 115.747 -0.66 . . . . 0.0 113.805 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -113.61 112.22 48.56 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 117.253 0.527 . . . . 0.0 111.057 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.87 -25.18 8.22 Favored 'Cis proline' 0 C--N 1.378 2.088 0 C-N-CA 125.038 -0.818 . . . . 0.0 113.278 -0.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.516 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.1 p30 -153.34 150.93 29.39 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.814 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.55 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -139.95 -168.43 11.33 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.5 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.5 134.56 41.29 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.731 0.3 . . . . 0.0 111.494 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.615 ' SG ' ' HB1' ' A' ' 4' ' ' ALA . 79.7 m -80.27 107.67 13.26 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.392 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -112.43 147.43 36.48 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.744 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.44 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.67 129.4 34.68 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.322 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--O 1.252 1.189 0 CA-C-O 118.483 -0.77 . . . . 0.0 111.511 -179.539 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.193 0 N-CA-C 112.563 -0.215 . . . . 0.0 112.563 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.62 113.31 10.21 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 120.708 0.29 . . . . 0.0 110.472 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.611 ' HB1' ' SG ' ' A' ' 34' ' ' CYS . . . -117.99 148.33 42.32 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.847 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -92.3 172.33 8.47 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.999 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.7 tt0 -65.42 137.03 57.2 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.771 0.32 . . . . 0.0 111.046 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.89 -5.21 80.15 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.982 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -93.46 157.07 16.4 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 122.711 0.404 . . . . 0.0 110.712 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.55 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.6 t -96.97 115.86 28.18 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.961 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.508 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.04 153.84 34.09 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.601 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.515 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.1 m-80 -100.72 138.24 38.04 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.794 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.684 HG21 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -91.93 20.46 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.97 0.414 . . . . 0.0 111.086 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.86 -30.01 7.19 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.764 -178.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.84 -45.13 0.15 Allowed 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -178.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -115.55 74.18 4.4 Favored Pre-proline 0 CA--C 1.547 0.855 0 O-C-N 123.088 0.243 . . . . 0.0 111.319 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.5 -171.99 0.84 Allowed 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 122.741 2.294 . . . . 0.0 112.907 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.508 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 93.0 m -70.29 -177.58 1.47 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 122.431 0.293 . . . . 0.0 111.152 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.9 m -84.31 118.48 71.3 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 122.328 0.251 . . . . 0.0 111.384 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -78.46 157.83 29.02 Favored 'Trans proline' 0 C--N 1.368 1.599 0 C-N-CA 122.711 2.274 . . . . 0.0 113.044 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.52 -32.27 5.62 Favored Glycine 0 C--N 1.338 0.669 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.895 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.5 mt -84.12 -60.44 2.09 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 122.706 0.403 . . . . 0.0 111.024 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.22 36.37 0.3 Allowed Glycine 0 C--N 1.341 0.86 0 O-C-N 123.476 0.485 . . . . 0.0 113.251 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -90.54 155.63 18.75 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.903 0.383 . . . . 0.0 111.426 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.9 t -142.53 129.23 20.4 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.345 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.08 123.77 30.99 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 123.217 0.323 . . . . 0.0 110.785 179.852 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.2 mm -123.22 120.41 27.29 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.126 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.38 -31.73 5.01 Favored 'Cis proline' 0 C--N 1.371 1.75 0 C-N-CA 124.159 -1.184 . . . . 0.0 113.146 -0.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.684 ' O ' HG21 ' A' ' 12' ' ' VAL . . . 100.71 -25.03 29.86 Favored Glycine 0 C--N 1.338 0.677 0 CA-C-N 115.694 -0.685 . . . . 0.0 113.767 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -113.5 112.18 48.9 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 117.235 0.517 . . . . 0.0 111.023 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -69.96 -25.04 8.35 Favored 'Cis proline' 0 C--N 1.379 2.148 0 C-N-CA 124.995 -0.835 . . . . 0.0 113.367 -0.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.515 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.1 p-10 -153.49 150.96 29.29 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.803 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.55 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.08 -168.45 11.34 Favored Glycine 0 C--N 1.335 0.519 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.492 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.44 134.63 41.16 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 120.77 0.319 . . . . 0.0 111.446 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.611 ' SG ' ' HB1' ' A' ' 4' ' ' ALA . 78.2 m -80.39 107.71 13.42 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.319 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -112.38 147.42 36.45 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.693 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.44 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.5 m-85 -78.56 129.5 34.89 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.356 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.5 mt . . . . . 0 C--O 1.252 1.201 0 CA-C-O 118.526 -0.749 . . . . 0.0 111.474 -179.57 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.191 0 CA-C-O 120.263 -0.187 . . . . 0.0 112.73 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -138.84 113.87 9.36 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.777 0.323 . . . . 0.0 110.482 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.603 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -117.17 147.97 42.0 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.904 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -92.67 172.74 8.17 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.027 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.6 tt0 -65.81 137.3 57.14 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.8 0.334 . . . . 0.0 110.951 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.81 -5.29 79.54 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 115.267 -0.879 . . . . 0.0 113.023 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -93.77 157.01 16.35 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 122.651 0.38 . . . . 0.0 110.733 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.55 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 52.7 m -96.75 116.07 28.51 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.182 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.05 153.93 33.95 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.656 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.516 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.1 m-80 -100.71 138.26 38.0 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.824 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.685 HG23 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -91.98 20.47 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.912 0.387 . . . . 0.0 110.967 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.85 -29.79 7.27 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.817 -178.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -149.09 -45.01 0.14 Allowed 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -115.67 74.13 4.59 Favored Pre-proline 0 CA--C 1.548 0.884 0 O-C-N 123.193 0.308 . . . . 0.0 111.304 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.65 -171.92 0.84 Allowed 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 122.739 2.293 . . . . 0.0 112.892 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 95.3 m -70.16 -177.84 1.49 Allowed 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.163 0.289 . . . . 0.0 111.082 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.5 m -83.84 118.46 71.45 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 122.294 0.238 . . . . 0.0 111.367 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -78.53 157.25 28.67 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.681 2.254 . . . . 0.0 113.065 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.94 -32.22 5.76 Favored Glycine 0 C--N 1.338 0.64 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.891 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.8 mt -84.17 -60.61 2.04 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 122.674 0.389 . . . . 0.0 110.993 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.49 36.4 0.29 Allowed Glycine 0 C--N 1.34 0.794 0 O-C-N 123.489 0.493 . . . . 0.0 113.249 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.61 155.71 18.66 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.884 0.374 . . . . 0.0 111.379 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.7 129.42 20.41 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.301 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.2 123.74 31.05 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.275 0.359 . . . . 0.0 110.794 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.1 mm -123.23 120.42 27.28 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.149 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.29 -31.84 4.94 Favored 'Cis proline' 0 C--N 1.371 1.717 0 C-N-CA 124.166 -1.181 . . . . 0.0 113.155 -0.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.685 ' O ' HG23 ' A' ' 12' ' ' VAL . . . 100.69 -24.83 30.56 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-O 119.413 -0.659 . . . . 0.0 113.878 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -113.58 112.13 48.7 Favored Pre-proline 0 CA--C 1.543 0.705 0 CA-C-N 117.239 0.52 . . . . 0.0 111.072 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -69.91 -25.26 8.19 Favored 'Cis proline' 0 C--N 1.377 2.032 0 CA-C-N 119.386 0.816 . . . . 0.0 113.251 -0.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.516 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.28 151.0 29.52 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.84 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.55 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -139.89 -168.43 11.32 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.522 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.59 134.62 41.27 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 120.733 0.302 . . . . 0.0 111.38 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.603 ' SG ' ' HB3' ' A' ' 4' ' ' ALA . 76.5 m -80.38 107.82 13.49 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.398 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -112.51 147.36 36.74 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.72 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.441 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.62 129.5 34.84 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.256 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.08 -0.962 . . . . 0.0 111.466 -179.547 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.187 0 CA-C-O 120.249 -0.195 . . . . 0.0 112.857 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -141.26 113.07 7.74 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 120.724 0.297 . . . . 0.0 110.592 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.644 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . . . -116.57 149.11 40.17 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.846 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -93.8 171.66 8.73 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.502 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.8 tt0 -65.02 136.8 57.21 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 122.482 0.313 . . . . 0.0 111.002 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.9 -5.0 81.13 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.966 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -94.02 157.13 16.24 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 122.673 0.389 . . . . 0.0 110.672 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 52.3 m -96.85 116.76 29.72 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.194 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.512 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.84 154.03 34.91 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.622 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.515 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.1 m-80 -100.77 138.19 38.15 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.719 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.684 HG21 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -91.87 20.24 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 120.909 0.385 . . . . 0.0 111.097 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.79 -29.93 7.24 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.842 -178.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -148.91 -44.96 0.14 Allowed 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -115.45 73.99 4.17 Favored Pre-proline 0 CA--C 1.548 0.894 0 O-C-N 123.149 0.281 . . . . 0.0 111.375 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.66 -172.3 0.91 Allowed 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 122.743 2.295 . . . . 0.0 112.918 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.512 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 90.6 m -70.32 -177.1 1.34 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 122.408 0.283 . . . . 0.0 111.137 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 16.0 m -84.56 118.47 71.16 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 122.354 0.262 . . . . 0.0 111.274 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -78.57 157.65 28.59 Favored 'Trans proline' 0 C--N 1.368 1.587 0 C-N-CA 122.711 2.274 . . . . 0.0 113.053 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.6 -32.16 5.7 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.89 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.7 mt -84.1 -60.76 2.0 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.643 0.377 . . . . 0.0 111.025 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.78 36.43 0.28 Allowed Glycine 0 C--N 1.341 0.835 0 O-C-N 123.461 0.476 . . . . 0.0 113.218 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.66 155.71 18.64 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.946 0.373 . . . . 0.0 111.427 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.69 129.34 20.33 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.305 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.11 123.68 30.91 Favored 'General case' 0 C--O 1.236 0.391 0 O-C-N 123.201 0.313 . . . . 0.0 110.825 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.3 mm -123.22 120.37 27.3 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.121 -178.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.34 -31.72 5.02 Favored 'Cis proline' 0 C--N 1.371 1.746 0 C-N-CA 124.223 -1.157 . . . . 0.0 113.226 -0.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.684 ' O ' HG21 ' A' ' 12' ' ' VAL . . . 100.6 -25.03 29.82 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.854 179.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -113.54 112.1 48.83 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 117.237 0.519 . . . . 0.0 111.025 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -69.94 -25.14 8.28 Favored 'Cis proline' 0 C--N 1.379 2.147 0 C-N-CA 124.993 -0.836 . . . . 0.0 113.359 -0.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.515 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.39 151.0 29.43 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.784 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.546 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.08 -168.44 11.34 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.499 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.5 134.51 41.37 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 120.717 0.294 . . . . 0.0 111.487 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.644 ' SG ' ' HB2' ' A' ' 4' ' ' ALA . 83.1 m -80.25 107.62 13.2 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.374 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -112.41 147.72 35.85 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.687 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.438 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.5 m-85 -78.82 129.54 34.72 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.308 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.4 mt . . . . . 0 C--O 1.251 1.165 0 CA-C-O 118.46 -0.781 . . . . 0.0 111.474 -179.542 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.234 0 N-CA-C 112.702 -0.159 . . . . 0.0 112.702 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -138.3 113.82 9.64 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 120.764 0.316 . . . . 0.0 110.479 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.601 ' HB1' ' SG ' ' A' ' 34' ' ' CYS . . . -117.29 147.81 42.24 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.828 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -92.43 172.65 8.25 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.023 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.498 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.3 tt0 -65.63 137.44 57.34 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.822 0.344 . . . . 0.0 111.023 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.8 -5.37 79.11 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.941 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -93.84 157.03 16.33 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 122.639 0.376 . . . . 0.0 110.662 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.553 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 52.6 m -96.69 115.91 28.24 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.209 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.504 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -118.95 153.88 33.9 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.614 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.516 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.0 m-80 -100.68 138.15 38.13 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.814 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.686 HG21 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -91.91 20.42 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.904 0.383 . . . . 0.0 110.982 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.79 -29.93 7.23 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.764 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.95 -45.12 0.14 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -115.64 74.17 4.54 Favored Pre-proline 0 CA--C 1.548 0.884 0 O-C-N 123.152 0.282 . . . . 0.0 111.32 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.68 -171.93 0.85 Allowed 'Trans proline' 0 C--N 1.367 1.543 0 C-N-CA 122.68 2.253 . . . . 0.0 112.829 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.504 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 94.7 m -70.15 -177.78 1.48 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 122.366 0.267 . . . . 0.0 111.151 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.6 m -83.86 118.47 71.45 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 122.267 0.227 . . . . 0.0 111.373 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.54 157.23 28.66 Favored 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 122.715 2.277 . . . . 0.0 113.095 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.98 -32.2 5.79 Favored Glycine 0 C--N 1.339 0.702 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.854 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.8 mt -84.26 -60.53 2.06 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 122.606 0.362 . . . . 0.0 110.964 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.47 36.33 0.3 Allowed Glycine 0 C--N 1.341 0.828 0 O-C-N 123.472 0.482 . . . . 0.0 113.298 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.52 155.68 18.72 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.836 0.35 . . . . 0.0 111.38 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.66 129.43 20.46 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.32 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.22 123.73 31.05 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 123.258 0.349 . . . . 0.0 110.866 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.9 mm -123.22 120.45 27.28 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.145 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.18 -31.84 4.93 Favored 'Cis proline' 0 C--N 1.372 1.781 0 C-N-CA 124.21 -1.162 . . . . 0.0 113.208 -0.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.686 ' O ' HG21 ' A' ' 12' ' ' VAL . . . 100.7 -24.85 30.51 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-N 115.75 -0.659 . . . . 0.0 113.898 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -113.7 112.2 48.34 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 117.174 0.487 . . . . 0.0 111.003 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -69.85 -25.28 8.15 Favored 'Cis proline' 0 C--N 1.377 2.051 0 C-N-CA 125.071 -0.804 . . . . 0.0 113.327 -0.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.516 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.29 151.0 29.52 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.803 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.553 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -139.94 -168.49 11.34 Favored Glycine 0 C--N 1.335 0.521 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.505 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.44 134.63 41.15 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.762 0.315 . . . . 0.0 111.403 -179.924 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.601 ' SG ' ' HB1' ' A' ' 4' ' ' ALA . 76.6 m -80.36 107.77 13.42 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.333 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -112.55 147.24 37.03 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.745 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.443 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.53 129.51 34.92 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.368 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--O 1.252 1.203 0 CA-C-O 118.526 -0.749 . . . . 0.0 111.425 -179.5 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.177 0 N-CA-C 112.639 -0.184 . . . . 0.0 112.639 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -137.5 113.38 9.72 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.751 0.31 . . . . 0.0 110.408 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.635 ' HB1' ' SG ' ' A' ' 34' ' ' CYS . . . -118.08 148.63 42.1 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.914 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -93.28 173.49 7.69 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.953 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.504 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 24.0 tt0 -66.04 136.86 56.6 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.507 0.323 . . . . 0.0 111.053 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.89 -5.23 80.05 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 115.331 -0.85 . . . . 0.0 113.008 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -93.54 156.79 16.54 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 122.715 0.406 . . . . 0.0 110.624 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.547 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 16.8 t -97.03 116.61 29.53 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.044 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.5 p -119.72 154.26 34.39 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.647 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.514 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.0 m-80 -100.89 138.28 38.15 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.734 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.683 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -91.99 20.33 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.976 0.417 . . . . 0.0 111.06 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.8 -29.92 7.24 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.833 -178.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.82 -45.02 0.15 Allowed 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -115.57 74.27 4.47 Favored Pre-proline 0 CA--C 1.548 0.888 0 O-C-N 123.178 0.299 . . . . 0.0 111.389 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.68 -172.28 0.91 Allowed 'Trans proline' 0 C--N 1.368 1.574 0 C-N-CA 122.753 2.302 . . . . 0.0 112.825 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 92.5 m -69.96 -177.73 1.4 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 122.511 0.324 . . . . 0.0 111.184 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.1 m -84.56 119.06 72.47 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 122.324 0.25 . . . . 0.0 111.342 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -78.6 159.05 28.63 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 122.657 2.238 . . . . 0.0 113.052 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.65 -31.96 5.56 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.864 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.6 mt -84.7 -60.25 2.12 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 122.643 0.377 . . . . 0.0 111.008 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.46 36.78 0.32 Allowed Glycine 0 C--N 1.341 0.859 0 O-C-N 123.379 0.424 . . . . 0.0 113.268 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -90.4 155.87 18.63 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.935 0.368 . . . . 0.0 111.369 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.78 129.18 20.05 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.381 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.0 123.72 30.88 Favored 'General case' 0 C--O 1.235 0.342 0 O-C-N 123.256 0.347 . . . . 0.0 110.84 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.1 mm -123.19 120.32 27.35 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.18 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.39 -31.7 5.03 Favored 'Cis proline' 0 C--N 1.37 1.7 0 C-N-CA 124.242 -1.149 . . . . 0.0 113.105 -0.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.683 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.51 -24.87 30.44 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-N 115.778 -0.646 . . . . 0.0 113.824 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -113.63 112.15 48.54 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 117.17 0.485 . . . . 0.0 111.008 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -69.9 -25.25 8.19 Favored 'Cis proline' 0 C--N 1.378 2.092 0 C-N-CA 125.061 -0.808 . . . . 0.0 113.335 -0.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.514 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.35 151.04 29.51 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.803 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.11 -168.5 11.36 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.524 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.33 134.58 41.15 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 120.682 0.277 . . . . 0.0 111.506 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.635 ' SG ' ' HB1' ' A' ' 4' ' ' ALA . 79.2 m -80.29 107.69 13.29 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.366 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -112.59 147.11 37.34 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.761 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.435 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.3 m-85 -78.31 129.5 35.1 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.364 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.7 mt . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.487 -0.768 . . . . 0.0 111.481 -179.519 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.139 0 N-CA-C 112.586 -0.206 . . . . 0.0 112.586 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -137.75 113.08 9.33 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 120.771 0.32 . . . . 0.0 110.406 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.628 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -116.85 148.74 40.99 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.934 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -93.26 169.22 10.55 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.637 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.5 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.9 tt0 -62.89 136.94 58.11 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.78 0.324 . . . . 0.0 111.124 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.05 -5.25 80.52 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.993 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -93.83 157.08 16.31 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 122.707 0.403 . . . . 0.0 110.604 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.551 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 53.1 m -96.82 116.05 28.48 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.171 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.508 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.18 153.93 34.12 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.618 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.513 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.0 m-80 -100.69 138.23 38.03 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.827 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.685 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.6 m -91.87 20.31 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 120.941 0.401 . . . . 0.0 111.081 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -112.78 -29.86 7.26 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.819 -178.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.98 -45.01 0.14 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -115.59 74.2 4.48 Favored Pre-proline 0 CA--C 1.548 0.89 0 O-C-N 123.108 0.255 . . . . 0.0 111.291 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.68 -172.04 0.87 Allowed 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 122.739 2.293 . . . . 0.0 112.83 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.508 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 93.6 m -70.33 -177.44 1.44 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 122.428 0.291 . . . . 0.0 111.08 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 15.9 m -84.04 118.31 70.96 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 122.305 0.242 . . . . 0.0 111.312 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -78.54 157.4 28.67 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 122.668 2.246 . . . . 0.0 113.088 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.79 -32.19 5.74 Favored Glycine 0 C--N 1.338 0.666 0 CA-C-N 115.976 -0.557 . . . . 0.0 112.893 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.6 mt -84.14 -60.52 2.07 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.66 0.384 . . . . 0.0 111.046 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.61 36.19 0.3 Allowed Glycine 0 C--N 1.341 0.828 0 O-C-N 123.408 0.443 . . . . 0.0 113.315 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.52 155.67 18.72 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.869 0.334 . . . . 0.0 111.409 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.71 129.41 20.38 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.317 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.18 123.76 31.06 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 123.264 0.353 . . . . 0.0 110.811 179.853 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.1 mm -123.18 120.32 27.36 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.121 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -73.37 -31.72 5.02 Favored 'Cis proline' 0 C--N 1.371 1.731 0 C-N-CA 124.165 -1.181 . . . . 0.0 113.141 -0.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.685 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.63 -24.92 30.24 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-O 119.381 -0.677 . . . . 0.0 113.841 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.59 112.16 48.66 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 117.241 0.521 . . . . 0.0 111.021 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -69.96 -25.2 8.25 Favored 'Cis proline' 0 C--N 1.376 2.026 0 CA-C-N 119.343 0.801 . . . . 0.0 113.248 -0.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.513 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.34 150.97 29.43 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 123.543 0.527 . . . . 0.0 110.808 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -139.98 -168.41 11.32 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.424 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.58 134.58 41.32 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 120.758 0.313 . . . . 0.0 111.399 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.628 ' SG ' ' HB3' ' A' ' 4' ' ' ALA . 80.1 m -80.31 107.85 13.44 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.35 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -112.55 147.5 36.49 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.736 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.442 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.73 129.37 34.6 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.299 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.424 -0.798 . . . . 0.0 111.517 -179.622 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 0.155 0 CA-C-O 120.319 -0.156 . . . . 0.0 112.764 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.4 t -137.1 112.01 8.92 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.912 0.387 . . . . 0.0 110.927 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.606 ' HB1' ' SG ' ' A' ' 34' ' ' CYS . . . -118.41 148.82 42.15 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.668 179.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -91.84 169.85 10.36 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.14 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.502 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 22.5 tt0 -63.98 137.14 57.87 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 120.732 0.301 . . . . 0.0 111.055 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.01 -5.01 81.4 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.959 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -93.95 157.69 15.99 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 122.688 0.395 . . . . 0.0 110.663 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.552 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.9 t -97.16 115.73 28.08 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.999 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.517 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.3 p -118.83 153.66 34.13 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.566 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.513 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 5.7 m-80 -100.73 138.37 37.88 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.754 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.683 HG21 ' O ' ' A' ' 28' ' ' GLY . 33.8 m -92.11 20.19 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 120.928 0.394 . . . . 0.0 110.994 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.85 -29.91 7.23 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.807 -178.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -149.03 -44.75 0.14 Allowed 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -115.47 73.92 4.18 Favored Pre-proline 0 CA--C 1.548 0.878 0 O-C-N 123.21 0.319 . . . . 0.0 111.429 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.53 -172.53 0.94 Allowed 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.826 2.351 . . . . 0.0 113.037 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.517 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 87.8 m -70.77 -176.26 1.28 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 122.395 0.278 . . . . 0.0 111.123 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 17.8 m -85.53 118.53 70.86 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 122.361 0.264 . . . . 0.0 111.342 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -78.62 158.34 28.49 Favored 'Trans proline' 0 C--N 1.37 1.662 0 C-N-CA 122.663 2.242 . . . . 0.0 112.939 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.14 -32.57 5.35 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.845 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.8 mt -83.71 -60.34 2.15 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 122.696 0.398 . . . . 0.0 110.978 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.2 36.47 0.3 Allowed Glycine 0 C--N 1.34 0.798 0 O-C-N 123.378 0.424 . . . . 0.0 113.303 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.63 155.61 18.72 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.826 0.346 . . . . 0.0 111.41 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.9 t -142.87 129.26 20.03 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.307 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.09 123.73 30.95 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 123.28 0.362 . . . . 0.0 110.823 179.838 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.8 mm -123.2 120.38 27.32 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.223 -178.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.32 -31.72 5.02 Favored 'Cis proline' 0 C--N 1.37 1.704 0 C-N-CA 124.196 -1.168 . . . . 0.0 113.178 -0.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.683 ' O ' HG21 ' A' ' 12' ' ' VAL . . . 100.5 -24.88 30.41 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.848 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -113.64 112.21 48.48 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 117.213 0.507 . . . . 0.0 111.005 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.82 -25.25 8.16 Favored 'Cis proline' 0 C--N 1.377 2.05 0 CA-C-N 119.381 0.815 . . . . 0.0 113.328 -0.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.513 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.1 p-10 -153.37 151.05 29.5 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.745 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.552 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.22 -168.44 11.35 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.441 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.7 OUTLIER -98.58 134.51 41.43 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 120.714 0.292 . . . . 0.0 111.501 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.606 ' SG ' ' HB1' ' A' ' 4' ' ' ALA . 89.4 m -80.16 107.7 13.17 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.287 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -112.41 147.44 36.44 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.86 -1.063 . . . . 0.0 110.698 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.44 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.71 129.63 34.9 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.315 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.1 mt . . . . . 0 C--O 1.25 1.113 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.46 -179.555 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.188 0 CA-C-O 120.298 -0.168 . . . . 0.0 112.773 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.6 t -139.37 112.62 8.18 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 120.735 0.303 . . . . 0.0 110.508 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.643 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . . . -116.38 149.65 39.02 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.947 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -93.92 168.87 10.69 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.695 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.5 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 24.3 tt0 -62.99 136.71 57.98 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.763 0.316 . . . . 0.0 111.082 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.06 -4.99 81.63 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.939 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -93.97 157.19 16.23 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 122.651 0.38 . . . . 0.0 110.634 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.551 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 53.5 m -96.72 116.41 29.09 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.26 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.512 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.48 153.97 34.48 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.607 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.513 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 5.9 m-80 -100.77 138.24 38.09 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.771 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -92.05 20.34 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.973 0.416 . . . . 0.0 111.074 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.77 -30.01 7.21 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.835 -178.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.81 -45.01 0.15 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -115.42 74.05 4.13 Favored Pre-proline 0 CA--C 1.547 0.858 0 O-C-N 123.188 0.305 . . . . 0.0 111.351 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.6 -172.43 0.93 Allowed 'Trans proline' 0 C--N 1.367 1.545 0 C-N-CA 122.839 2.359 . . . . 0.0 112.902 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.512 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 89.7 m -70.22 -177.06 1.31 Allowed 'General case' 0 CA--C 1.542 0.665 0 O-C-N 123.194 0.309 . . . . 0.0 111.166 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 16.5 m -84.42 118.33 70.88 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 122.324 0.25 . . . . 0.0 111.343 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.45 157.61 29.02 Favored 'Trans proline' 0 C--N 1.369 1.634 0 C-N-CA 122.673 2.249 . . . . 0.0 113.117 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.69 -32.09 5.77 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.889 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.6 mt -84.23 -60.47 2.08 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.614 0.366 . . . . 0.0 110.965 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.39 36.33 0.3 Allowed Glycine 0 C--N 1.341 0.857 0 O-C-N 123.458 0.474 . . . . 0.0 113.269 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.39 155.65 18.8 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.908 0.354 . . . . 0.0 111.391 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.74 129.18 20.1 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.341 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.03 123.63 30.8 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 123.273 0.358 . . . . 0.0 110.824 179.865 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.4 mm -123.16 120.36 27.36 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.102 -178.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.35 -31.8 4.97 Favored 'Cis proline' 0 C--N 1.372 1.791 0 C-N-CA 124.169 -1.179 . . . . 0.0 113.129 -0.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.683 ' O ' HG23 ' A' ' 12' ' ' VAL . . . 100.66 -24.93 30.22 Favored Glycine 0 C--N 1.338 0.69 0 CA-C-N 115.691 -0.686 . . . . 0.0 113.877 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -113.54 112.09 48.85 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 117.209 0.505 . . . . 0.0 111.053 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -69.89 -25.27 8.17 Favored 'Cis proline' 0 C--N 1.378 2.084 0 CA-C-N 119.437 0.835 . . . . 0.0 113.304 -0.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.513 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.24 150.99 29.56 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.821 179.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.05 -168.32 11.3 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.501 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.6 134.45 41.53 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 120.689 0.281 . . . . 0.0 111.452 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.643 ' SG ' ' HB2' ' A' ' 4' ' ' ALA . 83.4 m -80.35 107.7 13.36 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.292 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -112.47 147.42 36.56 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.689 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.439 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.6 129.41 34.75 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.332 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.122 -0.942 . . . . 0.0 111.507 -179.567 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.127 0 N-CA-C 112.55 -0.22 . . . . 0.0 112.55 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -135.58 113.26 10.89 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 120.734 0.302 . . . . 0.0 110.432 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.584 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -118.12 147.9 42.85 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.835 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -91.63 172.12 8.71 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.041 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.5 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.4 tt0 -65.4 137.49 57.51 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.833 0.349 . . . . 0.0 111.024 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.75 -5.2 79.75 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 115.32 -0.855 . . . . 0.0 113.025 -179.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -93.66 157.2 16.29 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 122.719 0.408 . . . . 0.0 110.63 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.555 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.3 t -96.86 115.43 27.41 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.98 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.507 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -118.6 153.73 33.79 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.591 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.514 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.0 m-80 -100.7 138.2 38.07 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.808 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.686 HG21 ' O ' ' A' ' 28' ' ' GLY . 33.6 m -91.89 20.32 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 120.9 0.381 . . . . 0.0 111.071 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.76 -29.95 7.24 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.803 -178.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -148.94 -45.0 0.14 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -178.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -115.63 74.22 4.56 Favored Pre-proline 0 CA--C 1.548 0.89 0 O-C-N 123.196 0.31 . . . . 0.0 111.34 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.71 -171.98 0.86 Allowed 'Trans proline' 0 C--N 1.367 1.527 0 C-N-CA 122.745 2.296 . . . . 0.0 112.827 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.507 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 92.7 m -70.32 -177.51 1.46 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 122.39 0.276 . . . . 0.0 111.123 179.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.8 m -84.31 118.49 71.3 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 122.369 0.268 . . . . 0.0 111.373 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.43 157.88 29.13 Favored 'Trans proline' 0 C--N 1.37 1.665 0 C-N-CA 122.695 2.263 . . . . 0.0 113.066 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.52 -32.28 5.61 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.894 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.7 mt -84.18 -60.31 2.13 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 122.685 0.394 . . . . 0.0 110.934 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.01 36.36 0.31 Allowed Glycine 0 C--N 1.341 0.847 0 O-C-N 123.406 0.441 . . . . 0.0 113.321 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.39 155.69 18.77 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.868 0.366 . . . . 0.0 111.418 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.77 129.28 20.17 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.325 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.08 123.77 30.98 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 123.291 0.369 . . . . 0.0 110.785 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.3 mm -123.3 120.39 27.22 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.104 -178.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.3 -31.84 4.94 Favored 'Cis proline' 0 C--N 1.371 1.75 0 C-N-CA 124.222 -1.158 . . . . 0.0 113.148 -0.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.686 ' O ' HG21 ' A' ' 12' ' ' VAL . . . 100.73 -24.85 30.51 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-O 119.412 -0.66 . . . . 0.0 113.852 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -113.65 112.16 48.49 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 117.158 0.479 . . . . 0.0 110.982 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -69.95 -25.13 8.29 Favored 'Cis proline' 0 C--N 1.379 2.152 0 C-N-CA 125.024 -0.823 . . . . 0.0 113.249 -0.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.514 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p30 -153.39 151.03 29.45 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.767 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.555 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.02 -168.42 11.33 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.484 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.51 134.6 41.25 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.726 0.298 . . . . 0.0 111.359 -179.864 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.584 ' SG ' ' HB3' ' A' ' 4' ' ' ALA . 81.3 m -80.3 107.66 13.28 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.361 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -112.46 147.12 37.17 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.733 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.442 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.47 129.45 34.9 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.24 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.129 -0.938 . . . . 0.0 111.498 -179.597 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.135 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -137.45 113.08 9.5 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 120.815 0.34 . . . . 0.0 110.425 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.635 ' HB1' ' SG ' ' A' ' 34' ' ' CYS . . . -117.07 148.65 41.33 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.895 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -93.38 169.54 10.29 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.727 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.5 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.7 tt0 -62.94 137.05 58.16 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 120.87 0.367 . . . . 0.0 111.078 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.06 -5.44 79.71 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.956 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -93.53 157.01 16.41 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 122.702 0.401 . . . . 0.0 110.635 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.55 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.2 t -97.03 115.99 28.43 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.995 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.509 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.07 154.03 33.81 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.631 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.516 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.1 m-80 -100.78 138.27 38.05 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.823 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.685 HG21 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -91.95 20.39 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.015 0.436 . . . . 0.0 111.064 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -112.67 -29.9 7.28 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.818 -178.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -149.02 -45.05 0.14 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -115.58 74.1 4.42 Favored Pre-proline 0 CA--C 1.548 0.888 0 O-C-N 123.126 0.266 . . . . 0.0 111.362 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.65 -172.04 0.86 Allowed 'Trans proline' 0 C--N 1.368 1.557 0 C-N-CA 122.743 2.295 . . . . 0.0 112.795 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.509 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 92.4 m -70.23 -177.41 1.4 Allowed 'General case' 0 CA--C 1.543 0.676 0 O-C-N 123.142 0.276 . . . . 0.0 111.161 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 15.6 m -84.11 118.29 70.88 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 122.345 0.258 . . . . 0.0 111.277 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -78.49 157.51 28.86 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 122.593 2.195 . . . . 0.0 113.081 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.77 -32.15 5.75 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.875 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.6 mt -84.26 -60.76 1.99 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 122.607 0.363 . . . . 0.0 110.992 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 133.0 36.15 0.28 Allowed Glycine 0 C--N 1.34 0.779 0 O-C-N 123.475 0.484 . . . . 0.0 113.271 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.63 155.45 18.84 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.91 0.355 . . . . 0.0 111.366 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.9 t -142.55 129.56 20.73 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.384 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.2 123.72 31.03 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.227 0.329 . . . . 0.0 110.807 179.853 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.0 mm -123.23 120.46 27.27 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.062 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.23 -31.83 4.94 Favored 'Cis proline' 0 C--N 1.372 1.781 0 C-N-CA 124.131 -1.196 . . . . 0.0 113.208 -0.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.685 ' O ' HG21 ' A' ' 12' ' ' VAL . . . 100.76 -24.89 30.37 Favored Glycine 0 C--N 1.338 0.667 0 CA-C-N 115.712 -0.677 . . . . 0.0 113.844 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.58 112.16 48.69 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 117.209 0.504 . . . . 0.0 111.026 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -69.85 -25.25 8.17 Favored 'Cis proline' 0 C--N 1.378 2.088 0 CA-C-N 119.372 0.811 . . . . 0.0 113.347 -0.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.516 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.3 151.01 29.52 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.774 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.55 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.02 -168.52 11.36 Favored Glycine 0 C--N 1.336 0.545 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.393 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.41 134.72 41.02 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 120.719 0.295 . . . . 0.0 111.499 -179.977 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.635 ' SG ' ' HB1' ' A' ' 4' ' ' ALA . 79.4 m -80.44 107.84 13.57 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.325 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -112.54 147.65 36.15 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.758 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.442 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.84 129.44 34.59 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.274 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.485 -0.769 . . . . 0.0 111.473 -179.575 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.2 0 CA-C-O 120.302 -0.166 . . . . 0.0 112.789 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.6 t -139.76 112.66 8.06 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 120.766 0.317 . . . . 0.0 110.517 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.644 ' HB1' ' SG ' ' A' ' 34' ' ' CYS . . . -116.45 149.63 39.15 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.866 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -94.05 168.78 10.73 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.65 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 24.1 tt0 -62.76 136.54 57.91 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.785 0.326 . . . . 0.0 111.053 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.31 -5.1 81.95 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.956 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -93.71 157.26 16.25 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 122.745 0.418 . . . . 0.0 110.693 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.55 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.1 t -96.95 116.07 28.54 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.082 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.511 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.3 153.95 34.26 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.627 179.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.514 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.0 m-80 -100.76 138.28 38.02 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.766 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.683 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.6 m -91.99 20.3 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 120.914 0.388 . . . . 0.0 111.083 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.79 -30.05 7.2 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.835 -178.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.8 -44.97 0.15 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -115.44 74.07 4.18 Favored Pre-proline 0 CA--C 1.548 0.893 0 O-C-N 123.177 0.298 . . . . 0.0 111.379 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.61 -172.31 0.91 Allowed 'Trans proline' 0 C--N 1.368 1.567 0 C-N-CA 122.792 2.328 . . . . 0.0 112.906 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.511 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 88.8 m -70.21 -177.01 1.29 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 122.414 0.286 . . . . 0.0 111.218 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 16.5 m -84.49 118.36 70.93 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 122.346 0.258 . . . . 0.0 111.321 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -78.58 157.66 28.55 Favored 'Trans proline' 0 C--N 1.368 1.568 0 C-N-CA 122.727 2.285 . . . . 0.0 113.071 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.66 -32.2 5.7 Favored Glycine 0 C--N 1.338 0.67 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.842 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.5 mt -84.11 -60.92 1.95 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 122.64 0.376 . . . . 0.0 111.016 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 133.03 36.26 0.28 Allowed Glycine 0 C--N 1.342 0.869 0 O-C-N 123.414 0.446 . . . . 0.0 113.217 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.56 155.58 18.77 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.919 0.36 . . . . 0.0 111.392 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.9 t -142.68 129.28 20.27 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.363 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.12 123.77 31.02 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 123.278 0.361 . . . . 0.0 110.785 179.857 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.3 mm -123.28 120.39 27.24 Favored Pre-proline 0 CA--C 1.541 0.629 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.062 -178.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.32 -31.8 4.97 Favored 'Cis proline' 0 C--N 1.372 1.764 0 C-N-CA 124.231 -1.154 . . . . 0.0 113.148 -0.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.683 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.6 -24.86 30.48 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-O 119.358 -0.69 . . . . 0.0 113.815 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -113.65 112.18 48.47 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-N 117.212 0.506 . . . . 0.0 111.035 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.92 -25.17 8.25 Favored 'Cis proline' 0 C--N 1.378 2.084 0 C-N-CA 125.016 -0.827 . . . . 0.0 113.303 -0.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.514 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.35 151.03 29.5 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.798 179.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.55 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.17 -168.41 11.34 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.453 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.57 134.47 41.48 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 120.765 0.317 . . . . 0.0 111.476 -179.909 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.644 ' SG ' ' HB1' ' A' ' 4' ' ' ALA . 85.4 m -80.36 107.72 13.39 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.327 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -112.4 147.79 35.7 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.714 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.442 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.5 m-85 -78.89 129.52 34.63 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.284 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.103 -0.951 . . . . 0.0 111.429 -179.526 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.119 0 N-CA-C 112.526 -0.23 . . . . 0.0 112.526 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.89 113.15 9.89 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.755 0.312 . . . . 0.0 110.431 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.614 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -117.78 148.17 42.31 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.805 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -92.26 172.09 8.64 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.034 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.5 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 24.2 tt0 -65.15 136.92 57.26 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.521 0.328 . . . . 0.0 111.021 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.88 -5.09 80.69 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.983 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -93.66 157.06 16.36 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 122.729 0.412 . . . . 0.0 110.669 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.551 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 52.6 m -96.93 116.09 28.57 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.211 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.505 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.16 155.01 32.4 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.658 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.523 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.5 m-80 -101.7 138.53 38.56 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.78 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.695 HG23 ' O ' ' A' ' 28' ' ' GLY . 35.7 m -91.86 21.22 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 120.91 0.386 . . . . 0.0 111.216 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -113.81 -31.05 6.56 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.931 -178.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -147.54 -44.94 0.17 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -115.69 74.2 4.65 Favored Pre-proline 0 CA--C 1.547 0.864 0 O-C-N 123.175 0.297 . . . . 0.0 111.304 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.67 -172.21 0.9 Allowed 'Trans proline' 0 C--N 1.367 1.537 0 C-N-CA 122.77 2.313 . . . . 0.0 112.8 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.505 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 93.0 m -70.17 -177.5 1.41 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 122.394 0.278 . . . . 0.0 111.152 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.9 m -84.36 118.38 71.03 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 122.222 0.209 . . . . 0.0 111.372 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.5 157.82 28.88 Favored 'Trans proline' 0 C--N 1.369 1.658 0 C-N-CA 122.654 2.236 . . . . 0.0 113.087 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.56 -32.17 5.69 Favored Glycine 0 C--N 1.337 0.598 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.882 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.5 mt -84.25 -60.39 2.1 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.671 0.388 . . . . 0.0 110.97 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.24 36.45 0.3 Allowed Glycine 0 C--N 1.342 0.884 0 O-C-N 123.393 0.433 . . . . 0.0 113.269 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.49 155.8 18.64 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.88 0.372 . . . . 0.0 111.356 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.66 128.79 19.75 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.316 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -84.87 123.76 30.84 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 123.226 0.329 . . . . 0.0 110.792 179.853 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.4 mm -122.98 119.84 27.72 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.236 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.12 -31.29 5.28 Favored 'Cis proline' 0 C--N 1.371 1.757 0 C-N-CA 124.147 -1.189 . . . . 0.0 113.129 -0.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.695 ' O ' HG23 ' A' ' 12' ' ' VAL . . . 100.02 -26.07 25.88 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 115.683 -0.69 . . . . 0.0 113.88 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -115.72 113.37 42.49 Favored Pre-proline 0 CA--C 1.546 0.797 0 CA-C-N 117.211 0.505 . . . . 0.0 111.156 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.59 -27.34 5.92 Favored 'Cis proline' 0 C--N 1.377 2.059 0 CA-C-N 119.323 0.794 . . . . 0.0 113.586 -0.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.523 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.63 151.44 29.71 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.783 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -141.37 -168.91 11.68 Favored Glycine 0 C--N 1.336 0.555 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.484 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.51 134.48 41.42 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 120.74 0.305 . . . . 0.0 111.561 -179.839 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.614 ' SG ' ' HB3' ' A' ' 4' ' ' ALA . 82.8 m -80.3 107.88 13.45 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.361 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -112.55 147.38 36.73 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.693 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.44 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.5 m-85 -78.61 129.62 34.99 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.341 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.057 -0.973 . . . . 0.0 111.45 -179.557 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.196 0 N-CA-C 112.644 -0.182 . . . . 0.0 112.644 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -138.82 113.47 9.05 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 122.451 0.301 . . . . 0.0 110.411 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.61 ' HB1' ' SG ' ' A' ' 34' ' ' CYS . . . -116.26 148.42 40.5 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.927 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -93.32 169.18 10.57 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.691 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.5 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.8 tt0 -62.99 137.21 58.2 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.872 0.368 . . . . 0.0 111.066 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.95 -5.19 80.43 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.999 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -93.66 157.26 16.26 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 122.707 0.403 . . . . 0.0 110.73 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.554 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.1 t -96.89 115.65 27.79 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.074 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -118.8 153.82 33.84 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.604 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.513 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.2 m-80 -100.66 138.25 37.98 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.794 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.686 HG21 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -92.01 20.48 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.971 0.415 . . . . 0.0 111.044 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.82 -29.82 7.27 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.857 -178.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -149.06 -45.13 0.14 Allowed 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -115.58 74.15 4.44 Favored Pre-proline 0 CA--C 1.547 0.843 0 O-C-N 123.09 0.244 . . . . 0.0 111.34 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.73 -171.95 0.85 Allowed 'Trans proline' 0 C--N 1.368 1.562 0 C-N-CA 122.769 2.313 . . . . 0.0 112.826 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 94.5 m -70.2 -177.53 1.42 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 122.382 0.273 . . . . 0.0 111.145 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 15.2 m -83.83 118.27 70.91 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 122.231 0.212 . . . . 0.0 111.298 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -78.53 156.95 28.62 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.623 2.215 . . . . 0.0 113.133 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.18 -32.02 5.95 Favored Glycine 0 C--N 1.338 0.657 0 O-C-N 123.682 0.614 . . . . 0.0 112.872 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.7 mt -84.31 -60.84 1.96 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.664 0.386 . . . . 0.0 111.045 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 133.09 36.2 0.28 Allowed Glycine 0 C--N 1.342 0.87 0 O-C-N 123.511 0.507 . . . . 0.0 113.243 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.6 155.71 18.67 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.838 0.351 . . . . 0.0 111.346 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.79 129.46 20.33 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.28 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.24 123.79 31.13 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 123.237 0.335 . . . . 0.0 110.785 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.7 mm -123.28 120.49 27.21 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.11 -178.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.29 -31.73 5.01 Favored 'Cis proline' 0 C--N 1.371 1.74 0 C-N-CA 124.182 -1.174 . . . . 0.0 113.117 -0.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.686 ' O ' HG21 ' A' ' 12' ' ' VAL . . . 100.67 -24.9 30.3 Favored Glycine 0 C--N 1.338 0.662 0 CA-C-N 115.788 -0.642 . . . . 0.0 113.859 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.65 112.19 48.46 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 117.225 0.513 . . . . 0.0 111.008 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -69.94 -25.17 8.26 Favored 'Cis proline' 0 C--N 1.378 2.095 0 C-N-CA 125.062 -0.807 . . . . 0.0 113.292 -0.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.513 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p30 -153.4 150.94 29.36 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.811 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.554 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -139.94 -168.34 11.3 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.498 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.46 134.65 41.15 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.76 0.314 . . . . 0.0 111.437 -179.917 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.61 ' SG ' ' HB1' ' A' ' 4' ' ' ALA . 78.5 m -80.51 107.82 13.63 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.358 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -112.54 147.61 36.25 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.709 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.446 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.81 129.43 34.59 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.269 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.555 -0.736 . . . . 0.0 111.452 -179.552 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.274 0 CA-C-O 120.236 -0.202 . . . . 0.0 112.915 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.6 t -141.96 112.86 7.37 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 120.743 0.306 . . . . 0.0 110.623 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.642 ' HB1' ' SG ' ' A' ' 34' ' ' CYS . . . -115.99 149.82 38.2 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.877 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -94.24 168.67 10.77 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.64 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.5 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 24.6 tt0 -63.07 136.73 57.97 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.747 0.308 . . . . 0.0 111.088 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.02 -4.83 81.95 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.913 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -93.88 157.63 16.04 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 122.725 0.41 . . . . 0.0 110.705 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.551 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.1 t -96.92 116.1 28.59 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.066 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.514 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.3 p -119.39 153.75 34.7 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.609 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.512 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.1 m-80 -100.72 138.22 38.06 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.775 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 28' ' ' GLY . 33.5 m -92.03 20.31 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.926 0.394 . . . . 0.0 111.04 -179.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.86 -29.9 7.23 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.849 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -148.97 -44.86 0.14 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -115.38 74.07 4.08 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 122.259 0.223 . . . . 0.0 111.36 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.71 -172.41 0.94 Allowed 'Trans proline' 0 C--N 1.367 1.505 0 C-N-CA 122.821 2.347 . . . . 0.0 112.921 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.514 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 88.8 m -70.38 -176.86 1.31 Allowed 'General case' 0 CA--C 1.543 0.692 0 O-C-N 123.168 0.293 . . . . 0.0 111.168 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 17.1 m -84.68 118.36 70.85 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 122.327 0.251 . . . . 0.0 111.348 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.54 157.74 28.7 Favored 'Trans proline' 0 C--N 1.368 1.587 0 C-N-CA 122.705 2.27 . . . . 0.0 113.114 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.64 -32.19 5.7 Favored Glycine 0 C--N 1.337 0.59 0 O-C-N 123.669 0.606 . . . . 0.0 112.853 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.7 mt -84.22 -60.2 2.16 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 122.624 0.37 . . . . 0.0 110.991 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.15 36.28 0.31 Allowed Glycine 0 C--N 1.341 0.846 0 O-C-N 123.399 0.437 . . . . 0.0 113.311 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.18 155.7 18.84 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.86 0.33 . . . . 0.0 111.425 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.82 129.08 19.89 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.324 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -84.94 123.72 30.83 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.317 0.386 . . . . 0.0 110.85 179.829 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.2 mm -123.15 120.37 27.38 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.057 -178.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.32 -31.76 4.99 Favored 'Cis proline' 0 C--N 1.371 1.731 0 C-N-CA 124.185 -1.173 . . . . 0.0 113.143 -0.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.683 ' O ' HG23 ' A' ' 12' ' ' VAL . . . 100.58 -24.88 30.38 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.843 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.65 112.15 48.48 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-N 117.187 0.494 . . . . 0.0 111.012 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -69.88 -25.18 8.23 Favored 'Cis proline' 0 C--N 1.378 2.087 0 C-N-CA 125.036 -0.818 . . . . 0.0 113.34 -0.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.512 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p30 -153.39 150.98 29.41 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.796 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.22 -168.27 11.3 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.4 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.54 134.33 41.65 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.697 0.284 . . . . 0.0 111.518 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.642 ' SG ' ' HB1' ' A' ' 4' ' ' ALA . 87.1 m -80.27 107.62 13.22 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.344 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -112.4 147.35 36.62 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.789 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.436 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.3 m-85 -78.61 129.46 34.8 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.259 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--O 1.251 1.152 0 CA-C-O 118.533 -0.746 . . . . 0.0 111.389 -179.548 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.189 0 N-CA-C 112.589 -0.205 . . . . 0.0 112.589 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.64 113.3 10.2 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 120.778 0.323 . . . . 0.0 110.416 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.6 ' HB1' ' SG ' ' A' ' 34' ' ' CYS . . . -117.94 148.08 42.53 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.886 179.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -92.2 171.86 8.8 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.059 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.498 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.3 tt0 -64.88 137.24 57.64 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.726 0.298 . . . . 0.0 111.108 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.73 -5.02 80.53 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.949 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -93.72 157.04 16.35 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 122.697 0.399 . . . . 0.0 110.662 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.551 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.4 t -96.89 115.94 28.3 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.984 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.06 153.96 33.91 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.62 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.514 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.2 m-80 -100.75 138.23 38.08 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.79 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.686 HG21 ' O ' ' A' ' 28' ' ' GLY . 33.6 m -91.96 20.45 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.961 0.41 . . . . 0.0 111.086 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -112.74 -30.09 7.19 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.736 -178.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.78 -45.02 0.15 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -115.69 74.22 4.66 Favored Pre-proline 0 CA--C 1.548 0.888 0 O-C-N 123.114 0.259 . . . . 0.0 111.294 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.72 -171.84 0.83 Allowed 'Trans proline' 0 C--N 1.368 1.557 0 C-N-CA 122.71 2.273 . . . . 0.0 112.886 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 90.5 m -70.27 -177.55 1.45 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 122.405 0.282 . . . . 0.0 111.069 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.7 m -84.28 118.55 71.47 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 122.249 0.22 . . . . 0.0 111.388 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -78.42 158.18 29.21 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 122.715 2.277 . . . . 0.0 113.094 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.27 -32.1 5.65 Favored Glycine 0 C--N 1.337 0.591 0 O-C-N 123.628 0.58 . . . . 0.0 112.882 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.9 mt -84.34 -61.12 1.88 Allowed 'General case' 0 C--O 1.236 0.36 0 C-N-CA 122.668 0.387 . . . . 0.0 111.024 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.91 36.31 0.28 Allowed Glycine 0 C--N 1.341 0.849 0 O-C-N 123.377 0.423 . . . . 0.0 113.214 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.34 156.2 18.43 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.885 0.343 . . . . 0.0 111.318 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.1 t -143.29 129.61 19.91 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.301 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.34 123.79 31.22 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 123.32 0.388 . . . . 0.0 110.848 179.839 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.3 mm -123.3 120.36 27.22 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.116 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.41 -31.76 5.0 Favored 'Cis proline' 0 C--N 1.372 1.768 0 C-N-CA 124.155 -1.185 . . . . 0.0 113.142 -0.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.686 ' O ' HG21 ' A' ' 12' ' ' VAL . . . 100.64 -24.71 31.03 Favored Glycine 0 C--N 1.337 0.601 0 CA-C-O 119.386 -0.675 . . . . 0.0 113.874 179.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.62 112.13 48.6 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 117.198 0.499 . . . . 0.0 111.06 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -69.95 -25.18 8.25 Favored 'Cis proline' 0 C--N 1.376 2.026 0 CA-C-N 119.416 0.827 . . . . 0.0 113.244 -0.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.514 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.1 p30 -153.25 151.08 29.65 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.836 179.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.11 -168.43 11.34 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.46 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.53 134.52 41.37 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 120.77 0.319 . . . . 0.0 111.418 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.6 ' SG ' ' HB1' ' A' ' 4' ' ' ALA . 80.0 m -80.55 107.78 13.64 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.329 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -112.5 147.73 35.93 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.712 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.448 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.3 m-85 -78.11 128.94 34.57 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.171 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.251 1.18 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.451 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.271 . . . . . . . 0 C--O 1.235 0.341 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 101.37 56.44 0.87 Allowed Glycine 0 C--N 1.336 0.532 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.602 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.72 113.14 9.99 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 120.803 0.335 . . . . 0.0 110.398 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.628 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . . . -117.8 148.93 41.61 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.918 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -93.19 172.48 8.27 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.981 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.505 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 24.5 tt0 -65.35 136.81 56.99 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.813 0.34 . . . . 0.0 111.01 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.04 -5.36 79.96 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.941 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -93.54 156.79 16.53 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 122.721 0.409 . . . . 0.0 110.647 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.548 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 51.7 m -96.88 116.23 28.81 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.199 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.26 154.17 33.88 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.646 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.516 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.0 m-80 -100.85 138.27 38.13 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.773 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.686 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -91.98 20.45 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.997 0.427 . . . . 0.0 111.051 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.78 -30.13 7.17 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.823 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.72 -45.02 0.15 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -115.56 74.2 4.43 Favored Pre-proline 0 CA--C 1.547 0.852 0 O-C-N 123.19 0.306 . . . . 0.0 111.367 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.59 -172.18 0.88 Allowed 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 122.762 2.308 . . . . 0.0 112.831 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 92.8 m -70.16 -177.69 1.45 Allowed 'General case' 0 CA--C 1.543 0.686 0 O-C-N 123.107 0.255 . . . . 0.0 111.137 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.6 m -84.11 118.6 71.68 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 122.271 0.228 . . . . 0.0 111.334 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.49 157.62 28.87 Favored 'Trans proline' 0 C--N 1.369 1.629 0 C-N-CA 122.676 2.251 . . . . 0.0 113.065 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.72 -32.27 5.67 Favored Glycine 0 C--N 1.338 0.661 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.862 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.4 mt -84.15 -60.46 2.09 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 122.643 0.377 . . . . 0.0 111.02 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.28 36.36 0.3 Allowed Glycine 0 C--N 1.341 0.837 0 O-C-N 123.459 0.475 . . . . 0.0 113.286 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.58 155.59 18.76 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.8 0.333 . . . . 0.0 111.381 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.63 129.39 20.45 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.333 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.11 123.69 30.92 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 123.265 0.353 . . . . 0.0 110.818 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.8 mm -123.26 120.45 27.23 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.127 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.37 -31.64 5.07 Favored 'Cis proline' 0 C--N 1.372 1.773 0 C-N-CA 124.192 -1.17 . . . . 0.0 113.169 -0.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.686 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.59 -24.74 30.91 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-N 115.766 -0.652 . . . . 0.0 113.868 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -113.66 112.18 48.45 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 117.205 0.502 . . . . 0.0 111.009 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -69.96 -25.12 8.3 Favored 'Cis proline' 0 C--N 1.378 2.111 0 C-N-CA 124.978 -0.842 . . . . 0.0 113.321 -0.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.516 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.1 p-10 -153.25 150.98 29.54 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.79 179.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -139.91 -168.54 11.36 Favored Glycine 0 C--N 1.335 0.521 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.473 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.5 134.62 41.21 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.729 0.299 . . . . 0.0 111.459 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.628 ' SG ' ' HB2' ' A' ' 4' ' ' ALA . 77.4 m -80.35 107.73 13.38 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.355 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -112.51 147.51 36.42 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.691 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.441 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.5 m-85 -78.65 129.41 34.7 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.281 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.1 mt . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.473 -0.775 . . . . 0.0 111.475 -179.554 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.272 . . . . . . . 0 C--O 1.235 0.321 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 100.15 54.31 1.04 Allowed Glycine 0 C--N 1.336 0.543 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.602 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.87 113.26 9.99 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 122.427 0.291 . . . . 0.0 110.462 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.619 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . . . -117.73 148.16 42.28 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.851 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -92.47 172.2 8.54 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.079 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.5 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.5 tt0 -65.17 137.05 57.38 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.51 0.324 . . . . 0.0 111.015 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.93 -5.41 79.4 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.978 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -93.61 156.81 16.5 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 122.772 0.429 . . . . 0.0 110.682 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.548 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 52.9 m -96.8 116.23 28.79 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.18 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.29 154.06 34.08 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.591 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.515 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.0 m-80 -100.75 138.2 38.11 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.801 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.685 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.6 m -91.83 20.34 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 120.945 0.402 . . . . 0.0 111.071 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.71 -30.05 7.22 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.8 -178.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.91 -44.97 0.14 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -115.61 74.16 4.5 Favored Pre-proline 0 CA--C 1.548 0.888 0 O-C-N 123.2 0.312 . . . . 0.0 111.408 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.58 -172.05 0.86 Allowed 'Trans proline' 0 C--N 1.366 1.472 0 C-N-CA 122.768 2.312 . . . . 0.0 112.86 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 93.7 m -70.21 -177.62 1.45 Allowed 'General case' 0 CA--C 1.542 0.663 0 O-C-N 123.155 0.284 . . . . 0.0 111.16 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.7 m -84.15 118.46 71.3 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 122.33 0.252 . . . . 0.0 111.325 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -78.49 157.55 28.87 Favored 'Trans proline' 0 C--N 1.369 1.639 0 C-N-CA 122.64 2.227 . . . . 0.0 113.121 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.77 -32.28 5.68 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.845 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.7 mt -84.14 -60.71 2.01 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 122.617 0.367 . . . . 0.0 110.99 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.66 36.4 0.29 Allowed Glycine 0 C--N 1.341 0.848 0 O-C-N 123.442 0.464 . . . . 0.0 113.312 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.71 155.65 18.66 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.866 0.365 . . . . 0.0 111.389 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.73 129.48 20.43 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.305 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.22 123.74 31.06 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.293 0.37 . . . . 0.0 110.796 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.2 mm -123.18 120.4 27.33 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.132 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -73.45 -31.7 5.04 Favored 'Cis proline' 0 C--N 1.372 1.764 0 C-N-CA 124.217 -1.16 . . . . 0.0 113.136 -0.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.685 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.67 -24.84 30.53 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-O 119.432 -0.649 . . . . 0.0 113.79 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.58 112.17 48.67 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 117.22 0.51 . . . . 0.0 111.001 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -69.85 -25.25 8.17 Favored 'Cis proline' 0 C--N 1.378 2.088 0 CA-C-N 119.386 0.817 . . . . 0.0 113.299 -0.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.515 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.27 151.03 29.57 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.832 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.06 -168.58 11.39 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 115.811 -0.632 . . . . 0.0 112.458 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.4 134.6 41.17 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.723 0.296 . . . . 0.0 111.46 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.619 ' SG ' ' HB2' ' A' ' 4' ' ' ALA . 78.9 m -80.32 107.73 13.36 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.329 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -112.51 147.68 36.06 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.727 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.442 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.5 m-85 -78.83 129.43 34.58 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.311 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.156 -0.926 . . . . 0.0 111.44 -179.496 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.271 . . . . . . . 0 C--O 1.236 0.346 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 103.04 55.67 0.81 Allowed Glycine 0 C--N 1.335 0.517 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.558 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.86 112.98 9.75 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 120.843 0.354 . . . . 0.0 110.382 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.632 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -117.66 148.6 41.82 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.843 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -92.81 172.13 8.54 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.983 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.502 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.9 tt0 -65.16 137.0 57.35 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.796 0.331 . . . . 0.0 110.975 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.88 -5.31 79.69 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.987 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -93.7 156.84 16.47 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 122.648 0.379 . . . . 0.0 110.635 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.548 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 52.3 m -96.86 116.45 29.19 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.185 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.57 154.16 34.32 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.588 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.515 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.0 m-80 -100.84 138.2 38.2 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.782 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.685 HG21 ' O ' ' A' ' 28' ' ' GLY . 33.6 m -91.87 20.3 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 120.983 0.421 . . . . 0.0 111.064 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -112.68 -30.03 7.23 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.802 -178.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.8 -45.01 0.15 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -115.58 74.21 4.46 Favored Pre-proline 0 CA--C 1.548 0.891 0 O-C-N 123.091 0.244 . . . . 0.0 111.334 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.65 -172.12 0.88 Allowed 'Trans proline' 0 C--N 1.367 1.545 0 C-N-CA 122.704 2.269 . . . . 0.0 112.824 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 91.9 m -70.18 -177.54 1.42 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 122.427 0.291 . . . . 0.0 111.145 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 15.1 m -84.22 118.55 71.51 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 122.272 0.229 . . . . 0.0 111.408 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -78.55 157.69 28.66 Favored 'Trans proline' 0 C--N 1.368 1.563 0 C-N-CA 122.73 2.287 . . . . 0.0 113.04 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.64 -32.21 5.69 Favored Glycine 0 C--N 1.337 0.632 0 O-C-N 123.717 0.636 . . . . 0.0 112.916 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.9 mt -84.22 -60.79 1.98 Allowed 'General case' 0 C--O 1.236 0.385 0 C-N-CA 122.645 0.378 . . . . 0.0 110.962 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.78 36.26 0.29 Allowed Glycine 0 C--N 1.341 0.813 0 O-C-N 123.447 0.467 . . . . 0.0 113.279 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.63 155.77 18.61 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.921 0.361 . . . . 0.0 111.413 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.86 129.4 20.19 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.36 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.17 123.68 30.96 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.299 0.374 . . . . 0.0 110.801 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.4 mm -123.22 120.47 27.28 Favored Pre-proline 0 CA--C 1.542 0.649 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.099 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.39 -31.59 5.1 Favored 'Cis proline' 0 C--N 1.371 1.746 0 C-N-CA 124.192 -1.17 . . . . 0.0 113.19 -0.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.685 ' O ' HG21 ' A' ' 12' ' ' VAL . . . 100.51 -24.77 30.83 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 115.747 -0.66 . . . . 0.0 113.891 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.67 112.17 48.44 Favored Pre-proline 0 CA--C 1.542 0.673 0 CA-C-N 117.199 0.499 . . . . 0.0 111.025 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -69.87 -25.25 8.18 Favored 'Cis proline' 0 C--N 1.378 2.088 0 C-N-CA 125.069 -0.804 . . . . 0.0 113.298 -0.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.515 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.24 150.98 29.55 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.782 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.05 -168.43 11.34 Favored Glycine 0 C--N 1.336 0.533 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.461 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.53 134.64 41.21 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.77 0.319 . . . . 0.0 111.436 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.632 ' SG ' ' HB3' ' A' ' 4' ' ' ALA . 79.9 m -80.28 107.76 13.34 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.334 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -112.59 147.76 36.0 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.654 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.441 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.5 m-85 -78.81 129.36 34.52 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.279 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.134 -0.936 . . . . 0.0 111.45 -179.603 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.273 . . . . . . . 0 C--O 1.235 0.31 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.9 56.44 0.95 Allowed Glycine 0 C--N 1.336 0.554 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.587 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.23 113.69 10.85 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.832 0.349 . . . . 0.0 110.45 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.642 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . . . -119.14 146.71 44.91 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.776 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -92.18 173.67 7.7 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.985 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.511 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.5 tt0 -65.22 137.42 57.58 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.792 0.33 . . . . 0.0 111.204 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.84 -5.74 77.57 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 115.254 -0.885 . . . . 0.0 113.085 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -93.47 156.36 16.8 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 122.625 0.37 . . . . 0.0 110.778 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.544 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 53.3 m -96.88 116.2 28.76 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.127 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.17 154.32 33.5 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.673 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.52 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 5.9 m-80 -101.09 138.33 38.28 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.749 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.687 HG21 ' O ' ' A' ' 28' ' ' GLY . 33.6 m -91.9 20.37 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 120.954 0.407 . . . . 0.0 110.99 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -112.58 -29.92 7.3 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.825 -178.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -149.03 -45.2 0.14 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -115.49 74.16 4.3 Favored Pre-proline 0 CA--C 1.548 0.891 0 O-C-N 123.185 0.303 . . . . 0.0 111.369 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.63 -172.03 0.86 Allowed 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 122.73 2.287 . . . . 0.0 112.798 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 95.4 m -70.26 -177.92 1.55 Allowed 'General case' 0 CA--C 1.543 0.701 0 O-C-N 123.128 0.268 . . . . 0.0 111.13 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.6 m -83.94 118.35 71.11 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 122.237 0.215 . . . . 0.0 111.28 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -78.44 157.87 29.11 Favored 'Trans proline' 0 C--N 1.368 1.604 0 C-N-CA 122.679 2.253 . . . . 0.0 113.128 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.49 -32.03 5.75 Favored Glycine 0 C--N 1.338 0.664 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.858 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.2 mt -84.51 -60.59 2.02 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.63 0.372 . . . . 0.0 111.002 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.72 36.04 0.3 Allowed Glycine 0 C--N 1.341 0.813 0 O-C-N 123.425 0.453 . . . . 0.0 113.327 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.67 155.34 18.91 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.866 0.365 . . . . 0.0 111.361 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.9 t -142.29 129.75 21.28 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.357 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.42 123.72 31.19 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.3 0.375 . . . . 0.0 110.808 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.1 mm -123.07 120.48 27.43 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.092 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.5 -31.39 5.24 Favored 'Cis proline' 0 C--N 1.37 1.688 0 C-N-CA 124.166 -1.181 . . . . 0.0 113.175 -0.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.687 ' O ' HG21 ' A' ' 12' ' ' VAL . . . 100.36 -24.59 31.49 Favored Glycine 0 C--N 1.338 0.656 0 CA-C-N 115.75 -0.659 . . . . 0.0 113.891 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -113.7 112.06 48.42 Favored Pre-proline 0 CA--C 1.543 0.673 0 CA-C-N 117.218 0.509 . . . . 0.0 111.079 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -69.77 -25.35 8.07 Favored 'Cis proline' 0 C--N 1.378 2.106 0 CA-C-N 119.404 0.823 . . . . 0.0 113.313 -0.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.52 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.13 151.18 29.86 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.744 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.544 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.22 -168.67 11.43 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.429 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.33 134.67 41.02 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 120.769 0.319 . . . . 0.0 111.489 -179.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.642 ' SG ' ' HB2' ' A' ' 4' ' ' ALA . 77.9 m -80.24 107.98 13.47 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.3 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -112.82 147.42 36.98 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.769 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.442 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.5 m-85 -78.68 129.75 35.07 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.286 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.137 -0.935 . . . . 0.0 111.429 -179.508 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.271 . . . . . . . 0 C--O 1.236 0.346 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.75 55.6 1.0 Allowed Glycine 0 C--N 1.336 0.544 0 O-C-N 123.763 0.664 . . . . 0.0 112.578 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.67 113.36 10.23 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 120.77 0.319 . . . . 0.0 110.414 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.615 ' HB1' ' SG ' ' A' ' 34' ' ' CYS . . . -117.99 148.32 42.33 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.887 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -92.4 172.32 8.47 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.971 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.9 tt0 -65.36 137.07 57.26 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.767 0.318 . . . . 0.0 111.056 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.92 -5.3 79.84 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 115.311 -0.859 . . . . 0.0 113.038 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -93.46 156.97 16.45 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 122.66 0.384 . . . . 0.0 110.656 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.55 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.1 t -96.94 115.91 28.27 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.085 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.507 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.04 154.02 33.78 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.629 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.516 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.1 m-80 -100.8 138.25 38.11 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.784 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.686 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -91.99 20.5 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.032 0.444 . . . . 0.0 111.072 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -112.82 -30.0 7.2 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.796 -178.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -148.9 -45.07 0.14 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -178.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -115.57 74.2 4.44 Favored Pre-proline 0 CA--C 1.547 0.852 0 O-C-N 123.053 0.22 . . . . 0.0 111.37 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.67 -172.03 0.86 Allowed 'Trans proline' 0 C--N 1.367 1.535 0 C-N-CA 122.758 2.305 . . . . 0.0 112.8 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.507 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 93.2 m -70.22 -177.62 1.46 Allowed 'General case' 0 CA--C 1.542 0.663 0 O-C-N 123.152 0.282 . . . . 0.0 111.126 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.9 m -84.26 118.56 71.5 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 122.29 0.236 . . . . 0.0 111.379 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.51 157.85 28.85 Favored 'Trans proline' 0 C--N 1.37 1.658 0 C-N-CA 122.606 2.204 . . . . 0.0 113.073 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.53 -32.22 5.65 Favored Glycine 0 C--N 1.338 0.659 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.897 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.5 mt -84.19 -60.42 2.1 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 122.693 0.397 . . . . 0.0 111.023 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.19 36.42 0.3 Allowed Glycine 0 C--N 1.341 0.831 0 O-C-N 123.413 0.445 . . . . 0.0 113.248 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.51 155.72 18.69 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.891 0.345 . . . . 0.0 111.455 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.74 129.39 20.32 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.32 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.21 123.74 31.06 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.253 0.346 . . . . 0.0 110.843 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.2 mm -123.26 120.39 27.25 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.087 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.34 -31.74 5.01 Favored 'Cis proline' 0 C--N 1.371 1.75 0 C-N-CA 124.188 -1.172 . . . . 0.0 113.201 -0.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.686 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.66 -24.85 30.49 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-N 115.747 -0.66 . . . . 0.0 113.805 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -113.61 112.22 48.56 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 117.253 0.527 . . . . 0.0 111.057 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.87 -25.18 8.22 Favored 'Cis proline' 0 C--N 1.378 2.088 0 C-N-CA 125.038 -0.818 . . . . 0.0 113.278 -0.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.516 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.1 p30 -153.34 150.93 29.39 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.814 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.55 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -139.95 -168.43 11.33 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.5 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.5 134.56 41.29 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.731 0.3 . . . . 0.0 111.494 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.615 ' SG ' ' HB1' ' A' ' 4' ' ' ALA . 79.7 m -80.27 107.67 13.26 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.392 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -112.43 147.43 36.48 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.744 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.44 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.67 129.4 34.68 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.322 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--O 1.252 1.189 0 CA-C-O 118.483 -0.77 . . . . 0.0 111.511 -179.539 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.271 . . . . . . . 0 C--O 1.236 0.349 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 100.37 54.97 0.98 Allowed Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.563 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.62 113.31 10.21 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 120.708 0.29 . . . . 0.0 110.472 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.611 ' HB1' ' SG ' ' A' ' 34' ' ' CYS . . . -117.99 148.33 42.32 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.847 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -92.3 172.33 8.47 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.999 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.7 tt0 -65.42 137.03 57.2 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.771 0.32 . . . . 0.0 111.046 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.89 -5.21 80.15 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.982 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -93.46 157.07 16.4 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 122.711 0.404 . . . . 0.0 110.712 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.55 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.6 t -96.97 115.86 28.18 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.961 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.508 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.04 153.84 34.09 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.601 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.515 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.1 m-80 -100.72 138.24 38.04 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.794 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.684 HG21 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -91.93 20.46 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.97 0.414 . . . . 0.0 111.086 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.86 -30.01 7.19 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.764 -178.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.84 -45.13 0.15 Allowed 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -178.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -115.55 74.18 4.4 Favored Pre-proline 0 CA--C 1.547 0.855 0 O-C-N 123.088 0.243 . . . . 0.0 111.319 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.5 -171.99 0.84 Allowed 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 122.741 2.294 . . . . 0.0 112.907 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.508 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 93.0 m -70.29 -177.58 1.47 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 122.431 0.293 . . . . 0.0 111.152 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.9 m -84.31 118.48 71.3 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 122.328 0.251 . . . . 0.0 111.384 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -78.46 157.83 29.02 Favored 'Trans proline' 0 C--N 1.368 1.599 0 C-N-CA 122.711 2.274 . . . . 0.0 113.044 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.52 -32.27 5.62 Favored Glycine 0 C--N 1.338 0.669 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.895 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.5 mt -84.12 -60.44 2.09 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 122.706 0.403 . . . . 0.0 111.024 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.22 36.37 0.3 Allowed Glycine 0 C--N 1.341 0.86 0 O-C-N 123.476 0.485 . . . . 0.0 113.251 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -90.54 155.63 18.75 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.903 0.383 . . . . 0.0 111.426 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.9 t -142.53 129.23 20.4 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.345 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.08 123.77 30.99 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 123.217 0.323 . . . . 0.0 110.785 179.852 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.2 mm -123.22 120.41 27.29 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.126 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.38 -31.73 5.01 Favored 'Cis proline' 0 C--N 1.371 1.75 0 C-N-CA 124.159 -1.184 . . . . 0.0 113.146 -0.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.684 ' O ' HG21 ' A' ' 12' ' ' VAL . . . 100.71 -25.03 29.86 Favored Glycine 0 C--N 1.338 0.677 0 CA-C-N 115.694 -0.685 . . . . 0.0 113.767 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -113.5 112.18 48.9 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 117.235 0.517 . . . . 0.0 111.023 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -69.96 -25.04 8.35 Favored 'Cis proline' 0 C--N 1.379 2.148 0 C-N-CA 124.995 -0.835 . . . . 0.0 113.367 -0.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.515 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.1 p-10 -153.49 150.96 29.29 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.803 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.55 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.08 -168.45 11.34 Favored Glycine 0 C--N 1.335 0.519 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.492 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.44 134.63 41.16 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 120.77 0.319 . . . . 0.0 111.446 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.611 ' SG ' ' HB1' ' A' ' 4' ' ' ALA . 78.2 m -80.39 107.71 13.42 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.319 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -112.38 147.42 36.45 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.693 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.44 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.5 m-85 -78.56 129.5 34.89 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.356 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.5 mt . . . . . 0 C--O 1.252 1.201 0 CA-C-O 118.526 -0.749 . . . . 0.0 111.474 -179.57 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.271 . . . . . . . 0 N--CA 1.465 0.322 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 96.5 49.77 1.95 Allowed Glycine 0 C--N 1.34 0.754 0 O-C-N 123.456 0.473 . . . . 0.0 112.73 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -138.84 113.87 9.36 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.777 0.323 . . . . 0.0 110.482 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.603 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -117.17 147.97 42.0 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.904 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -92.67 172.74 8.17 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.027 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.6 tt0 -65.81 137.3 57.14 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.8 0.334 . . . . 0.0 110.951 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.81 -5.29 79.54 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 115.267 -0.879 . . . . 0.0 113.023 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -93.77 157.01 16.35 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 122.651 0.38 . . . . 0.0 110.733 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.55 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 52.7 m -96.75 116.07 28.51 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.182 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.05 153.93 33.95 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.656 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.516 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.1 m-80 -100.71 138.26 38.0 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.824 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.685 HG23 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -91.98 20.47 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.912 0.387 . . . . 0.0 110.967 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.85 -29.79 7.27 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.817 -178.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -149.09 -45.01 0.14 Allowed 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -115.67 74.13 4.59 Favored Pre-proline 0 CA--C 1.548 0.884 0 O-C-N 123.193 0.308 . . . . 0.0 111.304 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.65 -171.92 0.84 Allowed 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 122.739 2.293 . . . . 0.0 112.892 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 95.3 m -70.16 -177.84 1.49 Allowed 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.163 0.289 . . . . 0.0 111.082 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.5 m -83.84 118.46 71.45 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 122.294 0.238 . . . . 0.0 111.367 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -78.53 157.25 28.67 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.681 2.254 . . . . 0.0 113.065 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.94 -32.22 5.76 Favored Glycine 0 C--N 1.338 0.64 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.891 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.8 mt -84.17 -60.61 2.04 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 122.674 0.389 . . . . 0.0 110.993 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.49 36.4 0.29 Allowed Glycine 0 C--N 1.34 0.794 0 O-C-N 123.489 0.493 . . . . 0.0 113.249 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.61 155.71 18.66 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.884 0.374 . . . . 0.0 111.379 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.7 129.42 20.41 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.301 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.2 123.74 31.05 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.275 0.359 . . . . 0.0 110.794 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.1 mm -123.23 120.42 27.28 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.149 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.29 -31.84 4.94 Favored 'Cis proline' 0 C--N 1.371 1.717 0 C-N-CA 124.166 -1.181 . . . . 0.0 113.155 -0.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.685 ' O ' HG23 ' A' ' 12' ' ' VAL . . . 100.69 -24.83 30.56 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-O 119.413 -0.659 . . . . 0.0 113.878 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -113.58 112.13 48.7 Favored Pre-proline 0 CA--C 1.543 0.705 0 CA-C-N 117.239 0.52 . . . . 0.0 111.072 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -69.91 -25.26 8.19 Favored 'Cis proline' 0 C--N 1.377 2.032 0 CA-C-N 119.386 0.816 . . . . 0.0 113.251 -0.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.516 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.28 151.0 29.52 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.84 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.55 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -139.89 -168.43 11.32 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.522 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.59 134.62 41.27 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 120.733 0.302 . . . . 0.0 111.38 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.603 ' SG ' ' HB3' ' A' ' 4' ' ' ALA . 76.5 m -80.38 107.82 13.49 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.398 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -112.51 147.36 36.74 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.72 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.441 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.62 129.5 34.84 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.256 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.08 -0.962 . . . . 0.0 111.466 -179.547 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.273 . . . . . . . 0 C--O 1.235 0.33 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 118.79 45.26 0.47 Allowed Glycine 0 C--N 1.337 0.627 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.857 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -141.26 113.07 7.74 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 120.724 0.297 . . . . 0.0 110.592 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.644 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . . . -116.57 149.11 40.17 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.846 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -93.8 171.66 8.73 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.502 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.8 tt0 -65.02 136.8 57.21 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 122.482 0.313 . . . . 0.0 111.002 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.9 -5.0 81.13 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.966 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -94.02 157.13 16.24 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 122.673 0.389 . . . . 0.0 110.672 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 52.3 m -96.85 116.76 29.72 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.194 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.512 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.84 154.03 34.91 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.622 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.515 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.1 m-80 -100.77 138.19 38.15 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.719 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.684 HG21 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -91.87 20.24 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 120.909 0.385 . . . . 0.0 111.097 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.79 -29.93 7.24 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.842 -178.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -148.91 -44.96 0.14 Allowed 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -115.45 73.99 4.17 Favored Pre-proline 0 CA--C 1.548 0.894 0 O-C-N 123.149 0.281 . . . . 0.0 111.375 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.66 -172.3 0.91 Allowed 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 122.743 2.295 . . . . 0.0 112.918 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.512 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 90.6 m -70.32 -177.1 1.34 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 122.408 0.283 . . . . 0.0 111.137 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 16.0 m -84.56 118.47 71.16 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 122.354 0.262 . . . . 0.0 111.274 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -78.57 157.65 28.59 Favored 'Trans proline' 0 C--N 1.368 1.587 0 C-N-CA 122.711 2.274 . . . . 0.0 113.053 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.6 -32.16 5.7 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.89 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.7 mt -84.1 -60.76 2.0 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.643 0.377 . . . . 0.0 111.025 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.78 36.43 0.28 Allowed Glycine 0 C--N 1.341 0.835 0 O-C-N 123.461 0.476 . . . . 0.0 113.218 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.66 155.71 18.64 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.946 0.373 . . . . 0.0 111.427 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.69 129.34 20.33 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.305 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.11 123.68 30.91 Favored 'General case' 0 C--O 1.236 0.391 0 O-C-N 123.201 0.313 . . . . 0.0 110.825 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.3 mm -123.22 120.37 27.3 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.121 -178.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.34 -31.72 5.02 Favored 'Cis proline' 0 C--N 1.371 1.746 0 C-N-CA 124.223 -1.157 . . . . 0.0 113.226 -0.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.684 ' O ' HG21 ' A' ' 12' ' ' VAL . . . 100.6 -25.03 29.82 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.854 179.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -113.54 112.1 48.83 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 117.237 0.519 . . . . 0.0 111.025 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -69.94 -25.14 8.28 Favored 'Cis proline' 0 C--N 1.379 2.147 0 C-N-CA 124.993 -0.836 . . . . 0.0 113.359 -0.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.515 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.39 151.0 29.43 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.784 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.546 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.08 -168.44 11.34 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.499 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.5 134.51 41.37 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 120.717 0.294 . . . . 0.0 111.487 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.644 ' SG ' ' HB2' ' A' ' 4' ' ' ALA . 83.1 m -80.25 107.62 13.2 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.374 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -112.41 147.72 35.85 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.687 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.438 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.5 m-85 -78.82 129.54 34.72 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.308 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.4 mt . . . . . 0 C--O 1.251 1.165 0 CA-C-O 118.46 -0.781 . . . . 0.0 111.474 -179.542 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.27 . . . . . . . 0 C--O 1.235 0.331 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 96.38 49.85 1.96 Allowed Glycine 0 C--N 1.342 0.868 0 O-C-N 123.38 0.425 . . . . 0.0 112.702 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -138.3 113.82 9.64 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 120.764 0.316 . . . . 0.0 110.479 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.601 ' HB1' ' SG ' ' A' ' 34' ' ' CYS . . . -117.29 147.81 42.24 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.828 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -92.43 172.65 8.25 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.023 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.498 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.3 tt0 -65.63 137.44 57.34 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.822 0.344 . . . . 0.0 111.023 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.8 -5.37 79.11 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.941 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -93.84 157.03 16.33 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 122.639 0.376 . . . . 0.0 110.662 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.553 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 52.6 m -96.69 115.91 28.24 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.209 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.504 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -118.95 153.88 33.9 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.614 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.516 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.0 m-80 -100.68 138.15 38.13 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.814 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.686 HG21 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -91.91 20.42 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.904 0.383 . . . . 0.0 110.982 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.79 -29.93 7.23 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.764 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.95 -45.12 0.14 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -115.64 74.17 4.54 Favored Pre-proline 0 CA--C 1.548 0.884 0 O-C-N 123.152 0.282 . . . . 0.0 111.32 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.68 -171.93 0.85 Allowed 'Trans proline' 0 C--N 1.367 1.543 0 C-N-CA 122.68 2.253 . . . . 0.0 112.829 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.504 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 94.7 m -70.15 -177.78 1.48 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 122.366 0.267 . . . . 0.0 111.151 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.6 m -83.86 118.47 71.45 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 122.267 0.227 . . . . 0.0 111.373 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.54 157.23 28.66 Favored 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 122.715 2.277 . . . . 0.0 113.095 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.98 -32.2 5.79 Favored Glycine 0 C--N 1.339 0.702 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.854 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.8 mt -84.26 -60.53 2.06 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 122.606 0.362 . . . . 0.0 110.964 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.47 36.33 0.3 Allowed Glycine 0 C--N 1.341 0.828 0 O-C-N 123.472 0.482 . . . . 0.0 113.298 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.52 155.68 18.72 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.836 0.35 . . . . 0.0 111.38 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.66 129.43 20.46 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.32 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.22 123.73 31.05 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 123.258 0.349 . . . . 0.0 110.866 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.9 mm -123.22 120.45 27.28 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.145 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.18 -31.84 4.93 Favored 'Cis proline' 0 C--N 1.372 1.781 0 C-N-CA 124.21 -1.162 . . . . 0.0 113.208 -0.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.686 ' O ' HG21 ' A' ' 12' ' ' VAL . . . 100.7 -24.85 30.51 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-N 115.75 -0.659 . . . . 0.0 113.898 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -113.7 112.2 48.34 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 117.174 0.487 . . . . 0.0 111.003 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -69.85 -25.28 8.15 Favored 'Cis proline' 0 C--N 1.377 2.051 0 C-N-CA 125.071 -0.804 . . . . 0.0 113.327 -0.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.516 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.29 151.0 29.52 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.803 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.553 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -139.94 -168.49 11.34 Favored Glycine 0 C--N 1.335 0.521 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.505 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.44 134.63 41.15 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.762 0.315 . . . . 0.0 111.403 -179.924 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.601 ' SG ' ' HB1' ' A' ' 4' ' ' ALA . 76.6 m -80.36 107.77 13.42 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.333 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -112.55 147.24 37.03 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.745 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.443 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.53 129.51 34.92 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.368 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--O 1.252 1.203 0 CA-C-O 118.526 -0.749 . . . . 0.0 111.425 -179.5 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.271 . . . . . . . 0 C--O 1.235 0.306 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 104.19 55.56 0.76 Allowed Glycine 0 C--N 1.336 0.55 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.639 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -137.5 113.38 9.72 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.751 0.31 . . . . 0.0 110.408 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.635 ' HB1' ' SG ' ' A' ' 34' ' ' CYS . . . -118.08 148.63 42.1 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.914 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -93.28 173.49 7.69 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.953 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.504 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 24.0 tt0 -66.04 136.86 56.6 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.507 0.323 . . . . 0.0 111.053 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.89 -5.23 80.05 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 115.331 -0.85 . . . . 0.0 113.008 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -93.54 156.79 16.54 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 122.715 0.406 . . . . 0.0 110.624 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.547 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 16.8 t -97.03 116.61 29.53 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.044 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.5 p -119.72 154.26 34.39 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.647 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.514 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.0 m-80 -100.89 138.28 38.15 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.734 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.683 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -91.99 20.33 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.976 0.417 . . . . 0.0 111.06 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.8 -29.92 7.24 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.833 -178.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.82 -45.02 0.15 Allowed 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -115.57 74.27 4.47 Favored Pre-proline 0 CA--C 1.548 0.888 0 O-C-N 123.178 0.299 . . . . 0.0 111.389 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.68 -172.28 0.91 Allowed 'Trans proline' 0 C--N 1.368 1.574 0 C-N-CA 122.753 2.302 . . . . 0.0 112.825 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 92.5 m -69.96 -177.73 1.4 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 122.511 0.324 . . . . 0.0 111.184 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.1 m -84.56 119.06 72.47 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 122.324 0.25 . . . . 0.0 111.342 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -78.6 159.05 28.63 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 122.657 2.238 . . . . 0.0 113.052 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.65 -31.96 5.56 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.864 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.6 mt -84.7 -60.25 2.12 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 122.643 0.377 . . . . 0.0 111.008 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.46 36.78 0.32 Allowed Glycine 0 C--N 1.341 0.859 0 O-C-N 123.379 0.424 . . . . 0.0 113.268 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -90.4 155.87 18.63 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.935 0.368 . . . . 0.0 111.369 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.78 129.18 20.05 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.381 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.0 123.72 30.88 Favored 'General case' 0 C--O 1.235 0.342 0 O-C-N 123.256 0.347 . . . . 0.0 110.84 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.1 mm -123.19 120.32 27.35 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.18 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.39 -31.7 5.03 Favored 'Cis proline' 0 C--N 1.37 1.7 0 C-N-CA 124.242 -1.149 . . . . 0.0 113.105 -0.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.683 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.51 -24.87 30.44 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-N 115.778 -0.646 . . . . 0.0 113.824 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -113.63 112.15 48.54 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 117.17 0.485 . . . . 0.0 111.008 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -69.9 -25.25 8.19 Favored 'Cis proline' 0 C--N 1.378 2.092 0 C-N-CA 125.061 -0.808 . . . . 0.0 113.335 -0.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.514 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.35 151.04 29.51 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.803 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.11 -168.5 11.36 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.524 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.33 134.58 41.15 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 120.682 0.277 . . . . 0.0 111.506 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.635 ' SG ' ' HB1' ' A' ' 4' ' ' ALA . 79.2 m -80.29 107.69 13.29 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.366 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -112.59 147.11 37.34 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.761 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.435 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.3 m-85 -78.31 129.5 35.1 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.364 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.7 mt . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.487 -0.768 . . . . 0.0 111.481 -179.519 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.271 . . . . . . . 0 C--O 1.234 0.276 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 100.0 53.97 1.07 Allowed Glycine 0 C--N 1.335 0.524 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.586 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -137.75 113.08 9.33 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 120.771 0.32 . . . . 0.0 110.406 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.628 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -116.85 148.74 40.99 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.934 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -93.26 169.22 10.55 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.637 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.5 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.9 tt0 -62.89 136.94 58.11 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.78 0.324 . . . . 0.0 111.124 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.05 -5.25 80.52 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.993 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -93.83 157.08 16.31 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 122.707 0.403 . . . . 0.0 110.604 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.551 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 53.1 m -96.82 116.05 28.48 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.171 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.508 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.18 153.93 34.12 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.618 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.513 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.0 m-80 -100.69 138.23 38.03 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.827 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.685 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.6 m -91.87 20.31 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 120.941 0.401 . . . . 0.0 111.081 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -112.78 -29.86 7.26 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.819 -178.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.98 -45.01 0.14 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -115.59 74.2 4.48 Favored Pre-proline 0 CA--C 1.548 0.89 0 O-C-N 123.108 0.255 . . . . 0.0 111.291 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.68 -172.04 0.87 Allowed 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 122.739 2.293 . . . . 0.0 112.83 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.508 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 93.6 m -70.33 -177.44 1.44 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 122.428 0.291 . . . . 0.0 111.08 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 15.9 m -84.04 118.31 70.96 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 122.305 0.242 . . . . 0.0 111.312 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -78.54 157.4 28.67 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 122.668 2.246 . . . . 0.0 113.088 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.79 -32.19 5.74 Favored Glycine 0 C--N 1.338 0.666 0 CA-C-N 115.976 -0.557 . . . . 0.0 112.893 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.6 mt -84.14 -60.52 2.07 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.66 0.384 . . . . 0.0 111.046 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.61 36.19 0.3 Allowed Glycine 0 C--N 1.341 0.828 0 O-C-N 123.408 0.443 . . . . 0.0 113.315 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.52 155.67 18.72 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.869 0.334 . . . . 0.0 111.409 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.71 129.41 20.38 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.317 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.18 123.76 31.06 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 123.264 0.353 . . . . 0.0 110.811 179.853 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.1 mm -123.18 120.32 27.36 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.121 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -73.37 -31.72 5.02 Favored 'Cis proline' 0 C--N 1.371 1.731 0 C-N-CA 124.165 -1.181 . . . . 0.0 113.141 -0.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.685 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.63 -24.92 30.24 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-O 119.381 -0.677 . . . . 0.0 113.841 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.59 112.16 48.66 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 117.241 0.521 . . . . 0.0 111.021 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -69.96 -25.2 8.25 Favored 'Cis proline' 0 C--N 1.376 2.026 0 CA-C-N 119.343 0.801 . . . . 0.0 113.248 -0.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.513 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.34 150.97 29.43 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 123.543 0.527 . . . . 0.0 110.808 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -139.98 -168.41 11.32 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.424 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.58 134.58 41.32 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 120.758 0.313 . . . . 0.0 111.399 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.628 ' SG ' ' HB3' ' A' ' 4' ' ' ALA . 80.1 m -80.31 107.85 13.44 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.35 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -112.55 147.5 36.49 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.736 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.442 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.73 129.37 34.6 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.299 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.424 -0.798 . . . . 0.0 111.517 -179.622 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.27 . . . . . . . 0 C--O 1.236 0.369 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 133.78 43.49 0.14 Allowed Glycine 0 C--N 1.339 0.71 0 O-C-N 123.494 0.496 . . . . 0.0 112.764 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.4 t -137.1 112.01 8.92 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.912 0.387 . . . . 0.0 110.927 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.606 ' HB1' ' SG ' ' A' ' 34' ' ' CYS . . . -118.41 148.82 42.15 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.668 179.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -91.84 169.85 10.36 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.14 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.502 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 22.5 tt0 -63.98 137.14 57.87 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 120.732 0.301 . . . . 0.0 111.055 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.01 -5.01 81.4 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.959 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -93.95 157.69 15.99 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 122.688 0.395 . . . . 0.0 110.663 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.552 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.9 t -97.16 115.73 28.08 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.999 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.517 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.3 p -118.83 153.66 34.13 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.566 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.513 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 5.7 m-80 -100.73 138.37 37.88 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.754 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.683 HG21 ' O ' ' A' ' 28' ' ' GLY . 33.8 m -92.11 20.19 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 120.928 0.394 . . . . 0.0 110.994 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.85 -29.91 7.23 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.807 -178.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -149.03 -44.75 0.14 Allowed 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -115.47 73.92 4.18 Favored Pre-proline 0 CA--C 1.548 0.878 0 O-C-N 123.21 0.319 . . . . 0.0 111.429 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.53 -172.53 0.94 Allowed 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.826 2.351 . . . . 0.0 113.037 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.517 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 87.8 m -70.77 -176.26 1.28 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 122.395 0.278 . . . . 0.0 111.123 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 17.8 m -85.53 118.53 70.86 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 122.361 0.264 . . . . 0.0 111.342 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -78.62 158.34 28.49 Favored 'Trans proline' 0 C--N 1.37 1.662 0 C-N-CA 122.663 2.242 . . . . 0.0 112.939 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.14 -32.57 5.35 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.845 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.8 mt -83.71 -60.34 2.15 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 122.696 0.398 . . . . 0.0 110.978 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.2 36.47 0.3 Allowed Glycine 0 C--N 1.34 0.798 0 O-C-N 123.378 0.424 . . . . 0.0 113.303 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.63 155.61 18.72 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.826 0.346 . . . . 0.0 111.41 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.9 t -142.87 129.26 20.03 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.307 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.09 123.73 30.95 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 123.28 0.362 . . . . 0.0 110.823 179.838 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.8 mm -123.2 120.38 27.32 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.223 -178.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.32 -31.72 5.02 Favored 'Cis proline' 0 C--N 1.37 1.704 0 C-N-CA 124.196 -1.168 . . . . 0.0 113.178 -0.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.683 ' O ' HG21 ' A' ' 12' ' ' VAL . . . 100.5 -24.88 30.41 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.848 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -113.64 112.21 48.48 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 117.213 0.507 . . . . 0.0 111.005 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.82 -25.25 8.16 Favored 'Cis proline' 0 C--N 1.377 2.05 0 CA-C-N 119.381 0.815 . . . . 0.0 113.328 -0.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.513 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.1 p-10 -153.37 151.05 29.5 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.745 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.552 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.22 -168.44 11.35 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.441 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.7 OUTLIER -98.58 134.51 41.43 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 120.714 0.292 . . . . 0.0 111.501 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.606 ' SG ' ' HB1' ' A' ' 4' ' ' ALA . 89.4 m -80.16 107.7 13.17 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.287 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -112.41 147.44 36.44 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.86 -1.063 . . . . 0.0 110.698 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.44 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.71 129.63 34.9 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.315 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.1 mt . . . . . 0 C--O 1.25 1.113 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.46 -179.555 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.272 . . . . . . . 0 C--O 1.235 0.316 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 110.41 52.0 0.6 Allowed Glycine 0 C--N 1.337 0.607 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.773 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.6 t -139.37 112.62 8.18 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 120.735 0.303 . . . . 0.0 110.508 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.643 ' HB2' ' SG ' ' A' ' 34' ' ' CYS . . . -116.38 149.65 39.02 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.947 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -93.92 168.87 10.69 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.695 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.5 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 24.3 tt0 -62.99 136.71 57.98 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.763 0.316 . . . . 0.0 111.082 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.06 -4.99 81.63 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.939 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -93.97 157.19 16.23 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 122.651 0.38 . . . . 0.0 110.634 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.551 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 53.5 m -96.72 116.41 29.09 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.26 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.512 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.48 153.97 34.48 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.607 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.513 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 5.9 m-80 -100.77 138.24 38.09 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.771 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -92.05 20.34 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.973 0.416 . . . . 0.0 111.074 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.77 -30.01 7.21 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.835 -178.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.81 -45.01 0.15 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -115.42 74.05 4.13 Favored Pre-proline 0 CA--C 1.547 0.858 0 O-C-N 123.188 0.305 . . . . 0.0 111.351 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.6 -172.43 0.93 Allowed 'Trans proline' 0 C--N 1.367 1.545 0 C-N-CA 122.839 2.359 . . . . 0.0 112.902 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.512 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 89.7 m -70.22 -177.06 1.31 Allowed 'General case' 0 CA--C 1.542 0.665 0 O-C-N 123.194 0.309 . . . . 0.0 111.166 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 16.5 m -84.42 118.33 70.88 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 122.324 0.25 . . . . 0.0 111.343 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.45 157.61 29.02 Favored 'Trans proline' 0 C--N 1.369 1.634 0 C-N-CA 122.673 2.249 . . . . 0.0 113.117 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.69 -32.09 5.77 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.889 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.6 mt -84.23 -60.47 2.08 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.614 0.366 . . . . 0.0 110.965 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.39 36.33 0.3 Allowed Glycine 0 C--N 1.341 0.857 0 O-C-N 123.458 0.474 . . . . 0.0 113.269 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.39 155.65 18.8 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.908 0.354 . . . . 0.0 111.391 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.74 129.18 20.1 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.341 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.03 123.63 30.8 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 123.273 0.358 . . . . 0.0 110.824 179.865 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.4 mm -123.16 120.36 27.36 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.102 -178.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.35 -31.8 4.97 Favored 'Cis proline' 0 C--N 1.372 1.791 0 C-N-CA 124.169 -1.179 . . . . 0.0 113.129 -0.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.683 ' O ' HG23 ' A' ' 12' ' ' VAL . . . 100.66 -24.93 30.22 Favored Glycine 0 C--N 1.338 0.69 0 CA-C-N 115.691 -0.686 . . . . 0.0 113.877 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -113.54 112.09 48.85 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 117.209 0.505 . . . . 0.0 111.053 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -69.89 -25.27 8.17 Favored 'Cis proline' 0 C--N 1.378 2.084 0 CA-C-N 119.437 0.835 . . . . 0.0 113.304 -0.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.513 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.24 150.99 29.56 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.821 179.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.05 -168.32 11.3 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.501 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.6 134.45 41.53 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 120.689 0.281 . . . . 0.0 111.452 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.643 ' SG ' ' HB2' ' A' ' 4' ' ' ALA . 83.4 m -80.35 107.7 13.36 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.292 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -112.47 147.42 36.56 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.689 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.439 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.6 129.41 34.75 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.332 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.122 -0.942 . . . . 0.0 111.507 -179.567 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.275 . . . . . . . 0 N--CA 1.467 0.398 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 98.86 53.85 1.16 Allowed Glycine 0 C--N 1.339 0.708 0 O-C-N 123.348 0.405 . . . . 0.0 112.55 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -135.58 113.26 10.89 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 120.734 0.302 . . . . 0.0 110.432 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.584 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -118.12 147.9 42.85 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.835 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -91.63 172.12 8.71 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.041 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.5 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.4 tt0 -65.4 137.49 57.51 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.833 0.349 . . . . 0.0 111.024 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.75 -5.2 79.75 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 115.32 -0.855 . . . . 0.0 113.025 -179.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -93.66 157.2 16.29 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 122.719 0.408 . . . . 0.0 110.63 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.555 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.3 t -96.86 115.43 27.41 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.98 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.507 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -118.6 153.73 33.79 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.591 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.514 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.0 m-80 -100.7 138.2 38.07 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.808 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.686 HG21 ' O ' ' A' ' 28' ' ' GLY . 33.6 m -91.89 20.32 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 120.9 0.381 . . . . 0.0 111.071 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.76 -29.95 7.24 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.803 -178.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -148.94 -45.0 0.14 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -178.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -115.63 74.22 4.56 Favored Pre-proline 0 CA--C 1.548 0.89 0 O-C-N 123.196 0.31 . . . . 0.0 111.34 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.71 -171.98 0.86 Allowed 'Trans proline' 0 C--N 1.367 1.527 0 C-N-CA 122.745 2.296 . . . . 0.0 112.827 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.507 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 92.7 m -70.32 -177.51 1.46 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 122.39 0.276 . . . . 0.0 111.123 179.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.8 m -84.31 118.49 71.3 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 122.369 0.268 . . . . 0.0 111.373 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.43 157.88 29.13 Favored 'Trans proline' 0 C--N 1.37 1.665 0 C-N-CA 122.695 2.263 . . . . 0.0 113.066 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.52 -32.28 5.61 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.894 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.7 mt -84.18 -60.31 2.13 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 122.685 0.394 . . . . 0.0 110.934 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.01 36.36 0.31 Allowed Glycine 0 C--N 1.341 0.847 0 O-C-N 123.406 0.441 . . . . 0.0 113.321 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.39 155.69 18.77 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.868 0.366 . . . . 0.0 111.418 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.77 129.28 20.17 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.325 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.08 123.77 30.98 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 123.291 0.369 . . . . 0.0 110.785 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.3 mm -123.3 120.39 27.22 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.104 -178.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.3 -31.84 4.94 Favored 'Cis proline' 0 C--N 1.371 1.75 0 C-N-CA 124.222 -1.158 . . . . 0.0 113.148 -0.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.686 ' O ' HG21 ' A' ' 12' ' ' VAL . . . 100.73 -24.85 30.51 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-O 119.412 -0.66 . . . . 0.0 113.852 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -113.65 112.16 48.49 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 117.158 0.479 . . . . 0.0 110.982 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -69.95 -25.13 8.29 Favored 'Cis proline' 0 C--N 1.379 2.152 0 C-N-CA 125.024 -0.823 . . . . 0.0 113.249 -0.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.514 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p30 -153.39 151.03 29.45 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.767 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.555 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.02 -168.42 11.33 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.484 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.51 134.6 41.25 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.726 0.298 . . . . 0.0 111.359 -179.864 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.584 ' SG ' ' HB3' ' A' ' 4' ' ' ALA . 81.3 m -80.3 107.66 13.28 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.361 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -112.46 147.12 37.17 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.733 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.442 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.47 129.45 34.9 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.24 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.129 -0.938 . . . . 0.0 111.498 -179.597 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.271 . . . . . . . 0 C--O 1.235 0.315 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.71 55.27 1.02 Allowed Glycine 0 C--N 1.337 0.586 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.536 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -137.45 113.08 9.5 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 120.815 0.34 . . . . 0.0 110.425 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.635 ' HB1' ' SG ' ' A' ' 34' ' ' CYS . . . -117.07 148.65 41.33 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.895 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -93.38 169.54 10.29 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.727 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.5 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.7 tt0 -62.94 137.05 58.16 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 120.87 0.367 . . . . 0.0 111.078 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.06 -5.44 79.71 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.956 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -93.53 157.01 16.41 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 122.702 0.401 . . . . 0.0 110.635 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.55 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.2 t -97.03 115.99 28.43 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.995 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.509 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.07 154.03 33.81 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.631 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.516 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.1 m-80 -100.78 138.27 38.05 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.823 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.685 HG21 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -91.95 20.39 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.015 0.436 . . . . 0.0 111.064 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -112.67 -29.9 7.28 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.818 -178.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -149.02 -45.05 0.14 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -115.58 74.1 4.42 Favored Pre-proline 0 CA--C 1.548 0.888 0 O-C-N 123.126 0.266 . . . . 0.0 111.362 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.65 -172.04 0.86 Allowed 'Trans proline' 0 C--N 1.368 1.557 0 C-N-CA 122.743 2.295 . . . . 0.0 112.795 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.509 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 92.4 m -70.23 -177.41 1.4 Allowed 'General case' 0 CA--C 1.543 0.676 0 O-C-N 123.142 0.276 . . . . 0.0 111.161 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 15.6 m -84.11 118.29 70.88 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 122.345 0.258 . . . . 0.0 111.277 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -78.49 157.51 28.86 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 122.593 2.195 . . . . 0.0 113.081 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.77 -32.15 5.75 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.875 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.6 mt -84.26 -60.76 1.99 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 122.607 0.363 . . . . 0.0 110.992 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 133.0 36.15 0.28 Allowed Glycine 0 C--N 1.34 0.779 0 O-C-N 123.475 0.484 . . . . 0.0 113.271 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.63 155.45 18.84 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.91 0.355 . . . . 0.0 111.366 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.9 t -142.55 129.56 20.73 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.384 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.2 123.72 31.03 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.227 0.329 . . . . 0.0 110.807 179.853 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.0 mm -123.23 120.46 27.27 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.062 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.23 -31.83 4.94 Favored 'Cis proline' 0 C--N 1.372 1.781 0 C-N-CA 124.131 -1.196 . . . . 0.0 113.208 -0.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.685 ' O ' HG21 ' A' ' 12' ' ' VAL . . . 100.76 -24.89 30.37 Favored Glycine 0 C--N 1.338 0.667 0 CA-C-N 115.712 -0.677 . . . . 0.0 113.844 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.58 112.16 48.69 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 117.209 0.504 . . . . 0.0 111.026 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -69.85 -25.25 8.17 Favored 'Cis proline' 0 C--N 1.378 2.088 0 CA-C-N 119.372 0.811 . . . . 0.0 113.347 -0.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.516 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.3 151.01 29.52 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.774 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.55 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.02 -168.52 11.36 Favored Glycine 0 C--N 1.336 0.545 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.393 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.41 134.72 41.02 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 120.719 0.295 . . . . 0.0 111.499 -179.977 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.635 ' SG ' ' HB1' ' A' ' 4' ' ' ALA . 79.4 m -80.44 107.84 13.57 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.325 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -112.54 147.65 36.15 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.758 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.442 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.84 129.44 34.59 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.274 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.485 -0.769 . . . . 0.0 111.473 -179.575 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.273 . . . . . . . 0 C--O 1.235 0.335 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 111.89 51.64 0.56 Allowed Glycine 0 C--N 1.336 0.541 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.789 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.6 t -139.76 112.66 8.06 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 120.766 0.317 . . . . 0.0 110.517 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.644 ' HB1' ' SG ' ' A' ' 34' ' ' CYS . . . -116.45 149.63 39.15 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.866 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -94.05 168.78 10.73 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.65 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 24.1 tt0 -62.76 136.54 57.91 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.785 0.326 . . . . 0.0 111.053 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.31 -5.1 81.95 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.956 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -93.71 157.26 16.25 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 122.745 0.418 . . . . 0.0 110.693 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.55 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.1 t -96.95 116.07 28.54 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.082 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.511 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.3 153.95 34.26 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.627 179.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.514 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.0 m-80 -100.76 138.28 38.02 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.766 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.683 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.6 m -91.99 20.3 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 120.914 0.388 . . . . 0.0 111.083 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.79 -30.05 7.2 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.835 -178.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.8 -44.97 0.15 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -115.44 74.07 4.18 Favored Pre-proline 0 CA--C 1.548 0.893 0 O-C-N 123.177 0.298 . . . . 0.0 111.379 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.61 -172.31 0.91 Allowed 'Trans proline' 0 C--N 1.368 1.567 0 C-N-CA 122.792 2.328 . . . . 0.0 112.906 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.511 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 88.8 m -70.21 -177.01 1.29 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 122.414 0.286 . . . . 0.0 111.218 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 16.5 m -84.49 118.36 70.93 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 122.346 0.258 . . . . 0.0 111.321 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -78.58 157.66 28.55 Favored 'Trans proline' 0 C--N 1.368 1.568 0 C-N-CA 122.727 2.285 . . . . 0.0 113.071 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.66 -32.2 5.7 Favored Glycine 0 C--N 1.338 0.67 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.842 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.5 mt -84.11 -60.92 1.95 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 122.64 0.376 . . . . 0.0 111.016 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 133.03 36.26 0.28 Allowed Glycine 0 C--N 1.342 0.869 0 O-C-N 123.414 0.446 . . . . 0.0 113.217 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.56 155.58 18.77 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.919 0.36 . . . . 0.0 111.392 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.9 t -142.68 129.28 20.27 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.363 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.12 123.77 31.02 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 123.278 0.361 . . . . 0.0 110.785 179.857 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.3 mm -123.28 120.39 27.24 Favored Pre-proline 0 CA--C 1.541 0.629 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.062 -178.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.32 -31.8 4.97 Favored 'Cis proline' 0 C--N 1.372 1.764 0 C-N-CA 124.231 -1.154 . . . . 0.0 113.148 -0.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.683 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.6 -24.86 30.48 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-O 119.358 -0.69 . . . . 0.0 113.815 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -113.65 112.18 48.47 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-N 117.212 0.506 . . . . 0.0 111.035 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.92 -25.17 8.25 Favored 'Cis proline' 0 C--N 1.378 2.084 0 C-N-CA 125.016 -0.827 . . . . 0.0 113.303 -0.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.514 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.35 151.03 29.5 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.798 179.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.55 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.17 -168.41 11.34 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.453 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.57 134.47 41.48 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 120.765 0.317 . . . . 0.0 111.476 -179.909 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.644 ' SG ' ' HB1' ' A' ' 4' ' ' ALA . 85.4 m -80.36 107.72 13.39 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.327 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -112.4 147.79 35.7 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.714 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.442 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.5 m-85 -78.89 129.52 34.63 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.284 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.103 -0.951 . . . . 0.0 111.429 -179.526 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.272 . . . . . . . 0 C--O 1.234 0.268 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 100.83 55.11 0.95 Allowed Glycine 0 C--N 1.336 0.529 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.526 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.89 113.15 9.89 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.755 0.312 . . . . 0.0 110.431 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.614 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -117.78 148.17 42.31 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.805 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -92.26 172.09 8.64 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.034 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.5 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 24.2 tt0 -65.15 136.92 57.26 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.521 0.328 . . . . 0.0 111.021 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.88 -5.09 80.69 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.983 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -93.66 157.06 16.36 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 122.729 0.412 . . . . 0.0 110.669 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.551 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 52.6 m -96.93 116.09 28.57 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.211 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.505 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.16 155.01 32.4 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.658 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.523 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.5 m-80 -101.7 138.53 38.56 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.78 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.695 HG23 ' O ' ' A' ' 28' ' ' GLY . 35.7 m -91.86 21.22 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 120.91 0.386 . . . . 0.0 111.216 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -113.81 -31.05 6.56 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.931 -178.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -147.54 -44.94 0.17 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -115.69 74.2 4.65 Favored Pre-proline 0 CA--C 1.547 0.864 0 O-C-N 123.175 0.297 . . . . 0.0 111.304 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.67 -172.21 0.9 Allowed 'Trans proline' 0 C--N 1.367 1.537 0 C-N-CA 122.77 2.313 . . . . 0.0 112.8 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.505 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 93.0 m -70.17 -177.5 1.41 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 122.394 0.278 . . . . 0.0 111.152 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.9 m -84.36 118.38 71.03 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 122.222 0.209 . . . . 0.0 111.372 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.5 157.82 28.88 Favored 'Trans proline' 0 C--N 1.369 1.658 0 C-N-CA 122.654 2.236 . . . . 0.0 113.087 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.56 -32.17 5.69 Favored Glycine 0 C--N 1.337 0.598 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.882 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.5 mt -84.25 -60.39 2.1 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.671 0.388 . . . . 0.0 110.97 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.24 36.45 0.3 Allowed Glycine 0 C--N 1.342 0.884 0 O-C-N 123.393 0.433 . . . . 0.0 113.269 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.49 155.8 18.64 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.88 0.372 . . . . 0.0 111.356 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.66 128.79 19.75 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.316 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -84.87 123.76 30.84 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 123.226 0.329 . . . . 0.0 110.792 179.853 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.4 mm -122.98 119.84 27.72 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.236 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.12 -31.29 5.28 Favored 'Cis proline' 0 C--N 1.371 1.757 0 C-N-CA 124.147 -1.189 . . . . 0.0 113.129 -0.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.695 ' O ' HG23 ' A' ' 12' ' ' VAL . . . 100.02 -26.07 25.88 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 115.683 -0.69 . . . . 0.0 113.88 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -115.72 113.37 42.49 Favored Pre-proline 0 CA--C 1.546 0.797 0 CA-C-N 117.211 0.505 . . . . 0.0 111.156 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.59 -27.34 5.92 Favored 'Cis proline' 0 C--N 1.377 2.059 0 CA-C-N 119.323 0.794 . . . . 0.0 113.586 -0.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.523 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.63 151.44 29.71 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.783 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -141.37 -168.91 11.68 Favored Glycine 0 C--N 1.336 0.555 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.484 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.51 134.48 41.42 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 120.74 0.305 . . . . 0.0 111.561 -179.839 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.614 ' SG ' ' HB3' ' A' ' 4' ' ' ALA . 82.8 m -80.3 107.88 13.45 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.361 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -112.55 147.38 36.73 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.693 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.44 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.5 m-85 -78.61 129.62 34.99 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.341 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.057 -0.973 . . . . 0.0 111.45 -179.557 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.269 . . . . . . . 0 C--O 1.235 0.333 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.45 49.47 1.84 Allowed Glycine 0 C--N 1.34 0.791 0 O-C-N 123.348 0.405 . . . . 0.0 112.644 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -138.82 113.47 9.05 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 122.451 0.301 . . . . 0.0 110.411 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.61 ' HB1' ' SG ' ' A' ' 34' ' ' CYS . . . -116.26 148.42 40.5 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.927 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -93.32 169.18 10.57 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.691 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.5 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.8 tt0 -62.99 137.21 58.2 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.872 0.368 . . . . 0.0 111.066 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.95 -5.19 80.43 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.999 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -93.66 157.26 16.26 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 122.707 0.403 . . . . 0.0 110.73 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.554 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.1 t -96.89 115.65 27.79 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.074 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -118.8 153.82 33.84 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.604 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.513 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.2 m-80 -100.66 138.25 37.98 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.794 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.686 HG21 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -92.01 20.48 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.971 0.415 . . . . 0.0 111.044 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.82 -29.82 7.27 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.857 -178.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -149.06 -45.13 0.14 Allowed 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -115.58 74.15 4.44 Favored Pre-proline 0 CA--C 1.547 0.843 0 O-C-N 123.09 0.244 . . . . 0.0 111.34 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.73 -171.95 0.85 Allowed 'Trans proline' 0 C--N 1.368 1.562 0 C-N-CA 122.769 2.313 . . . . 0.0 112.826 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 94.5 m -70.2 -177.53 1.42 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 122.382 0.273 . . . . 0.0 111.145 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 15.2 m -83.83 118.27 70.91 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 122.231 0.212 . . . . 0.0 111.298 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -78.53 156.95 28.62 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.623 2.215 . . . . 0.0 113.133 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.18 -32.02 5.95 Favored Glycine 0 C--N 1.338 0.657 0 O-C-N 123.682 0.614 . . . . 0.0 112.872 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.7 mt -84.31 -60.84 1.96 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.664 0.386 . . . . 0.0 111.045 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 133.09 36.2 0.28 Allowed Glycine 0 C--N 1.342 0.87 0 O-C-N 123.511 0.507 . . . . 0.0 113.243 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.6 155.71 18.67 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.838 0.351 . . . . 0.0 111.346 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.79 129.46 20.33 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.28 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.24 123.79 31.13 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 123.237 0.335 . . . . 0.0 110.785 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.7 mm -123.28 120.49 27.21 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.11 -178.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.29 -31.73 5.01 Favored 'Cis proline' 0 C--N 1.371 1.74 0 C-N-CA 124.182 -1.174 . . . . 0.0 113.117 -0.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.686 ' O ' HG21 ' A' ' 12' ' ' VAL . . . 100.67 -24.9 30.3 Favored Glycine 0 C--N 1.338 0.662 0 CA-C-N 115.788 -0.642 . . . . 0.0 113.859 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.65 112.19 48.46 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 117.225 0.513 . . . . 0.0 111.008 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -69.94 -25.17 8.26 Favored 'Cis proline' 0 C--N 1.378 2.095 0 C-N-CA 125.062 -0.807 . . . . 0.0 113.292 -0.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.513 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p30 -153.4 150.94 29.36 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.811 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.554 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -139.94 -168.34 11.3 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.498 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.46 134.65 41.15 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.76 0.314 . . . . 0.0 111.437 -179.917 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.61 ' SG ' ' HB1' ' A' ' 4' ' ' ALA . 78.5 m -80.51 107.82 13.63 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.358 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -112.54 147.61 36.25 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.709 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.446 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.81 129.43 34.59 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.269 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.555 -0.736 . . . . 0.0 111.452 -179.552 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.27 . . . . . . . 0 C--O 1.235 0.309 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 126.77 42.0 0.29 Allowed Glycine 0 C--N 1.337 0.591 0 O-C-N 123.716 0.635 . . . . 0.0 112.915 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.6 t -141.96 112.86 7.37 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 120.743 0.306 . . . . 0.0 110.623 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.642 ' HB1' ' SG ' ' A' ' 34' ' ' CYS . . . -115.99 149.82 38.2 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.877 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -94.24 168.67 10.77 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.64 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.5 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 24.6 tt0 -63.07 136.73 57.97 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.747 0.308 . . . . 0.0 111.088 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.02 -4.83 81.95 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.913 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -93.88 157.63 16.04 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 122.725 0.41 . . . . 0.0 110.705 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.551 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.1 t -96.92 116.1 28.59 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.066 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.514 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.3 p -119.39 153.75 34.7 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.609 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.512 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.1 m-80 -100.72 138.22 38.06 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.775 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 28' ' ' GLY . 33.5 m -92.03 20.31 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.926 0.394 . . . . 0.0 111.04 -179.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.86 -29.9 7.23 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.849 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -148.97 -44.86 0.14 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -115.38 74.07 4.08 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 122.259 0.223 . . . . 0.0 111.36 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.71 -172.41 0.94 Allowed 'Trans proline' 0 C--N 1.367 1.505 0 C-N-CA 122.821 2.347 . . . . 0.0 112.921 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.514 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 88.8 m -70.38 -176.86 1.31 Allowed 'General case' 0 CA--C 1.543 0.692 0 O-C-N 123.168 0.293 . . . . 0.0 111.168 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 17.1 m -84.68 118.36 70.85 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 122.327 0.251 . . . . 0.0 111.348 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.54 157.74 28.7 Favored 'Trans proline' 0 C--N 1.368 1.587 0 C-N-CA 122.705 2.27 . . . . 0.0 113.114 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.64 -32.19 5.7 Favored Glycine 0 C--N 1.337 0.59 0 O-C-N 123.669 0.606 . . . . 0.0 112.853 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.7 mt -84.22 -60.2 2.16 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 122.624 0.37 . . . . 0.0 110.991 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.15 36.28 0.31 Allowed Glycine 0 C--N 1.341 0.846 0 O-C-N 123.399 0.437 . . . . 0.0 113.311 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.18 155.7 18.84 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.86 0.33 . . . . 0.0 111.425 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.82 129.08 19.89 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.324 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -84.94 123.72 30.83 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.317 0.386 . . . . 0.0 110.85 179.829 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.2 mm -123.15 120.37 27.38 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.057 -178.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.32 -31.76 4.99 Favored 'Cis proline' 0 C--N 1.371 1.731 0 C-N-CA 124.185 -1.173 . . . . 0.0 113.143 -0.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.683 ' O ' HG23 ' A' ' 12' ' ' VAL . . . 100.58 -24.88 30.38 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.843 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.65 112.15 48.48 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-N 117.187 0.494 . . . . 0.0 111.012 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -69.88 -25.18 8.23 Favored 'Cis proline' 0 C--N 1.378 2.087 0 C-N-CA 125.036 -0.818 . . . . 0.0 113.34 -0.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.512 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p30 -153.39 150.98 29.41 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.796 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.22 -168.27 11.3 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.4 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.54 134.33 41.65 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.697 0.284 . . . . 0.0 111.518 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.642 ' SG ' ' HB1' ' A' ' 4' ' ' ALA . 87.1 m -80.27 107.62 13.22 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.344 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -112.4 147.35 36.62 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.789 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.436 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.3 m-85 -78.61 129.46 34.8 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.259 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--O 1.251 1.152 0 CA-C-O 118.533 -0.746 . . . . 0.0 111.389 -179.548 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.272 . . . . . . . 0 C--O 1.235 0.297 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.66 55.6 1.0 Allowed Glycine 0 C--N 1.335 0.523 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.589 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.64 113.3 10.2 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 120.778 0.323 . . . . 0.0 110.416 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.6 ' HB1' ' SG ' ' A' ' 34' ' ' CYS . . . -117.94 148.08 42.53 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.886 179.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -92.2 171.86 8.8 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.059 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.498 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.3 tt0 -64.88 137.24 57.64 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.726 0.298 . . . . 0.0 111.108 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.73 -5.02 80.53 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.949 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -93.72 157.04 16.35 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 122.697 0.399 . . . . 0.0 110.662 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.551 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.4 t -96.89 115.94 28.3 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.984 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.06 153.96 33.91 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.62 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.514 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.2 m-80 -100.75 138.23 38.08 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.79 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.686 HG21 ' O ' ' A' ' 28' ' ' GLY . 33.6 m -91.96 20.45 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.961 0.41 . . . . 0.0 111.086 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -112.74 -30.09 7.19 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.736 -178.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.78 -45.02 0.15 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -115.69 74.22 4.66 Favored Pre-proline 0 CA--C 1.548 0.888 0 O-C-N 123.114 0.259 . . . . 0.0 111.294 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.72 -171.84 0.83 Allowed 'Trans proline' 0 C--N 1.368 1.557 0 C-N-CA 122.71 2.273 . . . . 0.0 112.886 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 90.5 m -70.27 -177.55 1.45 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 122.405 0.282 . . . . 0.0 111.069 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.7 m -84.28 118.55 71.47 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 122.249 0.22 . . . . 0.0 111.388 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -78.42 158.18 29.21 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 122.715 2.277 . . . . 0.0 113.094 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.27 -32.1 5.65 Favored Glycine 0 C--N 1.337 0.591 0 O-C-N 123.628 0.58 . . . . 0.0 112.882 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.9 mt -84.34 -61.12 1.88 Allowed 'General case' 0 C--O 1.236 0.36 0 C-N-CA 122.668 0.387 . . . . 0.0 111.024 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.91 36.31 0.28 Allowed Glycine 0 C--N 1.341 0.849 0 O-C-N 123.377 0.423 . . . . 0.0 113.214 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.34 156.2 18.43 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.885 0.343 . . . . 0.0 111.318 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.1 t -143.29 129.61 19.91 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.301 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.34 123.79 31.22 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 123.32 0.388 . . . . 0.0 110.848 179.839 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.3 mm -123.3 120.36 27.22 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.116 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.41 -31.76 5.0 Favored 'Cis proline' 0 C--N 1.372 1.768 0 C-N-CA 124.155 -1.185 . . . . 0.0 113.142 -0.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.686 ' O ' HG21 ' A' ' 12' ' ' VAL . . . 100.64 -24.71 31.03 Favored Glycine 0 C--N 1.337 0.601 0 CA-C-O 119.386 -0.675 . . . . 0.0 113.874 179.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.62 112.13 48.6 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 117.198 0.499 . . . . 0.0 111.06 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -69.95 -25.18 8.25 Favored 'Cis proline' 0 C--N 1.376 2.026 0 CA-C-N 119.416 0.827 . . . . 0.0 113.244 -0.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.514 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.1 p30 -153.25 151.08 29.65 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.836 179.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.11 -168.43 11.34 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.46 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.53 134.52 41.37 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 120.77 0.319 . . . . 0.0 111.418 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.6 ' SG ' ' HB1' ' A' ' 4' ' ' ALA . 80.0 m -80.55 107.78 13.64 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.329 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -112.5 147.73 35.93 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.712 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.448 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.3 m-85 -78.11 128.94 34.57 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.171 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.251 1.18 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.451 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.149 0 N-CA-C 112.602 -0.199 . . . . 0.0 112.602 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.72 113.14 9.99 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 120.803 0.335 . . . . 0.0 110.398 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.462 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -117.8 148.93 41.61 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.918 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -93.19 172.48 8.27 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.981 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 24.5 tt0 -65.35 136.81 56.99 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.813 0.34 . . . . 0.0 111.01 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.04 -5.36 79.96 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.941 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -93.54 156.79 16.53 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 122.721 0.409 . . . . 0.0 110.647 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 51.7 m -96.88 116.23 28.81 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.199 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.26 154.17 33.88 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.646 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.522 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.0 m-80 -100.85 138.27 38.13 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.773 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.644 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -91.98 20.45 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.997 0.427 . . . . 0.0 111.051 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.78 -30.13 7.17 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.823 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.72 -45.02 0.15 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -115.56 74.2 4.43 Favored Pre-proline 0 CA--C 1.547 0.852 0 O-C-N 123.19 0.306 . . . . 0.0 111.367 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.59 -172.18 0.88 Allowed 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 122.762 2.308 . . . . 0.0 112.831 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 92.8 m -70.16 -177.69 1.45 Allowed 'General case' 0 CA--C 1.543 0.686 0 O-C-N 123.107 0.255 . . . . 0.0 111.137 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.6 m -84.11 118.6 71.68 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 122.271 0.228 . . . . 0.0 111.334 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.49 157.62 28.87 Favored 'Trans proline' 0 C--N 1.369 1.629 0 C-N-CA 122.676 2.251 . . . . 0.0 113.065 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.72 -32.27 5.67 Favored Glycine 0 C--N 1.338 0.661 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.862 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.4 mt -84.15 -60.46 2.09 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 122.643 0.377 . . . . 0.0 111.02 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.28 36.36 0.3 Allowed Glycine 0 C--N 1.341 0.837 0 O-C-N 123.459 0.475 . . . . 0.0 113.286 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.58 155.59 18.76 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.8 0.333 . . . . 0.0 111.381 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.63 129.39 20.45 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.333 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.11 123.69 30.92 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 123.265 0.353 . . . . 0.0 110.818 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.8 mm -123.26 120.45 27.23 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.127 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.37 -31.64 5.07 Favored 'Cis proline' 0 C--N 1.372 1.773 0 C-N-CA 124.192 -1.17 . . . . 0.0 113.169 -0.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.644 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.59 -24.74 30.91 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-N 115.766 -0.652 . . . . 0.0 113.868 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -113.66 112.18 48.45 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 117.205 0.502 . . . . 0.0 111.009 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -69.96 -25.12 8.3 Favored 'Cis proline' 0 C--N 1.378 2.111 0 C-N-CA 124.978 -0.842 . . . . 0.0 113.321 -0.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.522 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.1 p-10 -153.25 150.98 29.54 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.79 179.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.562 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -139.91 -168.54 11.36 Favored Glycine 0 C--N 1.335 0.521 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.473 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.5 134.62 41.21 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.729 0.299 . . . . 0.0 111.459 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 77.4 m -80.35 107.73 13.38 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.355 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -112.51 147.51 36.42 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.691 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.44 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.5 m-85 -78.65 129.41 34.7 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.281 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.1 mt . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.473 -0.775 . . . . 0.0 111.475 -179.554 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.153 0 N-CA-C 112.602 -0.199 . . . . 0.0 112.602 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.87 113.26 9.99 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 122.427 0.291 . . . . 0.0 110.462 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.463 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -117.73 148.16 42.28 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.851 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -92.47 172.2 8.54 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.079 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.511 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.5 tt0 -65.17 137.05 57.38 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.51 0.324 . . . . 0.0 111.015 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.93 -5.41 79.4 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.978 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -93.61 156.81 16.5 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 122.772 0.429 . . . . 0.0 110.682 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 52.9 m -96.8 116.23 28.79 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.18 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.29 154.06 34.08 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.591 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.521 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.0 m-80 -100.75 138.2 38.11 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.801 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.644 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.6 m -91.83 20.34 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 120.945 0.402 . . . . 0.0 111.071 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.71 -30.05 7.22 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.8 -178.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.91 -44.97 0.14 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -115.61 74.16 4.5 Favored Pre-proline 0 CA--C 1.548 0.888 0 O-C-N 123.2 0.312 . . . . 0.0 111.408 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.58 -172.05 0.86 Allowed 'Trans proline' 0 C--N 1.366 1.472 0 C-N-CA 122.768 2.312 . . . . 0.0 112.86 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 93.7 m -70.21 -177.62 1.45 Allowed 'General case' 0 CA--C 1.542 0.663 0 O-C-N 123.155 0.284 . . . . 0.0 111.16 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.7 m -84.15 118.46 71.3 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 122.33 0.252 . . . . 0.0 111.325 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -78.49 157.55 28.87 Favored 'Trans proline' 0 C--N 1.369 1.639 0 C-N-CA 122.64 2.227 . . . . 0.0 113.121 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.77 -32.28 5.68 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.845 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.7 mt -84.14 -60.71 2.01 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 122.617 0.367 . . . . 0.0 110.99 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.66 36.4 0.29 Allowed Glycine 0 C--N 1.341 0.848 0 O-C-N 123.442 0.464 . . . . 0.0 113.312 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.71 155.65 18.66 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.866 0.365 . . . . 0.0 111.389 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.73 129.48 20.43 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.305 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.22 123.74 31.06 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.293 0.37 . . . . 0.0 110.796 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.2 mm -123.18 120.4 27.33 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.132 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -73.45 -31.7 5.04 Favored 'Cis proline' 0 C--N 1.372 1.764 0 C-N-CA 124.217 -1.16 . . . . 0.0 113.136 -0.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.644 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.67 -24.84 30.53 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-O 119.432 -0.649 . . . . 0.0 113.79 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.58 112.17 48.67 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 117.22 0.51 . . . . 0.0 111.001 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -69.85 -25.25 8.17 Favored 'Cis proline' 0 C--N 1.378 2.088 0 CA-C-N 119.386 0.817 . . . . 0.0 113.299 -0.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.521 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.27 151.03 29.57 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.832 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.563 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.06 -168.58 11.39 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 115.811 -0.632 . . . . 0.0 112.458 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.4 134.6 41.17 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.723 0.296 . . . . 0.0 111.46 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 78.9 m -80.32 107.73 13.36 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.329 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -112.51 147.68 36.06 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.727 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.44 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.5 m-85 -78.83 129.43 34.58 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.311 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.156 -0.926 . . . . 0.0 111.44 -179.496 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.134 0 N-CA-C 112.558 -0.217 . . . . 0.0 112.558 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.86 112.98 9.75 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 120.843 0.354 . . . . 0.0 110.382 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.466 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -117.66 148.6 41.82 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.843 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -92.81 172.13 8.54 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.983 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.515 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.9 tt0 -65.16 137.0 57.35 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.796 0.331 . . . . 0.0 110.975 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.88 -5.31 79.69 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.987 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -93.7 156.84 16.47 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 122.648 0.379 . . . . 0.0 110.635 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.561 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 52.3 m -96.86 116.45 29.19 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.185 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.57 154.16 34.32 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.588 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.522 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.0 m-80 -100.84 138.2 38.2 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.782 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.6 m -91.87 20.3 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 120.983 0.421 . . . . 0.0 111.064 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -112.68 -30.03 7.23 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.802 -178.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.8 -45.01 0.15 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -115.58 74.21 4.46 Favored Pre-proline 0 CA--C 1.548 0.891 0 O-C-N 123.091 0.244 . . . . 0.0 111.334 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.65 -172.12 0.88 Allowed 'Trans proline' 0 C--N 1.367 1.545 0 C-N-CA 122.704 2.269 . . . . 0.0 112.824 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 91.9 m -70.18 -177.54 1.42 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 122.427 0.291 . . . . 0.0 111.145 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 15.1 m -84.22 118.55 71.51 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 122.272 0.229 . . . . 0.0 111.408 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -78.55 157.69 28.66 Favored 'Trans proline' 0 C--N 1.368 1.563 0 C-N-CA 122.73 2.287 . . . . 0.0 113.04 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.64 -32.21 5.69 Favored Glycine 0 C--N 1.337 0.632 0 O-C-N 123.717 0.636 . . . . 0.0 112.916 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.9 mt -84.22 -60.79 1.98 Allowed 'General case' 0 C--O 1.236 0.385 0 C-N-CA 122.645 0.378 . . . . 0.0 110.962 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.78 36.26 0.29 Allowed Glycine 0 C--N 1.341 0.813 0 O-C-N 123.447 0.467 . . . . 0.0 113.279 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.63 155.77 18.61 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.921 0.361 . . . . 0.0 111.413 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.86 129.4 20.19 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.36 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.17 123.68 30.96 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.299 0.374 . . . . 0.0 110.801 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.4 mm -123.22 120.47 27.28 Favored Pre-proline 0 CA--C 1.542 0.649 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.099 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.39 -31.59 5.1 Favored 'Cis proline' 0 C--N 1.371 1.746 0 C-N-CA 124.192 -1.17 . . . . 0.0 113.19 -0.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.643 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.51 -24.77 30.83 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 115.747 -0.66 . . . . 0.0 113.891 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.67 112.17 48.44 Favored Pre-proline 0 CA--C 1.542 0.673 0 CA-C-N 117.199 0.499 . . . . 0.0 111.025 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -69.87 -25.25 8.18 Favored 'Cis proline' 0 C--N 1.378 2.088 0 C-N-CA 125.069 -0.804 . . . . 0.0 113.298 -0.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.522 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.24 150.98 29.55 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.782 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.561 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.05 -168.43 11.34 Favored Glycine 0 C--N 1.336 0.533 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.461 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.53 134.64 41.21 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.77 0.319 . . . . 0.0 111.436 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 79.9 m -80.28 107.76 13.34 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.334 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -112.59 147.76 36.0 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.654 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.44 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.5 m-85 -78.81 129.36 34.52 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.279 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.134 -0.936 . . . . 0.0 111.45 -179.603 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.169 0 N-CA-C 112.587 -0.205 . . . . 0.0 112.587 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.23 113.69 10.85 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.832 0.349 . . . . 0.0 110.45 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.469 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -119.14 146.71 44.91 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.776 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -92.18 173.67 7.7 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.985 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.5 tt0 -65.22 137.42 57.58 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.792 0.33 . . . . 0.0 111.204 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.84 -5.74 77.57 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 115.254 -0.885 . . . . 0.0 113.085 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -93.47 156.36 16.8 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 122.625 0.37 . . . . 0.0 110.778 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.559 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 53.3 m -96.88 116.2 28.76 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.127 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.17 154.32 33.5 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.673 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.527 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 5.9 m-80 -101.09 138.33 38.28 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.749 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.644 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.6 m -91.9 20.37 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 120.954 0.407 . . . . 0.0 110.99 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -112.58 -29.92 7.3 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.825 -178.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -149.03 -45.2 0.14 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -115.49 74.16 4.3 Favored Pre-proline 0 CA--C 1.548 0.891 0 O-C-N 123.185 0.303 . . . . 0.0 111.369 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.63 -172.03 0.86 Allowed 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 122.73 2.287 . . . . 0.0 112.798 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 95.4 m -70.26 -177.92 1.55 Allowed 'General case' 0 CA--C 1.543 0.701 0 O-C-N 123.128 0.268 . . . . 0.0 111.13 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.6 m -83.94 118.35 71.11 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 122.237 0.215 . . . . 0.0 111.28 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -78.44 157.87 29.11 Favored 'Trans proline' 0 C--N 1.368 1.604 0 C-N-CA 122.679 2.253 . . . . 0.0 113.128 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.49 -32.03 5.75 Favored Glycine 0 C--N 1.338 0.664 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.858 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.2 mt -84.51 -60.59 2.02 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.63 0.372 . . . . 0.0 111.002 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.72 36.04 0.3 Allowed Glycine 0 C--N 1.341 0.813 0 O-C-N 123.425 0.453 . . . . 0.0 113.327 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.67 155.34 18.91 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.866 0.365 . . . . 0.0 111.361 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.9 t -142.29 129.75 21.28 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.357 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.42 123.72 31.19 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.3 0.375 . . . . 0.0 110.808 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.1 mm -123.07 120.48 27.43 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.092 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.5 -31.39 5.24 Favored 'Cis proline' 0 C--N 1.37 1.688 0 C-N-CA 124.166 -1.181 . . . . 0.0 113.175 -0.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.644 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.36 -24.59 31.49 Favored Glycine 0 C--N 1.338 0.656 0 CA-C-N 115.75 -0.659 . . . . 0.0 113.891 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -113.7 112.06 48.42 Favored Pre-proline 0 CA--C 1.543 0.673 0 CA-C-N 117.218 0.509 . . . . 0.0 111.079 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -69.77 -25.35 8.07 Favored 'Cis proline' 0 C--N 1.378 2.106 0 CA-C-N 119.404 0.823 . . . . 0.0 113.313 -0.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.527 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.13 151.18 29.86 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.744 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.22 -168.67 11.43 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.429 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.33 134.67 41.02 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 120.769 0.319 . . . . 0.0 111.489 -179.906 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 77.9 m -80.24 107.98 13.47 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.3 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -112.82 147.42 36.98 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.769 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.441 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.5 m-85 -78.68 129.75 35.07 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.286 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.137 -0.935 . . . . 0.0 111.429 -179.508 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 0.118 0 N-CA-C 112.578 -0.209 . . . . 0.0 112.578 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.67 113.36 10.23 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 120.77 0.319 . . . . 0.0 110.414 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.459 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -117.99 148.32 42.33 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.887 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -92.4 172.32 8.47 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.971 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.51 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.9 tt0 -65.36 137.07 57.26 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.767 0.318 . . . . 0.0 111.056 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.92 -5.3 79.84 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 115.311 -0.859 . . . . 0.0 113.038 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -93.46 156.97 16.45 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 122.66 0.384 . . . . 0.0 110.656 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.567 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.1 t -96.94 115.91 28.27 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.085 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.507 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.04 154.02 33.78 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.629 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.521 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.1 m-80 -100.8 138.25 38.11 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.784 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -91.99 20.5 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.032 0.444 . . . . 0.0 111.072 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -112.82 -30.0 7.2 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.796 -178.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -148.9 -45.07 0.14 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -178.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -115.57 74.2 4.44 Favored Pre-proline 0 CA--C 1.547 0.852 0 O-C-N 123.053 0.22 . . . . 0.0 111.37 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.67 -172.03 0.86 Allowed 'Trans proline' 0 C--N 1.367 1.535 0 C-N-CA 122.758 2.305 . . . . 0.0 112.8 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.507 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 93.2 m -70.22 -177.62 1.46 Allowed 'General case' 0 CA--C 1.542 0.663 0 O-C-N 123.152 0.282 . . . . 0.0 111.126 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.9 m -84.26 118.56 71.5 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 122.29 0.236 . . . . 0.0 111.379 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.51 157.85 28.85 Favored 'Trans proline' 0 C--N 1.37 1.658 0 C-N-CA 122.606 2.204 . . . . 0.0 113.073 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.53 -32.22 5.65 Favored Glycine 0 C--N 1.338 0.659 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.897 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.5 mt -84.19 -60.42 2.1 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 122.693 0.397 . . . . 0.0 111.023 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.19 36.42 0.3 Allowed Glycine 0 C--N 1.341 0.831 0 O-C-N 123.413 0.445 . . . . 0.0 113.248 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.51 155.72 18.69 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.891 0.345 . . . . 0.0 111.455 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.74 129.39 20.32 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.32 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.21 123.74 31.06 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.253 0.346 . . . . 0.0 110.843 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.2 mm -123.26 120.39 27.25 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.087 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.34 -31.74 5.01 Favored 'Cis proline' 0 C--N 1.371 1.75 0 C-N-CA 124.188 -1.172 . . . . 0.0 113.201 -0.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.643 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.66 -24.85 30.49 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-N 115.747 -0.66 . . . . 0.0 113.805 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -113.61 112.22 48.56 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 117.253 0.527 . . . . 0.0 111.057 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.87 -25.18 8.22 Favored 'Cis proline' 0 C--N 1.378 2.088 0 C-N-CA 125.038 -0.818 . . . . 0.0 113.278 -0.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.521 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.1 p30 -153.34 150.93 29.39 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.814 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -139.95 -168.43 11.33 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.5 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.5 134.56 41.29 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.731 0.3 . . . . 0.0 111.494 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 79.7 m -80.27 107.67 13.26 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.392 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -112.43 147.43 36.48 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.744 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.439 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.67 129.4 34.68 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.322 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--O 1.252 1.189 0 CA-C-O 118.483 -0.77 . . . . 0.0 111.511 -179.539 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.193 0 N-CA-C 112.563 -0.215 . . . . 0.0 112.563 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.62 113.31 10.21 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 120.708 0.29 . . . . 0.0 110.472 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.459 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -117.99 148.33 42.32 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.847 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -92.3 172.33 8.47 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.999 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.7 tt0 -65.42 137.03 57.2 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.771 0.32 . . . . 0.0 111.046 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.89 -5.21 80.15 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.982 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -93.46 157.07 16.4 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 122.711 0.404 . . . . 0.0 110.712 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.567 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.6 t -96.97 115.86 28.18 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.961 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.508 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.04 153.84 34.09 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.601 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.521 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.1 m-80 -100.72 138.24 38.04 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.794 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -91.93 20.46 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.97 0.414 . . . . 0.0 111.086 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.86 -30.01 7.19 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.764 -178.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.84 -45.13 0.15 Allowed 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -178.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -115.55 74.18 4.4 Favored Pre-proline 0 CA--C 1.547 0.855 0 O-C-N 123.088 0.243 . . . . 0.0 111.319 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.5 -171.99 0.84 Allowed 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 122.741 2.294 . . . . 0.0 112.907 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.508 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 93.0 m -70.29 -177.58 1.47 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 122.431 0.293 . . . . 0.0 111.152 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.9 m -84.31 118.48 71.3 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 122.328 0.251 . . . . 0.0 111.384 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -78.46 157.83 29.02 Favored 'Trans proline' 0 C--N 1.368 1.599 0 C-N-CA 122.711 2.274 . . . . 0.0 113.044 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.52 -32.27 5.62 Favored Glycine 0 C--N 1.338 0.669 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.895 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.5 mt -84.12 -60.44 2.09 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 122.706 0.403 . . . . 0.0 111.024 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.22 36.37 0.3 Allowed Glycine 0 C--N 1.341 0.86 0 O-C-N 123.476 0.485 . . . . 0.0 113.251 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -90.54 155.63 18.75 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.903 0.383 . . . . 0.0 111.426 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.9 t -142.53 129.23 20.4 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.345 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.08 123.77 30.99 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 123.217 0.323 . . . . 0.0 110.785 179.852 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.2 mm -123.22 120.41 27.29 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.126 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.38 -31.73 5.01 Favored 'Cis proline' 0 C--N 1.371 1.75 0 C-N-CA 124.159 -1.184 . . . . 0.0 113.146 -0.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.643 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.71 -25.03 29.86 Favored Glycine 0 C--N 1.338 0.677 0 CA-C-N 115.694 -0.685 . . . . 0.0 113.767 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -113.5 112.18 48.9 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 117.235 0.517 . . . . 0.0 111.023 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -69.96 -25.04 8.35 Favored 'Cis proline' 0 C--N 1.379 2.148 0 C-N-CA 124.995 -0.835 . . . . 0.0 113.367 -0.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.521 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.1 p-10 -153.49 150.96 29.29 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.803 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.08 -168.45 11.34 Favored Glycine 0 C--N 1.335 0.519 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.492 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.44 134.63 41.16 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 120.77 0.319 . . . . 0.0 111.446 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 78.2 m -80.39 107.71 13.42 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.319 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -112.38 147.42 36.45 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.693 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.44 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.5 m-85 -78.56 129.5 34.89 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.356 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.5 mt . . . . . 0 C--O 1.252 1.201 0 CA-C-O 118.526 -0.749 . . . . 0.0 111.474 -179.57 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.191 0 CA-C-O 120.263 -0.187 . . . . 0.0 112.73 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -138.84 113.87 9.36 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.777 0.323 . . . . 0.0 110.482 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.477 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -117.17 147.97 42.0 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.904 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -92.67 172.74 8.17 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.027 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.51 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.6 tt0 -65.81 137.3 57.14 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.8 0.334 . . . . 0.0 110.951 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.81 -5.29 79.54 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 115.267 -0.879 . . . . 0.0 113.023 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -93.77 157.01 16.35 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 122.651 0.38 . . . . 0.0 110.733 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.564 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 52.7 m -96.75 116.07 28.51 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.182 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.05 153.93 33.95 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.656 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.522 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.1 m-80 -100.71 138.26 38.0 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.824 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -91.98 20.47 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.912 0.387 . . . . 0.0 110.967 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.85 -29.79 7.27 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.817 -178.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -149.09 -45.01 0.14 Allowed 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -115.67 74.13 4.59 Favored Pre-proline 0 CA--C 1.548 0.884 0 O-C-N 123.193 0.308 . . . . 0.0 111.304 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.65 -171.92 0.84 Allowed 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 122.739 2.293 . . . . 0.0 112.892 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 95.3 m -70.16 -177.84 1.49 Allowed 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.163 0.289 . . . . 0.0 111.082 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.5 m -83.84 118.46 71.45 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 122.294 0.238 . . . . 0.0 111.367 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -78.53 157.25 28.67 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.681 2.254 . . . . 0.0 113.065 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.94 -32.22 5.76 Favored Glycine 0 C--N 1.338 0.64 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.891 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.8 mt -84.17 -60.61 2.04 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 122.674 0.389 . . . . 0.0 110.993 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.49 36.4 0.29 Allowed Glycine 0 C--N 1.34 0.794 0 O-C-N 123.489 0.493 . . . . 0.0 113.249 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.61 155.71 18.66 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.884 0.374 . . . . 0.0 111.379 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.7 129.42 20.41 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.301 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.2 123.74 31.05 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.275 0.359 . . . . 0.0 110.794 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.1 mm -123.23 120.42 27.28 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.149 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.29 -31.84 4.94 Favored 'Cis proline' 0 C--N 1.371 1.717 0 C-N-CA 124.166 -1.181 . . . . 0.0 113.155 -0.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.643 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.69 -24.83 30.56 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-O 119.413 -0.659 . . . . 0.0 113.878 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -113.58 112.13 48.7 Favored Pre-proline 0 CA--C 1.543 0.705 0 CA-C-N 117.239 0.52 . . . . 0.0 111.072 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -69.91 -25.26 8.19 Favored 'Cis proline' 0 C--N 1.377 2.032 0 CA-C-N 119.386 0.816 . . . . 0.0 113.251 -0.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.522 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.28 151.0 29.52 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.84 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -139.89 -168.43 11.32 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.522 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.59 134.62 41.27 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 120.733 0.302 . . . . 0.0 111.38 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 76.5 m -80.38 107.82 13.49 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.398 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -112.51 147.36 36.74 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.72 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.439 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.62 129.5 34.84 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.256 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.08 -0.962 . . . . 0.0 111.466 -179.547 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.187 0 CA-C-O 120.249 -0.195 . . . . 0.0 112.857 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -141.26 113.07 7.74 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 120.724 0.297 . . . . 0.0 110.592 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.498 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -116.57 149.11 40.17 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.846 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -93.8 171.66 8.73 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.514 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.8 tt0 -65.02 136.8 57.21 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 122.482 0.313 . . . . 0.0 111.002 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.9 -5.0 81.13 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.966 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -94.02 157.13 16.24 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 122.673 0.389 . . . . 0.0 110.672 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.56 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 52.3 m -96.85 116.76 29.72 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.194 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.512 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.84 154.03 34.91 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.622 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.521 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.1 m-80 -100.77 138.19 38.15 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.719 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -91.87 20.24 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 120.909 0.385 . . . . 0.0 111.097 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.79 -29.93 7.24 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.842 -178.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -148.91 -44.96 0.14 Allowed 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -115.45 73.99 4.17 Favored Pre-proline 0 CA--C 1.548 0.894 0 O-C-N 123.149 0.281 . . . . 0.0 111.375 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.66 -172.3 0.91 Allowed 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 122.743 2.295 . . . . 0.0 112.918 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.512 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 90.6 m -70.32 -177.1 1.34 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 122.408 0.283 . . . . 0.0 111.137 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 16.0 m -84.56 118.47 71.16 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 122.354 0.262 . . . . 0.0 111.274 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -78.57 157.65 28.59 Favored 'Trans proline' 0 C--N 1.368 1.587 0 C-N-CA 122.711 2.274 . . . . 0.0 113.053 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.6 -32.16 5.7 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.89 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.7 mt -84.1 -60.76 2.0 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.643 0.377 . . . . 0.0 111.025 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.78 36.43 0.28 Allowed Glycine 0 C--N 1.341 0.835 0 O-C-N 123.461 0.476 . . . . 0.0 113.218 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.66 155.71 18.64 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.946 0.373 . . . . 0.0 111.427 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.69 129.34 20.33 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.305 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.11 123.68 30.91 Favored 'General case' 0 C--O 1.236 0.391 0 O-C-N 123.201 0.313 . . . . 0.0 110.825 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.3 mm -123.22 120.37 27.3 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.121 -178.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.34 -31.72 5.02 Favored 'Cis proline' 0 C--N 1.371 1.746 0 C-N-CA 124.223 -1.157 . . . . 0.0 113.226 -0.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.642 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.6 -25.03 29.82 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.854 179.359 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -113.54 112.1 48.83 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 117.237 0.519 . . . . 0.0 111.025 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -69.94 -25.14 8.28 Favored 'Cis proline' 0 C--N 1.379 2.147 0 C-N-CA 124.993 -0.836 . . . . 0.0 113.359 -0.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.521 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.39 151.0 29.43 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.784 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.56 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.08 -168.44 11.34 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.499 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.5 134.51 41.37 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 120.717 0.294 . . . . 0.0 111.487 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 83.1 m -80.25 107.62 13.2 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.374 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -112.41 147.72 35.85 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.687 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.437 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.5 m-85 -78.82 129.54 34.72 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.308 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.4 mt . . . . . 0 C--O 1.251 1.165 0 CA-C-O 118.46 -0.781 . . . . 0.0 111.474 -179.542 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.234 0 N-CA-C 112.702 -0.159 . . . . 0.0 112.702 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -138.3 113.82 9.64 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 120.764 0.316 . . . . 0.0 110.479 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.473 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -117.29 147.81 42.24 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.828 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -92.43 172.65 8.25 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.023 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.51 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.3 tt0 -65.63 137.44 57.34 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.822 0.344 . . . . 0.0 111.023 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.8 -5.37 79.11 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.941 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -93.84 157.03 16.33 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 122.639 0.376 . . . . 0.0 110.662 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.566 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 52.6 m -96.69 115.91 28.24 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.209 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.504 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -118.95 153.88 33.9 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.614 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.522 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.0 m-80 -100.68 138.15 38.13 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.814 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -91.91 20.42 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.904 0.383 . . . . 0.0 110.982 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.79 -29.93 7.23 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.764 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.95 -45.12 0.14 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -115.64 74.17 4.54 Favored Pre-proline 0 CA--C 1.548 0.884 0 O-C-N 123.152 0.282 . . . . 0.0 111.32 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.68 -171.93 0.85 Allowed 'Trans proline' 0 C--N 1.367 1.543 0 C-N-CA 122.68 2.253 . . . . 0.0 112.829 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.504 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 94.7 m -70.15 -177.78 1.48 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 122.366 0.267 . . . . 0.0 111.151 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.6 m -83.86 118.47 71.45 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 122.267 0.227 . . . . 0.0 111.373 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.54 157.23 28.66 Favored 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 122.715 2.277 . . . . 0.0 113.095 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.98 -32.2 5.79 Favored Glycine 0 C--N 1.339 0.702 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.854 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.8 mt -84.26 -60.53 2.06 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 122.606 0.362 . . . . 0.0 110.964 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.47 36.33 0.3 Allowed Glycine 0 C--N 1.341 0.828 0 O-C-N 123.472 0.482 . . . . 0.0 113.298 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.52 155.68 18.72 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.836 0.35 . . . . 0.0 111.38 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.66 129.43 20.46 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.32 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.22 123.73 31.05 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 123.258 0.349 . . . . 0.0 110.866 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.9 mm -123.22 120.45 27.28 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.145 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.18 -31.84 4.93 Favored 'Cis proline' 0 C--N 1.372 1.781 0 C-N-CA 124.21 -1.162 . . . . 0.0 113.208 -0.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.643 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.7 -24.85 30.51 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-N 115.75 -0.659 . . . . 0.0 113.898 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -113.7 112.2 48.34 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 117.174 0.487 . . . . 0.0 111.003 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -69.85 -25.28 8.15 Favored 'Cis proline' 0 C--N 1.377 2.051 0 C-N-CA 125.071 -0.804 . . . . 0.0 113.327 -0.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.522 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.29 151.0 29.52 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.803 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -139.94 -168.49 11.34 Favored Glycine 0 C--N 1.335 0.521 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.505 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.44 134.63 41.15 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.762 0.315 . . . . 0.0 111.403 -179.924 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 76.6 m -80.36 107.77 13.42 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.333 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -112.55 147.24 37.03 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.745 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.441 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.53 129.51 34.92 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.368 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--O 1.252 1.203 0 CA-C-O 118.526 -0.749 . . . . 0.0 111.425 -179.5 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.177 0 N-CA-C 112.639 -0.184 . . . . 0.0 112.639 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -137.5 113.38 9.72 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.751 0.31 . . . . 0.0 110.408 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.482 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -118.08 148.63 42.1 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.914 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -93.28 173.49 7.69 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.953 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 24.0 tt0 -66.04 136.86 56.6 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.507 0.323 . . . . 0.0 111.053 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.89 -5.23 80.05 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 115.331 -0.85 . . . . 0.0 113.008 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -93.54 156.79 16.54 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 122.715 0.406 . . . . 0.0 110.624 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 16.8 t -97.03 116.61 29.53 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.044 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.5 p -119.72 154.26 34.39 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.647 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.52 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.0 m-80 -100.89 138.28 38.15 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.734 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -91.99 20.33 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.976 0.417 . . . . 0.0 111.06 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.8 -29.92 7.24 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.833 -178.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.82 -45.02 0.15 Allowed 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -115.57 74.27 4.47 Favored Pre-proline 0 CA--C 1.548 0.888 0 O-C-N 123.178 0.299 . . . . 0.0 111.389 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.68 -172.28 0.91 Allowed 'Trans proline' 0 C--N 1.368 1.574 0 C-N-CA 122.753 2.302 . . . . 0.0 112.825 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 92.5 m -69.96 -177.73 1.4 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 122.511 0.324 . . . . 0.0 111.184 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.1 m -84.56 119.06 72.47 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 122.324 0.25 . . . . 0.0 111.342 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -78.6 159.05 28.63 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 122.657 2.238 . . . . 0.0 113.052 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.65 -31.96 5.56 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.864 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.6 mt -84.7 -60.25 2.12 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 122.643 0.377 . . . . 0.0 111.008 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.46 36.78 0.32 Allowed Glycine 0 C--N 1.341 0.859 0 O-C-N 123.379 0.424 . . . . 0.0 113.268 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -90.4 155.87 18.63 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.935 0.368 . . . . 0.0 111.369 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.78 129.18 20.05 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.381 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.0 123.72 30.88 Favored 'General case' 0 C--O 1.235 0.342 0 O-C-N 123.256 0.347 . . . . 0.0 110.84 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.1 mm -123.19 120.32 27.35 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.18 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.39 -31.7 5.03 Favored 'Cis proline' 0 C--N 1.37 1.7 0 C-N-CA 124.242 -1.149 . . . . 0.0 113.105 -0.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.643 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.51 -24.87 30.44 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-N 115.778 -0.646 . . . . 0.0 113.824 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -113.63 112.15 48.54 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 117.17 0.485 . . . . 0.0 111.008 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -69.9 -25.25 8.19 Favored 'Cis proline' 0 C--N 1.378 2.092 0 C-N-CA 125.061 -0.808 . . . . 0.0 113.335 -0.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.52 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.35 151.04 29.51 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.803 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.562 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.11 -168.5 11.36 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.524 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.33 134.58 41.15 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 120.682 0.277 . . . . 0.0 111.506 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 79.2 m -80.29 107.69 13.29 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.366 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -112.59 147.11 37.34 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.761 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.433 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.3 m-85 -78.31 129.5 35.1 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.364 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.7 mt . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.487 -0.768 . . . . 0.0 111.481 -179.519 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.139 0 N-CA-C 112.586 -0.206 . . . . 0.0 112.586 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -137.75 113.08 9.33 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 120.771 0.32 . . . . 0.0 110.406 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.462 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -116.85 148.74 40.99 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.934 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -93.26 169.22 10.55 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.637 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.9 tt0 -62.89 136.94 58.11 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.78 0.324 . . . . 0.0 111.124 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.05 -5.25 80.52 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.993 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -93.83 157.08 16.31 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 122.707 0.403 . . . . 0.0 110.604 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 53.1 m -96.82 116.05 28.48 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.171 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.508 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.18 153.93 34.12 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.618 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.52 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.0 m-80 -100.69 138.23 38.03 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.827 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.6 m -91.87 20.31 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 120.941 0.401 . . . . 0.0 111.081 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -112.78 -29.86 7.26 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.819 -178.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.98 -45.01 0.14 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -115.59 74.2 4.48 Favored Pre-proline 0 CA--C 1.548 0.89 0 O-C-N 123.108 0.255 . . . . 0.0 111.291 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.68 -172.04 0.87 Allowed 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 122.739 2.293 . . . . 0.0 112.83 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.508 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 93.6 m -70.33 -177.44 1.44 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 122.428 0.291 . . . . 0.0 111.08 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 15.9 m -84.04 118.31 70.96 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 122.305 0.242 . . . . 0.0 111.312 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -78.54 157.4 28.67 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 122.668 2.246 . . . . 0.0 113.088 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.79 -32.19 5.74 Favored Glycine 0 C--N 1.338 0.666 0 CA-C-N 115.976 -0.557 . . . . 0.0 112.893 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.6 mt -84.14 -60.52 2.07 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.66 0.384 . . . . 0.0 111.046 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.61 36.19 0.3 Allowed Glycine 0 C--N 1.341 0.828 0 O-C-N 123.408 0.443 . . . . 0.0 113.315 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.52 155.67 18.72 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.869 0.334 . . . . 0.0 111.409 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.71 129.41 20.38 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.317 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.18 123.76 31.06 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 123.264 0.353 . . . . 0.0 110.811 179.853 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.1 mm -123.18 120.32 27.36 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.121 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -73.37 -31.72 5.02 Favored 'Cis proline' 0 C--N 1.371 1.731 0 C-N-CA 124.165 -1.181 . . . . 0.0 113.141 -0.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.642 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.63 -24.92 30.24 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-O 119.381 -0.677 . . . . 0.0 113.841 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.59 112.16 48.66 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 117.241 0.521 . . . . 0.0 111.021 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -69.96 -25.2 8.25 Favored 'Cis proline' 0 C--N 1.376 2.026 0 CA-C-N 119.343 0.801 . . . . 0.0 113.248 -0.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.52 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.34 150.97 29.43 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 123.543 0.527 . . . . 0.0 110.808 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.565 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -139.98 -168.41 11.32 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.424 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.58 134.58 41.32 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 120.758 0.313 . . . . 0.0 111.399 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 80.1 m -80.31 107.85 13.44 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.35 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -112.55 147.5 36.49 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.736 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.44 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.73 129.37 34.6 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.299 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.424 -0.798 . . . . 0.0 111.517 -179.622 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 0.155 0 CA-C-O 120.319 -0.156 . . . . 0.0 112.764 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.4 t -137.1 112.01 8.92 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.912 0.387 . . . . 0.0 110.927 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.443 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -118.41 148.82 42.15 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.668 179.079 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -91.84 169.85 10.36 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.14 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.514 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 22.5 tt0 -63.98 137.14 57.87 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 120.732 0.301 . . . . 0.0 111.055 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.01 -5.01 81.4 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.959 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -93.95 157.69 15.99 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 122.688 0.395 . . . . 0.0 110.663 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.569 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.9 t -97.16 115.73 28.08 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.999 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.517 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.3 p -118.83 153.66 34.13 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.566 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.519 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 5.7 m-80 -100.73 138.37 37.88 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.754 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.8 m -92.11 20.19 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 120.928 0.394 . . . . 0.0 110.994 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.85 -29.91 7.23 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.807 -178.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -149.03 -44.75 0.14 Allowed 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -115.47 73.92 4.18 Favored Pre-proline 0 CA--C 1.548 0.878 0 O-C-N 123.21 0.319 . . . . 0.0 111.429 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.53 -172.53 0.94 Allowed 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.826 2.351 . . . . 0.0 113.037 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.517 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 87.8 m -70.77 -176.26 1.28 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 122.395 0.278 . . . . 0.0 111.123 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 17.8 m -85.53 118.53 70.86 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 122.361 0.264 . . . . 0.0 111.342 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -78.62 158.34 28.49 Favored 'Trans proline' 0 C--N 1.37 1.662 0 C-N-CA 122.663 2.242 . . . . 0.0 112.939 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.14 -32.57 5.35 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.845 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.8 mt -83.71 -60.34 2.15 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 122.696 0.398 . . . . 0.0 110.978 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.2 36.47 0.3 Allowed Glycine 0 C--N 1.34 0.798 0 O-C-N 123.378 0.424 . . . . 0.0 113.303 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.63 155.61 18.72 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.826 0.346 . . . . 0.0 111.41 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.9 t -142.87 129.26 20.03 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.307 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.09 123.73 30.95 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 123.28 0.362 . . . . 0.0 110.823 179.838 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.8 mm -123.2 120.38 27.32 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.223 -178.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.32 -31.72 5.02 Favored 'Cis proline' 0 C--N 1.37 1.704 0 C-N-CA 124.196 -1.168 . . . . 0.0 113.178 -0.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.643 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.5 -24.88 30.41 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.848 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -113.64 112.21 48.48 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 117.213 0.507 . . . . 0.0 111.005 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.82 -25.25 8.16 Favored 'Cis proline' 0 C--N 1.377 2.05 0 CA-C-N 119.381 0.815 . . . . 0.0 113.328 -0.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.519 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.1 p-10 -153.37 151.05 29.5 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.745 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.569 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.22 -168.44 11.35 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.441 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.7 OUTLIER -98.58 134.51 41.43 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 120.714 0.292 . . . . 0.0 111.501 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 89.4 m -80.16 107.7 13.17 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.287 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -112.41 147.44 36.44 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.86 -1.063 . . . . 0.0 110.698 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.439 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.71 129.63 34.9 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.315 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.1 mt . . . . . 0 C--O 1.25 1.113 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.46 -179.555 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.188 0 CA-C-O 120.298 -0.168 . . . . 0.0 112.773 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.6 t -139.37 112.62 8.18 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 120.735 0.303 . . . . 0.0 110.508 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.475 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -116.38 149.65 39.02 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.947 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -93.92 168.87 10.69 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.695 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.511 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 24.3 tt0 -62.99 136.71 57.98 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.763 0.316 . . . . 0.0 111.082 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.06 -4.99 81.63 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.939 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -93.97 157.19 16.23 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 122.651 0.38 . . . . 0.0 110.634 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.564 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 53.5 m -96.72 116.41 29.09 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.26 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.512 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.48 153.97 34.48 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.607 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.518 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 5.9 m-80 -100.77 138.24 38.09 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.771 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -92.05 20.34 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.973 0.416 . . . . 0.0 111.074 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.77 -30.01 7.21 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.835 -178.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.81 -45.01 0.15 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -115.42 74.05 4.13 Favored Pre-proline 0 CA--C 1.547 0.858 0 O-C-N 123.188 0.305 . . . . 0.0 111.351 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.6 -172.43 0.93 Allowed 'Trans proline' 0 C--N 1.367 1.545 0 C-N-CA 122.839 2.359 . . . . 0.0 112.902 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.512 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 89.7 m -70.22 -177.06 1.31 Allowed 'General case' 0 CA--C 1.542 0.665 0 O-C-N 123.194 0.309 . . . . 0.0 111.166 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 16.5 m -84.42 118.33 70.88 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 122.324 0.25 . . . . 0.0 111.343 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.45 157.61 29.02 Favored 'Trans proline' 0 C--N 1.369 1.634 0 C-N-CA 122.673 2.249 . . . . 0.0 113.117 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.69 -32.09 5.77 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.889 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.6 mt -84.23 -60.47 2.08 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.614 0.366 . . . . 0.0 110.965 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.39 36.33 0.3 Allowed Glycine 0 C--N 1.341 0.857 0 O-C-N 123.458 0.474 . . . . 0.0 113.269 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.39 155.65 18.8 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.908 0.354 . . . . 0.0 111.391 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.74 129.18 20.1 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.341 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.03 123.63 30.8 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 123.273 0.358 . . . . 0.0 110.824 179.865 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.4 mm -123.16 120.36 27.36 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.102 -178.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.35 -31.8 4.97 Favored 'Cis proline' 0 C--N 1.372 1.791 0 C-N-CA 124.169 -1.179 . . . . 0.0 113.129 -0.036 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.642 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.66 -24.93 30.22 Favored Glycine 0 C--N 1.338 0.69 0 CA-C-N 115.691 -0.686 . . . . 0.0 113.877 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -113.54 112.09 48.85 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 117.209 0.505 . . . . 0.0 111.053 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -69.89 -25.27 8.17 Favored 'Cis proline' 0 C--N 1.378 2.084 0 CA-C-N 119.437 0.835 . . . . 0.0 113.304 -0.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.518 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.24 150.99 29.56 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.821 179.15 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.05 -168.32 11.3 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.501 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.6 134.45 41.53 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 120.689 0.281 . . . . 0.0 111.452 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 83.4 m -80.35 107.7 13.36 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.292 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -112.47 147.42 36.56 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.689 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.439 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.6 129.41 34.75 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.332 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.122 -0.942 . . . . 0.0 111.507 -179.567 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.127 0 N-CA-C 112.55 -0.22 . . . . 0.0 112.55 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -135.58 113.26 10.89 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 120.734 0.302 . . . . 0.0 110.432 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.445 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -118.12 147.9 42.85 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.835 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -91.63 172.12 8.71 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.041 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.4 tt0 -65.4 137.49 57.51 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.833 0.349 . . . . 0.0 111.024 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.75 -5.2 79.75 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 115.32 -0.855 . . . . 0.0 113.025 -179.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -93.66 157.2 16.29 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 122.719 0.408 . . . . 0.0 110.63 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.571 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.3 t -96.86 115.43 27.41 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.98 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.507 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -118.6 153.73 33.79 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.591 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.52 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.0 m-80 -100.7 138.2 38.07 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.808 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.6 m -91.89 20.32 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 120.9 0.381 . . . . 0.0 111.071 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.76 -29.95 7.24 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.803 -178.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -148.94 -45.0 0.14 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -178.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -115.63 74.22 4.56 Favored Pre-proline 0 CA--C 1.548 0.89 0 O-C-N 123.196 0.31 . . . . 0.0 111.34 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.71 -171.98 0.86 Allowed 'Trans proline' 0 C--N 1.367 1.527 0 C-N-CA 122.745 2.296 . . . . 0.0 112.827 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.507 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 92.7 m -70.32 -177.51 1.46 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 122.39 0.276 . . . . 0.0 111.123 179.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.8 m -84.31 118.49 71.3 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 122.369 0.268 . . . . 0.0 111.373 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.43 157.88 29.13 Favored 'Trans proline' 0 C--N 1.37 1.665 0 C-N-CA 122.695 2.263 . . . . 0.0 113.066 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.52 -32.28 5.61 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.894 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.7 mt -84.18 -60.31 2.13 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 122.685 0.394 . . . . 0.0 110.934 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.01 36.36 0.31 Allowed Glycine 0 C--N 1.341 0.847 0 O-C-N 123.406 0.441 . . . . 0.0 113.321 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.39 155.69 18.77 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.868 0.366 . . . . 0.0 111.418 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.77 129.28 20.17 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.325 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.08 123.77 30.98 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 123.291 0.369 . . . . 0.0 110.785 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.3 mm -123.3 120.39 27.22 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.104 -178.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.3 -31.84 4.94 Favored 'Cis proline' 0 C--N 1.371 1.75 0 C-N-CA 124.222 -1.158 . . . . 0.0 113.148 -0.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.643 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.73 -24.85 30.51 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-O 119.412 -0.66 . . . . 0.0 113.852 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -113.65 112.16 48.49 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 117.158 0.479 . . . . 0.0 110.982 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -69.95 -25.13 8.29 Favored 'Cis proline' 0 C--N 1.379 2.152 0 C-N-CA 125.024 -0.823 . . . . 0.0 113.249 -0.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.52 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p30 -153.39 151.03 29.45 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.767 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.571 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.02 -168.42 11.33 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.484 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.51 134.6 41.25 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.726 0.298 . . . . 0.0 111.359 -179.864 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 81.3 m -80.3 107.66 13.28 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.361 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -112.46 147.12 37.17 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.733 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.44 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.47 129.45 34.9 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.24 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.129 -0.938 . . . . 0.0 111.498 -179.597 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.135 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -137.45 113.08 9.5 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 120.815 0.34 . . . . 0.0 110.425 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.463 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -117.07 148.65 41.33 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.895 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -93.38 169.54 10.29 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.727 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.7 tt0 -62.94 137.05 58.16 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 120.87 0.367 . . . . 0.0 111.078 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.06 -5.44 79.71 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.956 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -93.53 157.01 16.41 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 122.702 0.401 . . . . 0.0 110.635 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.566 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.2 t -97.03 115.99 28.43 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.995 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.509 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.07 154.03 33.81 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.631 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.521 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.1 m-80 -100.78 138.27 38.05 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.823 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.644 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -91.95 20.39 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.015 0.436 . . . . 0.0 111.064 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -112.67 -29.9 7.28 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.818 -178.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -149.02 -45.05 0.14 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -115.58 74.1 4.42 Favored Pre-proline 0 CA--C 1.548 0.888 0 O-C-N 123.126 0.266 . . . . 0.0 111.362 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.65 -172.04 0.86 Allowed 'Trans proline' 0 C--N 1.368 1.557 0 C-N-CA 122.743 2.295 . . . . 0.0 112.795 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.509 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 92.4 m -70.23 -177.41 1.4 Allowed 'General case' 0 CA--C 1.543 0.676 0 O-C-N 123.142 0.276 . . . . 0.0 111.161 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 15.6 m -84.11 118.29 70.88 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 122.345 0.258 . . . . 0.0 111.277 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -78.49 157.51 28.86 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 122.593 2.195 . . . . 0.0 113.081 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.77 -32.15 5.75 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.875 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.6 mt -84.26 -60.76 1.99 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 122.607 0.363 . . . . 0.0 110.992 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 133.0 36.15 0.28 Allowed Glycine 0 C--N 1.34 0.779 0 O-C-N 123.475 0.484 . . . . 0.0 113.271 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.63 155.45 18.84 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.91 0.355 . . . . 0.0 111.366 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.9 t -142.55 129.56 20.73 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.384 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.2 123.72 31.03 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.227 0.329 . . . . 0.0 110.807 179.853 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.0 mm -123.23 120.46 27.27 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.062 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.23 -31.83 4.94 Favored 'Cis proline' 0 C--N 1.372 1.781 0 C-N-CA 124.131 -1.196 . . . . 0.0 113.208 -0.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.644 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.76 -24.89 30.37 Favored Glycine 0 C--N 1.338 0.667 0 CA-C-N 115.712 -0.677 . . . . 0.0 113.844 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.58 112.16 48.69 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 117.209 0.504 . . . . 0.0 111.026 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -69.85 -25.25 8.17 Favored 'Cis proline' 0 C--N 1.378 2.088 0 CA-C-N 119.372 0.811 . . . . 0.0 113.347 -0.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.521 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.3 151.01 29.52 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.774 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.02 -168.52 11.36 Favored Glycine 0 C--N 1.336 0.545 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.393 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.41 134.72 41.02 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 120.719 0.295 . . . . 0.0 111.499 -179.977 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 79.4 m -80.44 107.84 13.57 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.325 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -112.54 147.65 36.15 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.758 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.44 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.84 129.44 34.59 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.274 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.485 -0.769 . . . . 0.0 111.473 -179.575 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.2 0 CA-C-O 120.302 -0.166 . . . . 0.0 112.789 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.6 t -139.76 112.66 8.06 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 120.766 0.317 . . . . 0.0 110.517 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.474 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -116.45 149.63 39.15 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.866 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -94.05 168.78 10.73 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.65 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.509 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 24.1 tt0 -62.76 136.54 57.91 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.785 0.326 . . . . 0.0 111.053 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.31 -5.1 81.95 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.956 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -93.71 157.26 16.25 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 122.745 0.418 . . . . 0.0 110.693 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.566 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.1 t -96.95 116.07 28.54 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.082 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.511 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.3 153.95 34.26 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.627 179.554 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.519 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.0 m-80 -100.76 138.28 38.02 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.766 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.6 m -91.99 20.3 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 120.914 0.388 . . . . 0.0 111.083 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.79 -30.05 7.2 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.835 -178.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.8 -44.97 0.15 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.095 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -115.44 74.07 4.18 Favored Pre-proline 0 CA--C 1.548 0.893 0 O-C-N 123.177 0.298 . . . . 0.0 111.379 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.61 -172.31 0.91 Allowed 'Trans proline' 0 C--N 1.368 1.567 0 C-N-CA 122.792 2.328 . . . . 0.0 112.906 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.511 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 88.8 m -70.21 -177.01 1.29 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 122.414 0.286 . . . . 0.0 111.218 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 16.5 m -84.49 118.36 70.93 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 122.346 0.258 . . . . 0.0 111.321 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -78.58 157.66 28.55 Favored 'Trans proline' 0 C--N 1.368 1.568 0 C-N-CA 122.727 2.285 . . . . 0.0 113.071 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.66 -32.2 5.7 Favored Glycine 0 C--N 1.338 0.67 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.842 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.5 mt -84.11 -60.92 1.95 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 122.64 0.376 . . . . 0.0 111.016 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 133.03 36.26 0.28 Allowed Glycine 0 C--N 1.342 0.869 0 O-C-N 123.414 0.446 . . . . 0.0 113.217 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.56 155.58 18.77 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.919 0.36 . . . . 0.0 111.392 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.9 t -142.68 129.28 20.27 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.363 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.12 123.77 31.02 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 123.278 0.361 . . . . 0.0 110.785 179.857 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.3 mm -123.28 120.39 27.24 Favored Pre-proline 0 CA--C 1.541 0.629 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.062 -178.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.32 -31.8 4.97 Favored 'Cis proline' 0 C--N 1.372 1.764 0 C-N-CA 124.231 -1.154 . . . . 0.0 113.148 -0.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.642 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.6 -24.86 30.48 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-O 119.358 -0.69 . . . . 0.0 113.815 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -113.65 112.18 48.47 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-N 117.212 0.506 . . . . 0.0 111.035 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.92 -25.17 8.25 Favored 'Cis proline' 0 C--N 1.378 2.084 0 C-N-CA 125.016 -0.827 . . . . 0.0 113.303 -0.113 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.519 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.35 151.03 29.5 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.798 179.139 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.17 -168.41 11.34 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.453 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.57 134.47 41.48 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 120.765 0.317 . . . . 0.0 111.476 -179.909 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 85.4 m -80.36 107.72 13.39 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.327 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -112.4 147.79 35.7 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.714 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.439 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.5 m-85 -78.89 129.52 34.63 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.284 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.103 -0.951 . . . . 0.0 111.429 -179.526 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.119 0 N-CA-C 112.526 -0.23 . . . . 0.0 112.526 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.89 113.15 9.89 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.755 0.312 . . . . 0.0 110.431 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.455 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -117.78 148.17 42.31 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.805 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -92.26 172.09 8.64 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.034 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 24.2 tt0 -65.15 136.92 57.26 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.521 0.328 . . . . 0.0 111.021 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.88 -5.09 80.69 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.983 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -93.66 157.06 16.36 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 122.729 0.412 . . . . 0.0 110.669 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.566 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 52.6 m -96.93 116.09 28.57 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.211 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.505 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.16 155.01 32.4 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.658 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.527 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.5 m-80 -101.7 138.53 38.56 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.78 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.646 HG22 ' O ' ' A' ' 28' ' ' GLY . 35.7 m -91.86 21.22 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 120.91 0.386 . . . . 0.0 111.216 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -113.81 -31.05 6.56 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.931 -178.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -147.54 -44.94 0.17 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -115.69 74.2 4.65 Favored Pre-proline 0 CA--C 1.547 0.864 0 O-C-N 123.175 0.297 . . . . 0.0 111.304 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.67 -172.21 0.9 Allowed 'Trans proline' 0 C--N 1.367 1.537 0 C-N-CA 122.77 2.313 . . . . 0.0 112.8 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.505 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 93.0 m -70.17 -177.5 1.41 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 122.394 0.278 . . . . 0.0 111.152 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.9 m -84.36 118.38 71.03 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 122.222 0.209 . . . . 0.0 111.372 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.5 157.82 28.88 Favored 'Trans proline' 0 C--N 1.369 1.658 0 C-N-CA 122.654 2.236 . . . . 0.0 113.087 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.56 -32.17 5.69 Favored Glycine 0 C--N 1.337 0.598 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.882 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.5 mt -84.25 -60.39 2.1 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.671 0.388 . . . . 0.0 110.97 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.24 36.45 0.3 Allowed Glycine 0 C--N 1.342 0.884 0 O-C-N 123.393 0.433 . . . . 0.0 113.269 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.49 155.8 18.64 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.88 0.372 . . . . 0.0 111.356 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.66 128.79 19.75 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.316 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -84.87 123.76 30.84 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 123.226 0.329 . . . . 0.0 110.792 179.853 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.4 mm -122.98 119.84 27.72 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.236 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.12 -31.29 5.28 Favored 'Cis proline' 0 C--N 1.371 1.757 0 C-N-CA 124.147 -1.189 . . . . 0.0 113.129 -0.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.646 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.02 -26.07 25.88 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 115.683 -0.69 . . . . 0.0 113.88 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -115.72 113.37 42.49 Favored Pre-proline 0 CA--C 1.546 0.797 0 CA-C-N 117.211 0.505 . . . . 0.0 111.156 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.59 -27.34 5.92 Favored 'Cis proline' 0 C--N 1.377 2.059 0 CA-C-N 119.323 0.794 . . . . 0.0 113.586 -0.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.527 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.63 151.44 29.71 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.783 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -141.37 -168.91 11.68 Favored Glycine 0 C--N 1.336 0.555 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.484 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.51 134.48 41.42 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 120.74 0.305 . . . . 0.0 111.561 -179.839 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 82.8 m -80.3 107.88 13.45 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.361 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -112.55 147.38 36.73 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.693 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.438 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.5 m-85 -78.61 129.62 34.99 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.341 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.057 -0.973 . . . . 0.0 111.45 -179.557 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.196 0 N-CA-C 112.644 -0.182 . . . . 0.0 112.644 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -138.82 113.47 9.05 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 122.451 0.301 . . . . 0.0 110.411 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.469 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -116.26 148.42 40.5 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.927 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -93.32 169.18 10.57 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.691 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.8 tt0 -62.99 137.21 58.2 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.872 0.368 . . . . 0.0 111.066 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.95 -5.19 80.43 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.999 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -93.66 157.26 16.26 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 122.707 0.403 . . . . 0.0 110.73 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.569 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.1 t -96.89 115.65 27.79 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.074 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -118.8 153.82 33.84 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.604 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.52 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.2 m-80 -100.66 138.25 37.98 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.794 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -92.01 20.48 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.971 0.415 . . . . 0.0 111.044 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.82 -29.82 7.27 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.857 -178.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -149.06 -45.13 0.14 Allowed 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -115.58 74.15 4.44 Favored Pre-proline 0 CA--C 1.547 0.843 0 O-C-N 123.09 0.244 . . . . 0.0 111.34 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.73 -171.95 0.85 Allowed 'Trans proline' 0 C--N 1.368 1.562 0 C-N-CA 122.769 2.313 . . . . 0.0 112.826 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 94.5 m -70.2 -177.53 1.42 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 122.382 0.273 . . . . 0.0 111.145 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 15.2 m -83.83 118.27 70.91 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 122.231 0.212 . . . . 0.0 111.298 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -78.53 156.95 28.62 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.623 2.215 . . . . 0.0 113.133 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.18 -32.02 5.95 Favored Glycine 0 C--N 1.338 0.657 0 O-C-N 123.682 0.614 . . . . 0.0 112.872 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.7 mt -84.31 -60.84 1.96 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.664 0.386 . . . . 0.0 111.045 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 133.09 36.2 0.28 Allowed Glycine 0 C--N 1.342 0.87 0 O-C-N 123.511 0.507 . . . . 0.0 113.243 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.6 155.71 18.67 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.838 0.351 . . . . 0.0 111.346 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.79 129.46 20.33 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.28 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.24 123.79 31.13 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 123.237 0.335 . . . . 0.0 110.785 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.7 mm -123.28 120.49 27.21 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.11 -178.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.29 -31.73 5.01 Favored 'Cis proline' 0 C--N 1.371 1.74 0 C-N-CA 124.182 -1.174 . . . . 0.0 113.117 -0.171 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.643 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.67 -24.9 30.3 Favored Glycine 0 C--N 1.338 0.662 0 CA-C-N 115.788 -0.642 . . . . 0.0 113.859 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.65 112.19 48.46 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 117.225 0.513 . . . . 0.0 111.008 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -69.94 -25.17 8.26 Favored 'Cis proline' 0 C--N 1.378 2.095 0 C-N-CA 125.062 -0.807 . . . . 0.0 113.292 -0.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.52 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p30 -153.4 150.94 29.36 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.811 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.569 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -139.94 -168.34 11.3 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.498 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.46 134.65 41.15 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.76 0.314 . . . . 0.0 111.437 -179.917 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 78.5 m -80.51 107.82 13.63 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.358 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -112.54 147.61 36.25 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.709 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.444 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.81 129.43 34.59 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.269 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.555 -0.736 . . . . 0.0 111.452 -179.552 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.274 0 CA-C-O 120.236 -0.202 . . . . 0.0 112.915 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.6 t -141.96 112.86 7.37 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 120.743 0.306 . . . . 0.0 110.623 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.488 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -115.99 149.82 38.2 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.877 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -94.24 168.67 10.77 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.64 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 24.6 tt0 -63.07 136.73 57.97 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.747 0.308 . . . . 0.0 111.088 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.02 -4.83 81.95 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.913 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -93.88 157.63 16.04 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 122.725 0.41 . . . . 0.0 110.705 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.567 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.1 t -96.92 116.1 28.59 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.066 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.514 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.3 p -119.39 153.75 34.7 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.609 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.519 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.1 m-80 -100.72 138.22 38.06 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.775 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.5 m -92.03 20.31 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.926 0.394 . . . . 0.0 111.04 -179.432 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.86 -29.9 7.23 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.849 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -148.97 -44.86 0.14 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -115.38 74.07 4.08 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 122.259 0.223 . . . . 0.0 111.36 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.71 -172.41 0.94 Allowed 'Trans proline' 0 C--N 1.367 1.505 0 C-N-CA 122.821 2.347 . . . . 0.0 112.921 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.514 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 88.8 m -70.38 -176.86 1.31 Allowed 'General case' 0 CA--C 1.543 0.692 0 O-C-N 123.168 0.293 . . . . 0.0 111.168 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 17.1 m -84.68 118.36 70.85 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 122.327 0.251 . . . . 0.0 111.348 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.54 157.74 28.7 Favored 'Trans proline' 0 C--N 1.368 1.587 0 C-N-CA 122.705 2.27 . . . . 0.0 113.114 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.64 -32.19 5.7 Favored Glycine 0 C--N 1.337 0.59 0 O-C-N 123.669 0.606 . . . . 0.0 112.853 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.7 mt -84.22 -60.2 2.16 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 122.624 0.37 . . . . 0.0 110.991 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.15 36.28 0.31 Allowed Glycine 0 C--N 1.341 0.846 0 O-C-N 123.399 0.437 . . . . 0.0 113.311 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.18 155.7 18.84 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.86 0.33 . . . . 0.0 111.425 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.82 129.08 19.89 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.324 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -84.94 123.72 30.83 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.317 0.386 . . . . 0.0 110.85 179.829 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.2 mm -123.15 120.37 27.38 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.057 -178.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.32 -31.76 4.99 Favored 'Cis proline' 0 C--N 1.371 1.731 0 C-N-CA 124.185 -1.173 . . . . 0.0 113.143 -0.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.642 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.58 -24.88 30.38 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.843 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.65 112.15 48.48 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-N 117.187 0.494 . . . . 0.0 111.012 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -69.88 -25.18 8.23 Favored 'Cis proline' 0 C--N 1.378 2.087 0 C-N-CA 125.036 -0.818 . . . . 0.0 113.34 -0.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.519 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p30 -153.39 150.98 29.41 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.796 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.22 -168.27 11.3 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.4 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.54 134.33 41.65 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.697 0.284 . . . . 0.0 111.518 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 87.1 m -80.27 107.62 13.22 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.344 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -112.4 147.35 36.62 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.789 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.436 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.3 m-85 -78.61 129.46 34.8 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.259 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--O 1.251 1.152 0 CA-C-O 118.533 -0.746 . . . . 0.0 111.389 -179.548 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.189 0 N-CA-C 112.589 -0.205 . . . . 0.0 112.589 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.64 113.3 10.2 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 120.778 0.323 . . . . 0.0 110.416 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.453 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -117.94 148.08 42.53 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.886 179.45 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -92.2 171.86 8.8 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.059 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.509 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.3 tt0 -64.88 137.24 57.64 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.726 0.298 . . . . 0.0 111.108 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.73 -5.02 80.53 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.949 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -93.72 157.04 16.35 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 122.697 0.399 . . . . 0.0 110.662 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.569 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.4 t -96.89 115.94 28.3 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.984 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.06 153.96 33.91 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.62 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.522 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.2 m-80 -100.75 138.23 38.08 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.79 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.6 m -91.96 20.45 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.961 0.41 . . . . 0.0 111.086 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -112.74 -30.09 7.19 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.736 -178.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.78 -45.02 0.15 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -115.69 74.22 4.66 Favored Pre-proline 0 CA--C 1.548 0.888 0 O-C-N 123.114 0.259 . . . . 0.0 111.294 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.72 -171.84 0.83 Allowed 'Trans proline' 0 C--N 1.368 1.557 0 C-N-CA 122.71 2.273 . . . . 0.0 112.886 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 90.5 m -70.27 -177.55 1.45 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 122.405 0.282 . . . . 0.0 111.069 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.7 m -84.28 118.55 71.47 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 122.249 0.22 . . . . 0.0 111.388 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -78.42 158.18 29.21 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 122.715 2.277 . . . . 0.0 113.094 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.27 -32.1 5.65 Favored Glycine 0 C--N 1.337 0.591 0 O-C-N 123.628 0.58 . . . . 0.0 112.882 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.9 mt -84.34 -61.12 1.88 Allowed 'General case' 0 C--O 1.236 0.36 0 C-N-CA 122.668 0.387 . . . . 0.0 111.024 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.91 36.31 0.28 Allowed Glycine 0 C--N 1.341 0.849 0 O-C-N 123.377 0.423 . . . . 0.0 113.214 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.34 156.2 18.43 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.885 0.343 . . . . 0.0 111.318 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.1 t -143.29 129.61 19.91 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.301 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.34 123.79 31.22 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 123.32 0.388 . . . . 0.0 110.848 179.839 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.3 mm -123.3 120.36 27.22 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.116 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.41 -31.76 5.0 Favored 'Cis proline' 0 C--N 1.372 1.768 0 C-N-CA 124.155 -1.185 . . . . 0.0 113.142 -0.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.643 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.64 -24.71 31.03 Favored Glycine 0 C--N 1.337 0.601 0 CA-C-O 119.386 -0.675 . . . . 0.0 113.874 179.343 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.62 112.13 48.6 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 117.198 0.499 . . . . 0.0 111.06 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -69.95 -25.18 8.25 Favored 'Cis proline' 0 C--N 1.376 2.026 0 CA-C-N 119.416 0.827 . . . . 0.0 113.244 -0.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.522 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.1 p30 -153.25 151.08 29.65 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.836 179.137 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.569 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.11 -168.43 11.34 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.46 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.53 134.52 41.37 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 120.77 0.319 . . . . 0.0 111.418 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 80.0 m -80.55 107.78 13.64 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.329 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -112.5 147.73 35.93 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.712 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.445 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.3 m-85 -78.11 128.94 34.57 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.171 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.251 1.18 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.451 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.271 . . . . . . . 0 C--O 1.235 0.341 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 101.37 56.44 0.87 Allowed Glycine 0 C--N 1.336 0.532 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.602 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.72 113.14 9.99 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 120.803 0.335 . . . . 0.0 110.398 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.462 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -117.8 148.93 41.61 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.918 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -93.19 172.48 8.27 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.981 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 24.5 tt0 -65.35 136.81 56.99 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.813 0.34 . . . . 0.0 111.01 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.04 -5.36 79.96 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.941 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -93.54 156.79 16.53 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 122.721 0.409 . . . . 0.0 110.647 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 51.7 m -96.88 116.23 28.81 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.199 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.26 154.17 33.88 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.646 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.522 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.0 m-80 -100.85 138.27 38.13 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.773 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.644 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -91.98 20.45 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.997 0.427 . . . . 0.0 111.051 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.78 -30.13 7.17 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.823 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.72 -45.02 0.15 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -115.56 74.2 4.43 Favored Pre-proline 0 CA--C 1.547 0.852 0 O-C-N 123.19 0.306 . . . . 0.0 111.367 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.59 -172.18 0.88 Allowed 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 122.762 2.308 . . . . 0.0 112.831 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 92.8 m -70.16 -177.69 1.45 Allowed 'General case' 0 CA--C 1.543 0.686 0 O-C-N 123.107 0.255 . . . . 0.0 111.137 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.6 m -84.11 118.6 71.68 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 122.271 0.228 . . . . 0.0 111.334 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.49 157.62 28.87 Favored 'Trans proline' 0 C--N 1.369 1.629 0 C-N-CA 122.676 2.251 . . . . 0.0 113.065 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.72 -32.27 5.67 Favored Glycine 0 C--N 1.338 0.661 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.862 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.4 mt -84.15 -60.46 2.09 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 122.643 0.377 . . . . 0.0 111.02 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.28 36.36 0.3 Allowed Glycine 0 C--N 1.341 0.837 0 O-C-N 123.459 0.475 . . . . 0.0 113.286 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.58 155.59 18.76 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.8 0.333 . . . . 0.0 111.381 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.63 129.39 20.45 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.333 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.11 123.69 30.92 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 123.265 0.353 . . . . 0.0 110.818 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.8 mm -123.26 120.45 27.23 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.127 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.37 -31.64 5.07 Favored 'Cis proline' 0 C--N 1.372 1.773 0 C-N-CA 124.192 -1.17 . . . . 0.0 113.169 -0.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.644 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.59 -24.74 30.91 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-N 115.766 -0.652 . . . . 0.0 113.868 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -113.66 112.18 48.45 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 117.205 0.502 . . . . 0.0 111.009 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -69.96 -25.12 8.3 Favored 'Cis proline' 0 C--N 1.378 2.111 0 C-N-CA 124.978 -0.842 . . . . 0.0 113.321 -0.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.522 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.1 p-10 -153.25 150.98 29.54 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.79 179.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.562 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -139.91 -168.54 11.36 Favored Glycine 0 C--N 1.335 0.521 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.473 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.5 134.62 41.21 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.729 0.299 . . . . 0.0 111.459 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 77.4 m -80.35 107.73 13.38 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.355 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -112.51 147.51 36.42 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.691 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.44 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.5 m-85 -78.65 129.41 34.7 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.281 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.1 mt . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.473 -0.775 . . . . 0.0 111.475 -179.554 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.272 . . . . . . . 0 C--O 1.235 0.321 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 100.15 54.31 1.04 Allowed Glycine 0 C--N 1.336 0.543 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.602 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.87 113.26 9.99 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 122.427 0.291 . . . . 0.0 110.462 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.463 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -117.73 148.16 42.28 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.851 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -92.47 172.2 8.54 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.079 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.511 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.5 tt0 -65.17 137.05 57.38 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.51 0.324 . . . . 0.0 111.015 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.93 -5.41 79.4 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.978 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -93.61 156.81 16.5 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 122.772 0.429 . . . . 0.0 110.682 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 52.9 m -96.8 116.23 28.79 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.18 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.29 154.06 34.08 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.591 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.521 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.0 m-80 -100.75 138.2 38.11 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.801 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.644 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.6 m -91.83 20.34 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 120.945 0.402 . . . . 0.0 111.071 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.71 -30.05 7.22 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.8 -178.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.91 -44.97 0.14 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -115.61 74.16 4.5 Favored Pre-proline 0 CA--C 1.548 0.888 0 O-C-N 123.2 0.312 . . . . 0.0 111.408 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.58 -172.05 0.86 Allowed 'Trans proline' 0 C--N 1.366 1.472 0 C-N-CA 122.768 2.312 . . . . 0.0 112.86 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 93.7 m -70.21 -177.62 1.45 Allowed 'General case' 0 CA--C 1.542 0.663 0 O-C-N 123.155 0.284 . . . . 0.0 111.16 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.7 m -84.15 118.46 71.3 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 122.33 0.252 . . . . 0.0 111.325 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -78.49 157.55 28.87 Favored 'Trans proline' 0 C--N 1.369 1.639 0 C-N-CA 122.64 2.227 . . . . 0.0 113.121 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.77 -32.28 5.68 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.845 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.7 mt -84.14 -60.71 2.01 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 122.617 0.367 . . . . 0.0 110.99 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.66 36.4 0.29 Allowed Glycine 0 C--N 1.341 0.848 0 O-C-N 123.442 0.464 . . . . 0.0 113.312 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.71 155.65 18.66 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.866 0.365 . . . . 0.0 111.389 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.73 129.48 20.43 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.305 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.22 123.74 31.06 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.293 0.37 . . . . 0.0 110.796 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.2 mm -123.18 120.4 27.33 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.132 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -73.45 -31.7 5.04 Favored 'Cis proline' 0 C--N 1.372 1.764 0 C-N-CA 124.217 -1.16 . . . . 0.0 113.136 -0.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.644 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.67 -24.84 30.53 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-O 119.432 -0.649 . . . . 0.0 113.79 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.58 112.17 48.67 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 117.22 0.51 . . . . 0.0 111.001 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -69.85 -25.25 8.17 Favored 'Cis proline' 0 C--N 1.378 2.088 0 CA-C-N 119.386 0.817 . . . . 0.0 113.299 -0.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.521 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.27 151.03 29.57 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.832 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.563 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.06 -168.58 11.39 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 115.811 -0.632 . . . . 0.0 112.458 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.4 134.6 41.17 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.723 0.296 . . . . 0.0 111.46 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 78.9 m -80.32 107.73 13.36 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.329 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -112.51 147.68 36.06 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.727 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.44 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.5 m-85 -78.83 129.43 34.58 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.311 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.156 -0.926 . . . . 0.0 111.44 -179.496 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.271 . . . . . . . 0 C--O 1.236 0.346 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 103.04 55.67 0.81 Allowed Glycine 0 C--N 1.335 0.517 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.558 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.86 112.98 9.75 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 120.843 0.354 . . . . 0.0 110.382 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.466 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -117.66 148.6 41.82 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.843 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -92.81 172.13 8.54 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.983 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.515 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.9 tt0 -65.16 137.0 57.35 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.796 0.331 . . . . 0.0 110.975 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.88 -5.31 79.69 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.987 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -93.7 156.84 16.47 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 122.648 0.379 . . . . 0.0 110.635 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.561 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 52.3 m -96.86 116.45 29.19 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.185 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.57 154.16 34.32 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.588 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.522 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.0 m-80 -100.84 138.2 38.2 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.782 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.6 m -91.87 20.3 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 120.983 0.421 . . . . 0.0 111.064 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -112.68 -30.03 7.23 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.802 -178.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.8 -45.01 0.15 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -115.58 74.21 4.46 Favored Pre-proline 0 CA--C 1.548 0.891 0 O-C-N 123.091 0.244 . . . . 0.0 111.334 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.65 -172.12 0.88 Allowed 'Trans proline' 0 C--N 1.367 1.545 0 C-N-CA 122.704 2.269 . . . . 0.0 112.824 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 91.9 m -70.18 -177.54 1.42 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 122.427 0.291 . . . . 0.0 111.145 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 15.1 m -84.22 118.55 71.51 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 122.272 0.229 . . . . 0.0 111.408 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -78.55 157.69 28.66 Favored 'Trans proline' 0 C--N 1.368 1.563 0 C-N-CA 122.73 2.287 . . . . 0.0 113.04 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.64 -32.21 5.69 Favored Glycine 0 C--N 1.337 0.632 0 O-C-N 123.717 0.636 . . . . 0.0 112.916 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.9 mt -84.22 -60.79 1.98 Allowed 'General case' 0 C--O 1.236 0.385 0 C-N-CA 122.645 0.378 . . . . 0.0 110.962 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.78 36.26 0.29 Allowed Glycine 0 C--N 1.341 0.813 0 O-C-N 123.447 0.467 . . . . 0.0 113.279 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.63 155.77 18.61 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.921 0.361 . . . . 0.0 111.413 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.86 129.4 20.19 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.36 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.17 123.68 30.96 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.299 0.374 . . . . 0.0 110.801 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.4 mm -123.22 120.47 27.28 Favored Pre-proline 0 CA--C 1.542 0.649 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.099 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.39 -31.59 5.1 Favored 'Cis proline' 0 C--N 1.371 1.746 0 C-N-CA 124.192 -1.17 . . . . 0.0 113.19 -0.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.643 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.51 -24.77 30.83 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 115.747 -0.66 . . . . 0.0 113.891 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.67 112.17 48.44 Favored Pre-proline 0 CA--C 1.542 0.673 0 CA-C-N 117.199 0.499 . . . . 0.0 111.025 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -69.87 -25.25 8.18 Favored 'Cis proline' 0 C--N 1.378 2.088 0 C-N-CA 125.069 -0.804 . . . . 0.0 113.298 -0.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.522 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.24 150.98 29.55 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.782 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.561 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.05 -168.43 11.34 Favored Glycine 0 C--N 1.336 0.533 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.461 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.53 134.64 41.21 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.77 0.319 . . . . 0.0 111.436 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 79.9 m -80.28 107.76 13.34 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.334 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -112.59 147.76 36.0 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.654 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.44 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.5 m-85 -78.81 129.36 34.52 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.279 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.134 -0.936 . . . . 0.0 111.45 -179.603 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.273 . . . . . . . 0 C--O 1.235 0.31 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.9 56.44 0.95 Allowed Glycine 0 C--N 1.336 0.554 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.587 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.23 113.69 10.85 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.832 0.349 . . . . 0.0 110.45 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.469 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -119.14 146.71 44.91 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.776 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -92.18 173.67 7.7 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.985 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.5 tt0 -65.22 137.42 57.58 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.792 0.33 . . . . 0.0 111.204 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.84 -5.74 77.57 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 115.254 -0.885 . . . . 0.0 113.085 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -93.47 156.36 16.8 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 122.625 0.37 . . . . 0.0 110.778 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.559 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 53.3 m -96.88 116.2 28.76 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.127 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.17 154.32 33.5 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.673 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.527 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 5.9 m-80 -101.09 138.33 38.28 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.749 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.644 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.6 m -91.9 20.37 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 120.954 0.407 . . . . 0.0 110.99 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -112.58 -29.92 7.3 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.825 -178.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -149.03 -45.2 0.14 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -115.49 74.16 4.3 Favored Pre-proline 0 CA--C 1.548 0.891 0 O-C-N 123.185 0.303 . . . . 0.0 111.369 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.63 -172.03 0.86 Allowed 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 122.73 2.287 . . . . 0.0 112.798 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 95.4 m -70.26 -177.92 1.55 Allowed 'General case' 0 CA--C 1.543 0.701 0 O-C-N 123.128 0.268 . . . . 0.0 111.13 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.6 m -83.94 118.35 71.11 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 122.237 0.215 . . . . 0.0 111.28 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -78.44 157.87 29.11 Favored 'Trans proline' 0 C--N 1.368 1.604 0 C-N-CA 122.679 2.253 . . . . 0.0 113.128 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.49 -32.03 5.75 Favored Glycine 0 C--N 1.338 0.664 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.858 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.2 mt -84.51 -60.59 2.02 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.63 0.372 . . . . 0.0 111.002 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.72 36.04 0.3 Allowed Glycine 0 C--N 1.341 0.813 0 O-C-N 123.425 0.453 . . . . 0.0 113.327 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.67 155.34 18.91 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.866 0.365 . . . . 0.0 111.361 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.9 t -142.29 129.75 21.28 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.357 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.42 123.72 31.19 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.3 0.375 . . . . 0.0 110.808 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.1 mm -123.07 120.48 27.43 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.092 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.5 -31.39 5.24 Favored 'Cis proline' 0 C--N 1.37 1.688 0 C-N-CA 124.166 -1.181 . . . . 0.0 113.175 -0.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.644 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.36 -24.59 31.49 Favored Glycine 0 C--N 1.338 0.656 0 CA-C-N 115.75 -0.659 . . . . 0.0 113.891 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -113.7 112.06 48.42 Favored Pre-proline 0 CA--C 1.543 0.673 0 CA-C-N 117.218 0.509 . . . . 0.0 111.079 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -69.77 -25.35 8.07 Favored 'Cis proline' 0 C--N 1.378 2.106 0 CA-C-N 119.404 0.823 . . . . 0.0 113.313 -0.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.527 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.13 151.18 29.86 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.744 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.22 -168.67 11.43 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.429 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.33 134.67 41.02 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 120.769 0.319 . . . . 0.0 111.489 -179.906 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 77.9 m -80.24 107.98 13.47 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.3 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -112.82 147.42 36.98 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.769 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.441 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.5 m-85 -78.68 129.75 35.07 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.286 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.137 -0.935 . . . . 0.0 111.429 -179.508 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.271 . . . . . . . 0 C--O 1.236 0.346 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.75 55.6 1.0 Allowed Glycine 0 C--N 1.336 0.544 0 O-C-N 123.763 0.664 . . . . 0.0 112.578 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.67 113.36 10.23 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 120.77 0.319 . . . . 0.0 110.414 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.459 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -117.99 148.32 42.33 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.887 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -92.4 172.32 8.47 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.971 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.51 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.9 tt0 -65.36 137.07 57.26 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.767 0.318 . . . . 0.0 111.056 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.92 -5.3 79.84 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 115.311 -0.859 . . . . 0.0 113.038 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -93.46 156.97 16.45 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 122.66 0.384 . . . . 0.0 110.656 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.567 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.1 t -96.94 115.91 28.27 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.085 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.507 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.04 154.02 33.78 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.629 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.521 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.1 m-80 -100.8 138.25 38.11 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.784 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -91.99 20.5 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.032 0.444 . . . . 0.0 111.072 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -112.82 -30.0 7.2 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.796 -178.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -148.9 -45.07 0.14 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -178.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -115.57 74.2 4.44 Favored Pre-proline 0 CA--C 1.547 0.852 0 O-C-N 123.053 0.22 . . . . 0.0 111.37 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.67 -172.03 0.86 Allowed 'Trans proline' 0 C--N 1.367 1.535 0 C-N-CA 122.758 2.305 . . . . 0.0 112.8 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.507 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 93.2 m -70.22 -177.62 1.46 Allowed 'General case' 0 CA--C 1.542 0.663 0 O-C-N 123.152 0.282 . . . . 0.0 111.126 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.9 m -84.26 118.56 71.5 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 122.29 0.236 . . . . 0.0 111.379 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.51 157.85 28.85 Favored 'Trans proline' 0 C--N 1.37 1.658 0 C-N-CA 122.606 2.204 . . . . 0.0 113.073 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.53 -32.22 5.65 Favored Glycine 0 C--N 1.338 0.659 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.897 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.5 mt -84.19 -60.42 2.1 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 122.693 0.397 . . . . 0.0 111.023 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.19 36.42 0.3 Allowed Glycine 0 C--N 1.341 0.831 0 O-C-N 123.413 0.445 . . . . 0.0 113.248 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.51 155.72 18.69 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.891 0.345 . . . . 0.0 111.455 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.74 129.39 20.32 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.32 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.21 123.74 31.06 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.253 0.346 . . . . 0.0 110.843 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.2 mm -123.26 120.39 27.25 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.087 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.34 -31.74 5.01 Favored 'Cis proline' 0 C--N 1.371 1.75 0 C-N-CA 124.188 -1.172 . . . . 0.0 113.201 -0.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.643 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.66 -24.85 30.49 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-N 115.747 -0.66 . . . . 0.0 113.805 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -113.61 112.22 48.56 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 117.253 0.527 . . . . 0.0 111.057 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.87 -25.18 8.22 Favored 'Cis proline' 0 C--N 1.378 2.088 0 C-N-CA 125.038 -0.818 . . . . 0.0 113.278 -0.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.521 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.1 p30 -153.34 150.93 29.39 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.814 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -139.95 -168.43 11.33 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.5 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.5 134.56 41.29 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.731 0.3 . . . . 0.0 111.494 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 79.7 m -80.27 107.67 13.26 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.392 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -112.43 147.43 36.48 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.744 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.439 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.67 129.4 34.68 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.322 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--O 1.252 1.189 0 CA-C-O 118.483 -0.77 . . . . 0.0 111.511 -179.539 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.271 . . . . . . . 0 C--O 1.236 0.349 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 100.37 54.97 0.98 Allowed Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.563 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.62 113.31 10.21 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 120.708 0.29 . . . . 0.0 110.472 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.459 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -117.99 148.33 42.32 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.847 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -92.3 172.33 8.47 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.999 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.7 tt0 -65.42 137.03 57.2 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.771 0.32 . . . . 0.0 111.046 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.89 -5.21 80.15 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.982 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -93.46 157.07 16.4 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 122.711 0.404 . . . . 0.0 110.712 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.567 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.6 t -96.97 115.86 28.18 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.961 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.508 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.04 153.84 34.09 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.601 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.521 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.1 m-80 -100.72 138.24 38.04 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.794 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -91.93 20.46 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.97 0.414 . . . . 0.0 111.086 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.86 -30.01 7.19 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.764 -178.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.84 -45.13 0.15 Allowed 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -178.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -115.55 74.18 4.4 Favored Pre-proline 0 CA--C 1.547 0.855 0 O-C-N 123.088 0.243 . . . . 0.0 111.319 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.5 -171.99 0.84 Allowed 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 122.741 2.294 . . . . 0.0 112.907 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.508 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 93.0 m -70.29 -177.58 1.47 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 122.431 0.293 . . . . 0.0 111.152 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.9 m -84.31 118.48 71.3 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 122.328 0.251 . . . . 0.0 111.384 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -78.46 157.83 29.02 Favored 'Trans proline' 0 C--N 1.368 1.599 0 C-N-CA 122.711 2.274 . . . . 0.0 113.044 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.52 -32.27 5.62 Favored Glycine 0 C--N 1.338 0.669 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.895 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.5 mt -84.12 -60.44 2.09 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 122.706 0.403 . . . . 0.0 111.024 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.22 36.37 0.3 Allowed Glycine 0 C--N 1.341 0.86 0 O-C-N 123.476 0.485 . . . . 0.0 113.251 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -90.54 155.63 18.75 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.903 0.383 . . . . 0.0 111.426 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.9 t -142.53 129.23 20.4 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.345 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.08 123.77 30.99 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 123.217 0.323 . . . . 0.0 110.785 179.852 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.2 mm -123.22 120.41 27.29 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.126 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.38 -31.73 5.01 Favored 'Cis proline' 0 C--N 1.371 1.75 0 C-N-CA 124.159 -1.184 . . . . 0.0 113.146 -0.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.643 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.71 -25.03 29.86 Favored Glycine 0 C--N 1.338 0.677 0 CA-C-N 115.694 -0.685 . . . . 0.0 113.767 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -113.5 112.18 48.9 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 117.235 0.517 . . . . 0.0 111.023 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -69.96 -25.04 8.35 Favored 'Cis proline' 0 C--N 1.379 2.148 0 C-N-CA 124.995 -0.835 . . . . 0.0 113.367 -0.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.521 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.1 p-10 -153.49 150.96 29.29 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.803 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.08 -168.45 11.34 Favored Glycine 0 C--N 1.335 0.519 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.492 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.44 134.63 41.16 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 120.77 0.319 . . . . 0.0 111.446 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 78.2 m -80.39 107.71 13.42 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.319 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -112.38 147.42 36.45 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.693 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.44 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.5 m-85 -78.56 129.5 34.89 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.356 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.5 mt . . . . . 0 C--O 1.252 1.201 0 CA-C-O 118.526 -0.749 . . . . 0.0 111.474 -179.57 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.271 . . . . . . . 0 N--CA 1.465 0.322 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 96.5 49.77 1.95 Allowed Glycine 0 C--N 1.34 0.754 0 O-C-N 123.456 0.473 . . . . 0.0 112.73 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -138.84 113.87 9.36 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.777 0.323 . . . . 0.0 110.482 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.477 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -117.17 147.97 42.0 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.904 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -92.67 172.74 8.17 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.027 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.51 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.6 tt0 -65.81 137.3 57.14 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.8 0.334 . . . . 0.0 110.951 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.81 -5.29 79.54 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 115.267 -0.879 . . . . 0.0 113.023 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -93.77 157.01 16.35 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 122.651 0.38 . . . . 0.0 110.733 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.564 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 52.7 m -96.75 116.07 28.51 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.182 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.05 153.93 33.95 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.656 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.522 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.1 m-80 -100.71 138.26 38.0 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.824 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -91.98 20.47 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.912 0.387 . . . . 0.0 110.967 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.85 -29.79 7.27 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.817 -178.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -149.09 -45.01 0.14 Allowed 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -115.67 74.13 4.59 Favored Pre-proline 0 CA--C 1.548 0.884 0 O-C-N 123.193 0.308 . . . . 0.0 111.304 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.65 -171.92 0.84 Allowed 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 122.739 2.293 . . . . 0.0 112.892 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 95.3 m -70.16 -177.84 1.49 Allowed 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.163 0.289 . . . . 0.0 111.082 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.5 m -83.84 118.46 71.45 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 122.294 0.238 . . . . 0.0 111.367 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -78.53 157.25 28.67 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.681 2.254 . . . . 0.0 113.065 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.94 -32.22 5.76 Favored Glycine 0 C--N 1.338 0.64 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.891 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.8 mt -84.17 -60.61 2.04 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 122.674 0.389 . . . . 0.0 110.993 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.49 36.4 0.29 Allowed Glycine 0 C--N 1.34 0.794 0 O-C-N 123.489 0.493 . . . . 0.0 113.249 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.61 155.71 18.66 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.884 0.374 . . . . 0.0 111.379 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.7 129.42 20.41 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.301 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.2 123.74 31.05 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.275 0.359 . . . . 0.0 110.794 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.1 mm -123.23 120.42 27.28 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.149 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.29 -31.84 4.94 Favored 'Cis proline' 0 C--N 1.371 1.717 0 C-N-CA 124.166 -1.181 . . . . 0.0 113.155 -0.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.643 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.69 -24.83 30.56 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-O 119.413 -0.659 . . . . 0.0 113.878 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -113.58 112.13 48.7 Favored Pre-proline 0 CA--C 1.543 0.705 0 CA-C-N 117.239 0.52 . . . . 0.0 111.072 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -69.91 -25.26 8.19 Favored 'Cis proline' 0 C--N 1.377 2.032 0 CA-C-N 119.386 0.816 . . . . 0.0 113.251 -0.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.522 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.28 151.0 29.52 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.84 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -139.89 -168.43 11.32 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.522 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.59 134.62 41.27 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 120.733 0.302 . . . . 0.0 111.38 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 76.5 m -80.38 107.82 13.49 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.398 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -112.51 147.36 36.74 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.72 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.439 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.62 129.5 34.84 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.256 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.08 -0.962 . . . . 0.0 111.466 -179.547 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.273 . . . . . . . 0 C--O 1.235 0.33 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 118.79 45.26 0.47 Allowed Glycine 0 C--N 1.337 0.627 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.857 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -141.26 113.07 7.74 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 120.724 0.297 . . . . 0.0 110.592 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.498 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -116.57 149.11 40.17 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.846 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -93.8 171.66 8.73 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.514 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.8 tt0 -65.02 136.8 57.21 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 122.482 0.313 . . . . 0.0 111.002 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.9 -5.0 81.13 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.966 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -94.02 157.13 16.24 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 122.673 0.389 . . . . 0.0 110.672 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.56 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 52.3 m -96.85 116.76 29.72 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.194 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.512 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.84 154.03 34.91 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.622 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.521 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.1 m-80 -100.77 138.19 38.15 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.719 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -91.87 20.24 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 120.909 0.385 . . . . 0.0 111.097 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.79 -29.93 7.24 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.842 -178.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -148.91 -44.96 0.14 Allowed 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -115.45 73.99 4.17 Favored Pre-proline 0 CA--C 1.548 0.894 0 O-C-N 123.149 0.281 . . . . 0.0 111.375 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.66 -172.3 0.91 Allowed 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 122.743 2.295 . . . . 0.0 112.918 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.512 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 90.6 m -70.32 -177.1 1.34 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 122.408 0.283 . . . . 0.0 111.137 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 16.0 m -84.56 118.47 71.16 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 122.354 0.262 . . . . 0.0 111.274 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -78.57 157.65 28.59 Favored 'Trans proline' 0 C--N 1.368 1.587 0 C-N-CA 122.711 2.274 . . . . 0.0 113.053 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.6 -32.16 5.7 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.89 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.7 mt -84.1 -60.76 2.0 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.643 0.377 . . . . 0.0 111.025 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.78 36.43 0.28 Allowed Glycine 0 C--N 1.341 0.835 0 O-C-N 123.461 0.476 . . . . 0.0 113.218 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.66 155.71 18.64 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.946 0.373 . . . . 0.0 111.427 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.69 129.34 20.33 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.305 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.11 123.68 30.91 Favored 'General case' 0 C--O 1.236 0.391 0 O-C-N 123.201 0.313 . . . . 0.0 110.825 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.3 mm -123.22 120.37 27.3 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.121 -178.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.34 -31.72 5.02 Favored 'Cis proline' 0 C--N 1.371 1.746 0 C-N-CA 124.223 -1.157 . . . . 0.0 113.226 -0.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.642 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.6 -25.03 29.82 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.854 179.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -113.54 112.1 48.83 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 117.237 0.519 . . . . 0.0 111.025 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -69.94 -25.14 8.28 Favored 'Cis proline' 0 C--N 1.379 2.147 0 C-N-CA 124.993 -0.836 . . . . 0.0 113.359 -0.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.521 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.39 151.0 29.43 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.784 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.56 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.08 -168.44 11.34 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.499 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.5 134.51 41.37 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 120.717 0.294 . . . . 0.0 111.487 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 83.1 m -80.25 107.62 13.2 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.374 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -112.41 147.72 35.85 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.687 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.437 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.5 m-85 -78.82 129.54 34.72 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.308 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.4 mt . . . . . 0 C--O 1.251 1.165 0 CA-C-O 118.46 -0.781 . . . . 0.0 111.474 -179.542 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.27 . . . . . . . 0 C--O 1.235 0.331 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 96.38 49.85 1.96 Allowed Glycine 0 C--N 1.342 0.868 0 O-C-N 123.38 0.425 . . . . 0.0 112.702 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -138.3 113.82 9.64 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 120.764 0.316 . . . . 0.0 110.479 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.473 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -117.29 147.81 42.24 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.828 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -92.43 172.65 8.25 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.023 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.51 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.3 tt0 -65.63 137.44 57.34 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.822 0.344 . . . . 0.0 111.023 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.8 -5.37 79.11 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.941 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -93.84 157.03 16.33 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 122.639 0.376 . . . . 0.0 110.662 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.566 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 52.6 m -96.69 115.91 28.24 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.209 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.504 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -118.95 153.88 33.9 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.614 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.522 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.0 m-80 -100.68 138.15 38.13 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.814 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -91.91 20.42 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.904 0.383 . . . . 0.0 110.982 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.79 -29.93 7.23 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.764 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.95 -45.12 0.14 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -115.64 74.17 4.54 Favored Pre-proline 0 CA--C 1.548 0.884 0 O-C-N 123.152 0.282 . . . . 0.0 111.32 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.68 -171.93 0.85 Allowed 'Trans proline' 0 C--N 1.367 1.543 0 C-N-CA 122.68 2.253 . . . . 0.0 112.829 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.504 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 94.7 m -70.15 -177.78 1.48 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 122.366 0.267 . . . . 0.0 111.151 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.6 m -83.86 118.47 71.45 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 122.267 0.227 . . . . 0.0 111.373 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.54 157.23 28.66 Favored 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 122.715 2.277 . . . . 0.0 113.095 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.98 -32.2 5.79 Favored Glycine 0 C--N 1.339 0.702 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.854 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.8 mt -84.26 -60.53 2.06 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 122.606 0.362 . . . . 0.0 110.964 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.47 36.33 0.3 Allowed Glycine 0 C--N 1.341 0.828 0 O-C-N 123.472 0.482 . . . . 0.0 113.298 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.52 155.68 18.72 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.836 0.35 . . . . 0.0 111.38 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.66 129.43 20.46 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.32 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.22 123.73 31.05 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 123.258 0.349 . . . . 0.0 110.866 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.9 mm -123.22 120.45 27.28 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.145 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.18 -31.84 4.93 Favored 'Cis proline' 0 C--N 1.372 1.781 0 C-N-CA 124.21 -1.162 . . . . 0.0 113.208 -0.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.643 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.7 -24.85 30.51 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-N 115.75 -0.659 . . . . 0.0 113.898 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -113.7 112.2 48.34 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 117.174 0.487 . . . . 0.0 111.003 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -69.85 -25.28 8.15 Favored 'Cis proline' 0 C--N 1.377 2.051 0 C-N-CA 125.071 -0.804 . . . . 0.0 113.327 -0.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.522 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.29 151.0 29.52 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.803 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -139.94 -168.49 11.34 Favored Glycine 0 C--N 1.335 0.521 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.505 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.44 134.63 41.15 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.762 0.315 . . . . 0.0 111.403 -179.924 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 76.6 m -80.36 107.77 13.42 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.333 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -112.55 147.24 37.03 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.745 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.441 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.53 129.51 34.92 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.368 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--O 1.252 1.203 0 CA-C-O 118.526 -0.749 . . . . 0.0 111.425 -179.5 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.271 . . . . . . . 0 C--O 1.235 0.306 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 104.19 55.56 0.76 Allowed Glycine 0 C--N 1.336 0.55 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.639 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -137.5 113.38 9.72 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.751 0.31 . . . . 0.0 110.408 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.482 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -118.08 148.63 42.1 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.914 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -93.28 173.49 7.69 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.953 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 24.0 tt0 -66.04 136.86 56.6 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.507 0.323 . . . . 0.0 111.053 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.89 -5.23 80.05 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 115.331 -0.85 . . . . 0.0 113.008 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -93.54 156.79 16.54 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 122.715 0.406 . . . . 0.0 110.624 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 16.8 t -97.03 116.61 29.53 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.044 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.5 p -119.72 154.26 34.39 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.647 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.52 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.0 m-80 -100.89 138.28 38.15 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.734 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -91.99 20.33 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.976 0.417 . . . . 0.0 111.06 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.8 -29.92 7.24 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.833 -178.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.82 -45.02 0.15 Allowed 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -115.57 74.27 4.47 Favored Pre-proline 0 CA--C 1.548 0.888 0 O-C-N 123.178 0.299 . . . . 0.0 111.389 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.68 -172.28 0.91 Allowed 'Trans proline' 0 C--N 1.368 1.574 0 C-N-CA 122.753 2.302 . . . . 0.0 112.825 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 92.5 m -69.96 -177.73 1.4 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 122.511 0.324 . . . . 0.0 111.184 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.1 m -84.56 119.06 72.47 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 122.324 0.25 . . . . 0.0 111.342 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -78.6 159.05 28.63 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 122.657 2.238 . . . . 0.0 113.052 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.65 -31.96 5.56 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.864 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.6 mt -84.7 -60.25 2.12 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 122.643 0.377 . . . . 0.0 111.008 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.46 36.78 0.32 Allowed Glycine 0 C--N 1.341 0.859 0 O-C-N 123.379 0.424 . . . . 0.0 113.268 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -90.4 155.87 18.63 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.935 0.368 . . . . 0.0 111.369 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.78 129.18 20.05 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.381 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.0 123.72 30.88 Favored 'General case' 0 C--O 1.235 0.342 0 O-C-N 123.256 0.347 . . . . 0.0 110.84 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.1 mm -123.19 120.32 27.35 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.18 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.39 -31.7 5.03 Favored 'Cis proline' 0 C--N 1.37 1.7 0 C-N-CA 124.242 -1.149 . . . . 0.0 113.105 -0.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.643 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.51 -24.87 30.44 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-N 115.778 -0.646 . . . . 0.0 113.824 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -113.63 112.15 48.54 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 117.17 0.485 . . . . 0.0 111.008 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -69.9 -25.25 8.19 Favored 'Cis proline' 0 C--N 1.378 2.092 0 C-N-CA 125.061 -0.808 . . . . 0.0 113.335 -0.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.52 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.35 151.04 29.51 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.803 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.562 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.11 -168.5 11.36 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.524 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.33 134.58 41.15 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 120.682 0.277 . . . . 0.0 111.506 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 79.2 m -80.29 107.69 13.29 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.366 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -112.59 147.11 37.34 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.761 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.433 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.3 m-85 -78.31 129.5 35.1 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.364 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.7 mt . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.487 -0.768 . . . . 0.0 111.481 -179.519 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.271 . . . . . . . 0 C--O 1.234 0.276 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 100.0 53.97 1.07 Allowed Glycine 0 C--N 1.335 0.524 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.586 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -137.75 113.08 9.33 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 120.771 0.32 . . . . 0.0 110.406 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.462 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -116.85 148.74 40.99 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.934 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -93.26 169.22 10.55 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.637 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.9 tt0 -62.89 136.94 58.11 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.78 0.324 . . . . 0.0 111.124 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.05 -5.25 80.52 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.993 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -93.83 157.08 16.31 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 122.707 0.403 . . . . 0.0 110.604 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 53.1 m -96.82 116.05 28.48 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.171 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.508 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.18 153.93 34.12 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.618 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.52 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.0 m-80 -100.69 138.23 38.03 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.827 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.6 m -91.87 20.31 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 120.941 0.401 . . . . 0.0 111.081 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -112.78 -29.86 7.26 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.819 -178.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.98 -45.01 0.14 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -115.59 74.2 4.48 Favored Pre-proline 0 CA--C 1.548 0.89 0 O-C-N 123.108 0.255 . . . . 0.0 111.291 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.68 -172.04 0.87 Allowed 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 122.739 2.293 . . . . 0.0 112.83 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.508 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 93.6 m -70.33 -177.44 1.44 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 122.428 0.291 . . . . 0.0 111.08 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 15.9 m -84.04 118.31 70.96 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 122.305 0.242 . . . . 0.0 111.312 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -78.54 157.4 28.67 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 122.668 2.246 . . . . 0.0 113.088 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.79 -32.19 5.74 Favored Glycine 0 C--N 1.338 0.666 0 CA-C-N 115.976 -0.557 . . . . 0.0 112.893 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.6 mt -84.14 -60.52 2.07 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.66 0.384 . . . . 0.0 111.046 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.61 36.19 0.3 Allowed Glycine 0 C--N 1.341 0.828 0 O-C-N 123.408 0.443 . . . . 0.0 113.315 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.52 155.67 18.72 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.869 0.334 . . . . 0.0 111.409 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.71 129.41 20.38 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.317 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.18 123.76 31.06 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 123.264 0.353 . . . . 0.0 110.811 179.853 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.1 mm -123.18 120.32 27.36 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.121 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -73.37 -31.72 5.02 Favored 'Cis proline' 0 C--N 1.371 1.731 0 C-N-CA 124.165 -1.181 . . . . 0.0 113.141 -0.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.642 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.63 -24.92 30.24 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-O 119.381 -0.677 . . . . 0.0 113.841 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.59 112.16 48.66 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 117.241 0.521 . . . . 0.0 111.021 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -69.96 -25.2 8.25 Favored 'Cis proline' 0 C--N 1.376 2.026 0 CA-C-N 119.343 0.801 . . . . 0.0 113.248 -0.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.52 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.34 150.97 29.43 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 123.543 0.527 . . . . 0.0 110.808 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.565 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -139.98 -168.41 11.32 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.424 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.58 134.58 41.32 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 120.758 0.313 . . . . 0.0 111.399 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 80.1 m -80.31 107.85 13.44 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.35 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -112.55 147.5 36.49 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.736 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.44 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.73 129.37 34.6 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.299 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.424 -0.798 . . . . 0.0 111.517 -179.622 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.27 . . . . . . . 0 C--O 1.236 0.369 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 133.78 43.49 0.14 Allowed Glycine 0 C--N 1.339 0.71 0 O-C-N 123.494 0.496 . . . . 0.0 112.764 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.4 t -137.1 112.01 8.92 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.912 0.387 . . . . 0.0 110.927 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.443 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -118.41 148.82 42.15 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.668 179.079 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -91.84 169.85 10.36 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.14 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.514 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 22.5 tt0 -63.98 137.14 57.87 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 120.732 0.301 . . . . 0.0 111.055 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.01 -5.01 81.4 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.959 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -93.95 157.69 15.99 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 122.688 0.395 . . . . 0.0 110.663 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.569 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.9 t -97.16 115.73 28.08 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.999 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.517 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.3 p -118.83 153.66 34.13 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.566 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.519 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 5.7 m-80 -100.73 138.37 37.88 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.754 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.8 m -92.11 20.19 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 120.928 0.394 . . . . 0.0 110.994 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.85 -29.91 7.23 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.807 -178.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -149.03 -44.75 0.14 Allowed 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -115.47 73.92 4.18 Favored Pre-proline 0 CA--C 1.548 0.878 0 O-C-N 123.21 0.319 . . . . 0.0 111.429 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.53 -172.53 0.94 Allowed 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.826 2.351 . . . . 0.0 113.037 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.517 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 87.8 m -70.77 -176.26 1.28 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 122.395 0.278 . . . . 0.0 111.123 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 17.8 m -85.53 118.53 70.86 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 122.361 0.264 . . . . 0.0 111.342 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -78.62 158.34 28.49 Favored 'Trans proline' 0 C--N 1.37 1.662 0 C-N-CA 122.663 2.242 . . . . 0.0 112.939 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.14 -32.57 5.35 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.845 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.8 mt -83.71 -60.34 2.15 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 122.696 0.398 . . . . 0.0 110.978 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.2 36.47 0.3 Allowed Glycine 0 C--N 1.34 0.798 0 O-C-N 123.378 0.424 . . . . 0.0 113.303 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.63 155.61 18.72 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.826 0.346 . . . . 0.0 111.41 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.9 t -142.87 129.26 20.03 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.307 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.09 123.73 30.95 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 123.28 0.362 . . . . 0.0 110.823 179.838 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.8 mm -123.2 120.38 27.32 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.223 -178.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.32 -31.72 5.02 Favored 'Cis proline' 0 C--N 1.37 1.704 0 C-N-CA 124.196 -1.168 . . . . 0.0 113.178 -0.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.643 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.5 -24.88 30.41 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.848 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -113.64 112.21 48.48 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 117.213 0.507 . . . . 0.0 111.005 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.82 -25.25 8.16 Favored 'Cis proline' 0 C--N 1.377 2.05 0 CA-C-N 119.381 0.815 . . . . 0.0 113.328 -0.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.519 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.1 p-10 -153.37 151.05 29.5 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.745 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.569 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.22 -168.44 11.35 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.441 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.7 OUTLIER -98.58 134.51 41.43 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 120.714 0.292 . . . . 0.0 111.501 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 89.4 m -80.16 107.7 13.17 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.287 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -112.41 147.44 36.44 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.86 -1.063 . . . . 0.0 110.698 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.439 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.71 129.63 34.9 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.315 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.1 mt . . . . . 0 C--O 1.25 1.113 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.46 -179.555 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.272 . . . . . . . 0 C--O 1.235 0.316 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 110.41 52.0 0.6 Allowed Glycine 0 C--N 1.337 0.607 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.773 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.6 t -139.37 112.62 8.18 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 120.735 0.303 . . . . 0.0 110.508 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.475 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -116.38 149.65 39.02 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.947 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -93.92 168.87 10.69 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.695 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.511 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 24.3 tt0 -62.99 136.71 57.98 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.763 0.316 . . . . 0.0 111.082 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.06 -4.99 81.63 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.939 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -93.97 157.19 16.23 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 122.651 0.38 . . . . 0.0 110.634 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.564 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 53.5 m -96.72 116.41 29.09 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.26 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.512 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.48 153.97 34.48 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.607 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.518 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 5.9 m-80 -100.77 138.24 38.09 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.771 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -92.05 20.34 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.973 0.416 . . . . 0.0 111.074 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.77 -30.01 7.21 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.835 -178.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.81 -45.01 0.15 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -115.42 74.05 4.13 Favored Pre-proline 0 CA--C 1.547 0.858 0 O-C-N 123.188 0.305 . . . . 0.0 111.351 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.6 -172.43 0.93 Allowed 'Trans proline' 0 C--N 1.367 1.545 0 C-N-CA 122.839 2.359 . . . . 0.0 112.902 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.512 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 89.7 m -70.22 -177.06 1.31 Allowed 'General case' 0 CA--C 1.542 0.665 0 O-C-N 123.194 0.309 . . . . 0.0 111.166 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 16.5 m -84.42 118.33 70.88 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 122.324 0.25 . . . . 0.0 111.343 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.45 157.61 29.02 Favored 'Trans proline' 0 C--N 1.369 1.634 0 C-N-CA 122.673 2.249 . . . . 0.0 113.117 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.69 -32.09 5.77 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.889 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.6 mt -84.23 -60.47 2.08 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.614 0.366 . . . . 0.0 110.965 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.39 36.33 0.3 Allowed Glycine 0 C--N 1.341 0.857 0 O-C-N 123.458 0.474 . . . . 0.0 113.269 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.39 155.65 18.8 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.908 0.354 . . . . 0.0 111.391 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.74 129.18 20.1 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.341 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.03 123.63 30.8 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 123.273 0.358 . . . . 0.0 110.824 179.865 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.4 mm -123.16 120.36 27.36 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.102 -178.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.35 -31.8 4.97 Favored 'Cis proline' 0 C--N 1.372 1.791 0 C-N-CA 124.169 -1.179 . . . . 0.0 113.129 -0.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.642 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.66 -24.93 30.22 Favored Glycine 0 C--N 1.338 0.69 0 CA-C-N 115.691 -0.686 . . . . 0.0 113.877 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -113.54 112.09 48.85 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 117.209 0.505 . . . . 0.0 111.053 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -69.89 -25.27 8.17 Favored 'Cis proline' 0 C--N 1.378 2.084 0 CA-C-N 119.437 0.835 . . . . 0.0 113.304 -0.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.518 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.24 150.99 29.56 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.821 179.15 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.05 -168.32 11.3 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.501 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.6 134.45 41.53 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 120.689 0.281 . . . . 0.0 111.452 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 83.4 m -80.35 107.7 13.36 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.292 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -112.47 147.42 36.56 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.689 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.439 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.6 129.41 34.75 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.332 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.122 -0.942 . . . . 0.0 111.507 -179.567 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.275 . . . . . . . 0 N--CA 1.467 0.398 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 98.86 53.85 1.16 Allowed Glycine 0 C--N 1.339 0.708 0 O-C-N 123.348 0.405 . . . . 0.0 112.55 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -135.58 113.26 10.89 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 120.734 0.302 . . . . 0.0 110.432 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.445 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -118.12 147.9 42.85 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.835 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -91.63 172.12 8.71 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.041 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.4 tt0 -65.4 137.49 57.51 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.833 0.349 . . . . 0.0 111.024 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.75 -5.2 79.75 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 115.32 -0.855 . . . . 0.0 113.025 -179.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -93.66 157.2 16.29 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 122.719 0.408 . . . . 0.0 110.63 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.571 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.3 t -96.86 115.43 27.41 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.98 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.507 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -118.6 153.73 33.79 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.591 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.52 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.0 m-80 -100.7 138.2 38.07 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.808 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.6 m -91.89 20.32 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 120.9 0.381 . . . . 0.0 111.071 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.76 -29.95 7.24 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.803 -178.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -148.94 -45.0 0.14 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -178.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -115.63 74.22 4.56 Favored Pre-proline 0 CA--C 1.548 0.89 0 O-C-N 123.196 0.31 . . . . 0.0 111.34 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.71 -171.98 0.86 Allowed 'Trans proline' 0 C--N 1.367 1.527 0 C-N-CA 122.745 2.296 . . . . 0.0 112.827 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.507 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 92.7 m -70.32 -177.51 1.46 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 122.39 0.276 . . . . 0.0 111.123 179.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.8 m -84.31 118.49 71.3 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 122.369 0.268 . . . . 0.0 111.373 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.43 157.88 29.13 Favored 'Trans proline' 0 C--N 1.37 1.665 0 C-N-CA 122.695 2.263 . . . . 0.0 113.066 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.52 -32.28 5.61 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.894 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.7 mt -84.18 -60.31 2.13 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 122.685 0.394 . . . . 0.0 110.934 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.01 36.36 0.31 Allowed Glycine 0 C--N 1.341 0.847 0 O-C-N 123.406 0.441 . . . . 0.0 113.321 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.39 155.69 18.77 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.868 0.366 . . . . 0.0 111.418 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.77 129.28 20.17 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.325 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.08 123.77 30.98 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 123.291 0.369 . . . . 0.0 110.785 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.3 mm -123.3 120.39 27.22 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.104 -178.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.3 -31.84 4.94 Favored 'Cis proline' 0 C--N 1.371 1.75 0 C-N-CA 124.222 -1.158 . . . . 0.0 113.148 -0.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.643 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.73 -24.85 30.51 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-O 119.412 -0.66 . . . . 0.0 113.852 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -113.65 112.16 48.49 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 117.158 0.479 . . . . 0.0 110.982 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -69.95 -25.13 8.29 Favored 'Cis proline' 0 C--N 1.379 2.152 0 C-N-CA 125.024 -0.823 . . . . 0.0 113.249 -0.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.52 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p30 -153.39 151.03 29.45 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.767 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.571 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.02 -168.42 11.33 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.484 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.51 134.6 41.25 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.726 0.298 . . . . 0.0 111.359 -179.864 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 81.3 m -80.3 107.66 13.28 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.361 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -112.46 147.12 37.17 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.733 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.44 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.47 129.45 34.9 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.24 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.129 -0.938 . . . . 0.0 111.498 -179.597 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.271 . . . . . . . 0 C--O 1.235 0.315 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.71 55.27 1.02 Allowed Glycine 0 C--N 1.337 0.586 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.536 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -137.45 113.08 9.5 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 120.815 0.34 . . . . 0.0 110.425 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.463 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -117.07 148.65 41.33 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.895 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -93.38 169.54 10.29 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.727 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.7 tt0 -62.94 137.05 58.16 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 120.87 0.367 . . . . 0.0 111.078 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.06 -5.44 79.71 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.956 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -93.53 157.01 16.41 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 122.702 0.401 . . . . 0.0 110.635 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.566 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.2 t -97.03 115.99 28.43 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.995 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.509 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.07 154.03 33.81 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.631 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.521 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.1 m-80 -100.78 138.27 38.05 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.823 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.644 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -91.95 20.39 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.015 0.436 . . . . 0.0 111.064 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -112.67 -29.9 7.28 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.818 -178.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -149.02 -45.05 0.14 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -115.58 74.1 4.42 Favored Pre-proline 0 CA--C 1.548 0.888 0 O-C-N 123.126 0.266 . . . . 0.0 111.362 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.65 -172.04 0.86 Allowed 'Trans proline' 0 C--N 1.368 1.557 0 C-N-CA 122.743 2.295 . . . . 0.0 112.795 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.509 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 92.4 m -70.23 -177.41 1.4 Allowed 'General case' 0 CA--C 1.543 0.676 0 O-C-N 123.142 0.276 . . . . 0.0 111.161 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 15.6 m -84.11 118.29 70.88 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 122.345 0.258 . . . . 0.0 111.277 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -78.49 157.51 28.86 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 122.593 2.195 . . . . 0.0 113.081 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.77 -32.15 5.75 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.875 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.6 mt -84.26 -60.76 1.99 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 122.607 0.363 . . . . 0.0 110.992 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 133.0 36.15 0.28 Allowed Glycine 0 C--N 1.34 0.779 0 O-C-N 123.475 0.484 . . . . 0.0 113.271 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.63 155.45 18.84 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.91 0.355 . . . . 0.0 111.366 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.9 t -142.55 129.56 20.73 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.384 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.2 123.72 31.03 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.227 0.329 . . . . 0.0 110.807 179.853 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.0 mm -123.23 120.46 27.27 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.062 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.23 -31.83 4.94 Favored 'Cis proline' 0 C--N 1.372 1.781 0 C-N-CA 124.131 -1.196 . . . . 0.0 113.208 -0.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.644 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.76 -24.89 30.37 Favored Glycine 0 C--N 1.338 0.667 0 CA-C-N 115.712 -0.677 . . . . 0.0 113.844 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.58 112.16 48.69 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 117.209 0.504 . . . . 0.0 111.026 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -69.85 -25.25 8.17 Favored 'Cis proline' 0 C--N 1.378 2.088 0 CA-C-N 119.372 0.811 . . . . 0.0 113.347 -0.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.521 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.3 151.01 29.52 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.774 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.02 -168.52 11.36 Favored Glycine 0 C--N 1.336 0.545 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.393 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.41 134.72 41.02 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 120.719 0.295 . . . . 0.0 111.499 -179.977 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 79.4 m -80.44 107.84 13.57 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.325 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -112.54 147.65 36.15 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.758 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.44 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.84 129.44 34.59 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.274 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.485 -0.769 . . . . 0.0 111.473 -179.575 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.273 . . . . . . . 0 C--O 1.235 0.335 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 111.89 51.64 0.56 Allowed Glycine 0 C--N 1.336 0.541 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.789 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.6 t -139.76 112.66 8.06 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 120.766 0.317 . . . . 0.0 110.517 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.474 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -116.45 149.63 39.15 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.866 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -94.05 168.78 10.73 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.65 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.509 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 24.1 tt0 -62.76 136.54 57.91 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.785 0.326 . . . . 0.0 111.053 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.31 -5.1 81.95 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.956 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -93.71 157.26 16.25 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 122.745 0.418 . . . . 0.0 110.693 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.566 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.1 t -96.95 116.07 28.54 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.082 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.511 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.3 153.95 34.26 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.627 179.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.519 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.0 m-80 -100.76 138.28 38.02 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.766 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.6 m -91.99 20.3 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 120.914 0.388 . . . . 0.0 111.083 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.79 -30.05 7.2 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.835 -178.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.8 -44.97 0.15 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -115.44 74.07 4.18 Favored Pre-proline 0 CA--C 1.548 0.893 0 O-C-N 123.177 0.298 . . . . 0.0 111.379 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.61 -172.31 0.91 Allowed 'Trans proline' 0 C--N 1.368 1.567 0 C-N-CA 122.792 2.328 . . . . 0.0 112.906 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.511 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 88.8 m -70.21 -177.01 1.29 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 122.414 0.286 . . . . 0.0 111.218 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 16.5 m -84.49 118.36 70.93 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 122.346 0.258 . . . . 0.0 111.321 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -78.58 157.66 28.55 Favored 'Trans proline' 0 C--N 1.368 1.568 0 C-N-CA 122.727 2.285 . . . . 0.0 113.071 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.66 -32.2 5.7 Favored Glycine 0 C--N 1.338 0.67 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.842 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.5 mt -84.11 -60.92 1.95 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 122.64 0.376 . . . . 0.0 111.016 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 133.03 36.26 0.28 Allowed Glycine 0 C--N 1.342 0.869 0 O-C-N 123.414 0.446 . . . . 0.0 113.217 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.56 155.58 18.77 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.919 0.36 . . . . 0.0 111.392 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.9 t -142.68 129.28 20.27 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.363 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.12 123.77 31.02 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 123.278 0.361 . . . . 0.0 110.785 179.857 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.3 mm -123.28 120.39 27.24 Favored Pre-proline 0 CA--C 1.541 0.629 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.062 -178.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.32 -31.8 4.97 Favored 'Cis proline' 0 C--N 1.372 1.764 0 C-N-CA 124.231 -1.154 . . . . 0.0 113.148 -0.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.642 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.6 -24.86 30.48 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-O 119.358 -0.69 . . . . 0.0 113.815 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -113.65 112.18 48.47 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-N 117.212 0.506 . . . . 0.0 111.035 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.92 -25.17 8.25 Favored 'Cis proline' 0 C--N 1.378 2.084 0 C-N-CA 125.016 -0.827 . . . . 0.0 113.303 -0.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.519 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.35 151.03 29.5 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.798 179.139 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.17 -168.41 11.34 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.453 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.57 134.47 41.48 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 120.765 0.317 . . . . 0.0 111.476 -179.909 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 85.4 m -80.36 107.72 13.39 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.327 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -112.4 147.79 35.7 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.714 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.439 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.5 m-85 -78.89 129.52 34.63 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.284 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.103 -0.951 . . . . 0.0 111.429 -179.526 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.272 . . . . . . . 0 C--O 1.234 0.268 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 100.83 55.11 0.95 Allowed Glycine 0 C--N 1.336 0.529 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.526 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.89 113.15 9.89 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.755 0.312 . . . . 0.0 110.431 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.455 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -117.78 148.17 42.31 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.805 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -92.26 172.09 8.64 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.034 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 24.2 tt0 -65.15 136.92 57.26 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.521 0.328 . . . . 0.0 111.021 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.88 -5.09 80.69 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.983 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -93.66 157.06 16.36 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 122.729 0.412 . . . . 0.0 110.669 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.566 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 52.6 m -96.93 116.09 28.57 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.211 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.505 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.16 155.01 32.4 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.658 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.527 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.5 m-80 -101.7 138.53 38.56 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.78 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.646 HG22 ' O ' ' A' ' 28' ' ' GLY . 35.7 m -91.86 21.22 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 120.91 0.386 . . . . 0.0 111.216 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -113.81 -31.05 6.56 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.931 -178.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -147.54 -44.94 0.17 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -115.69 74.2 4.65 Favored Pre-proline 0 CA--C 1.547 0.864 0 O-C-N 123.175 0.297 . . . . 0.0 111.304 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.67 -172.21 0.9 Allowed 'Trans proline' 0 C--N 1.367 1.537 0 C-N-CA 122.77 2.313 . . . . 0.0 112.8 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.505 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 93.0 m -70.17 -177.5 1.41 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 122.394 0.278 . . . . 0.0 111.152 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.9 m -84.36 118.38 71.03 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 122.222 0.209 . . . . 0.0 111.372 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.5 157.82 28.88 Favored 'Trans proline' 0 C--N 1.369 1.658 0 C-N-CA 122.654 2.236 . . . . 0.0 113.087 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.56 -32.17 5.69 Favored Glycine 0 C--N 1.337 0.598 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.882 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.5 mt -84.25 -60.39 2.1 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.671 0.388 . . . . 0.0 110.97 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.24 36.45 0.3 Allowed Glycine 0 C--N 1.342 0.884 0 O-C-N 123.393 0.433 . . . . 0.0 113.269 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.49 155.8 18.64 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.88 0.372 . . . . 0.0 111.356 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.66 128.79 19.75 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.316 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -84.87 123.76 30.84 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 123.226 0.329 . . . . 0.0 110.792 179.853 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.4 mm -122.98 119.84 27.72 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.236 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.12 -31.29 5.28 Favored 'Cis proline' 0 C--N 1.371 1.757 0 C-N-CA 124.147 -1.189 . . . . 0.0 113.129 -0.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.646 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.02 -26.07 25.88 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 115.683 -0.69 . . . . 0.0 113.88 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -115.72 113.37 42.49 Favored Pre-proline 0 CA--C 1.546 0.797 0 CA-C-N 117.211 0.505 . . . . 0.0 111.156 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.59 -27.34 5.92 Favored 'Cis proline' 0 C--N 1.377 2.059 0 CA-C-N 119.323 0.794 . . . . 0.0 113.586 -0.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.527 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.63 151.44 29.71 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.783 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -141.37 -168.91 11.68 Favored Glycine 0 C--N 1.336 0.555 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.484 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.51 134.48 41.42 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 120.74 0.305 . . . . 0.0 111.561 -179.839 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 82.8 m -80.3 107.88 13.45 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.361 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -112.55 147.38 36.73 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.693 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.438 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.5 m-85 -78.61 129.62 34.99 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.341 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.057 -0.973 . . . . 0.0 111.45 -179.557 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.269 . . . . . . . 0 C--O 1.235 0.333 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.45 49.47 1.84 Allowed Glycine 0 C--N 1.34 0.791 0 O-C-N 123.348 0.405 . . . . 0.0 112.644 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -138.82 113.47 9.05 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 122.451 0.301 . . . . 0.0 110.411 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.469 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -116.26 148.42 40.5 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.927 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -93.32 169.18 10.57 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.691 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.8 tt0 -62.99 137.21 58.2 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.872 0.368 . . . . 0.0 111.066 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.95 -5.19 80.43 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.999 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -93.66 157.26 16.26 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 122.707 0.403 . . . . 0.0 110.73 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.569 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.1 t -96.89 115.65 27.79 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.074 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -118.8 153.82 33.84 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.604 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.52 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.2 m-80 -100.66 138.25 37.98 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.794 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -92.01 20.48 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.971 0.415 . . . . 0.0 111.044 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.82 -29.82 7.27 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.857 -178.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -149.06 -45.13 0.14 Allowed 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -115.58 74.15 4.44 Favored Pre-proline 0 CA--C 1.547 0.843 0 O-C-N 123.09 0.244 . . . . 0.0 111.34 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.73 -171.95 0.85 Allowed 'Trans proline' 0 C--N 1.368 1.562 0 C-N-CA 122.769 2.313 . . . . 0.0 112.826 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 94.5 m -70.2 -177.53 1.42 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 122.382 0.273 . . . . 0.0 111.145 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 15.2 m -83.83 118.27 70.91 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 122.231 0.212 . . . . 0.0 111.298 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -78.53 156.95 28.62 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.623 2.215 . . . . 0.0 113.133 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.18 -32.02 5.95 Favored Glycine 0 C--N 1.338 0.657 0 O-C-N 123.682 0.614 . . . . 0.0 112.872 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.7 mt -84.31 -60.84 1.96 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.664 0.386 . . . . 0.0 111.045 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 133.09 36.2 0.28 Allowed Glycine 0 C--N 1.342 0.87 0 O-C-N 123.511 0.507 . . . . 0.0 113.243 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.6 155.71 18.67 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.838 0.351 . . . . 0.0 111.346 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.79 129.46 20.33 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.28 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.24 123.79 31.13 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 123.237 0.335 . . . . 0.0 110.785 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.7 mm -123.28 120.49 27.21 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.11 -178.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.29 -31.73 5.01 Favored 'Cis proline' 0 C--N 1.371 1.74 0 C-N-CA 124.182 -1.174 . . . . 0.0 113.117 -0.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.643 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.67 -24.9 30.3 Favored Glycine 0 C--N 1.338 0.662 0 CA-C-N 115.788 -0.642 . . . . 0.0 113.859 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.65 112.19 48.46 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 117.225 0.513 . . . . 0.0 111.008 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -69.94 -25.17 8.26 Favored 'Cis proline' 0 C--N 1.378 2.095 0 C-N-CA 125.062 -0.807 . . . . 0.0 113.292 -0.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.52 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p30 -153.4 150.94 29.36 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.811 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.569 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -139.94 -168.34 11.3 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.498 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.46 134.65 41.15 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.76 0.314 . . . . 0.0 111.437 -179.917 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 78.5 m -80.51 107.82 13.63 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.358 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -112.54 147.61 36.25 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.709 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.444 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.81 129.43 34.59 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.269 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.555 -0.736 . . . . 0.0 111.452 -179.552 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.27 . . . . . . . 0 C--O 1.235 0.309 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 126.77 42.0 0.29 Allowed Glycine 0 C--N 1.337 0.591 0 O-C-N 123.716 0.635 . . . . 0.0 112.915 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.6 t -141.96 112.86 7.37 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 120.743 0.306 . . . . 0.0 110.623 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.488 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -115.99 149.82 38.2 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.877 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -94.24 168.67 10.77 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.64 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 24.6 tt0 -63.07 136.73 57.97 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.747 0.308 . . . . 0.0 111.088 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.02 -4.83 81.95 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.913 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -93.88 157.63 16.04 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 122.725 0.41 . . . . 0.0 110.705 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.567 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.1 t -96.92 116.1 28.59 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.066 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.514 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.3 p -119.39 153.75 34.7 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.609 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.519 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.1 m-80 -100.72 138.22 38.06 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.775 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.5 m -92.03 20.31 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.926 0.394 . . . . 0.0 111.04 -179.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.86 -29.9 7.23 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.849 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -148.97 -44.86 0.14 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -115.38 74.07 4.08 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 122.259 0.223 . . . . 0.0 111.36 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.71 -172.41 0.94 Allowed 'Trans proline' 0 C--N 1.367 1.505 0 C-N-CA 122.821 2.347 . . . . 0.0 112.921 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.514 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 88.8 m -70.38 -176.86 1.31 Allowed 'General case' 0 CA--C 1.543 0.692 0 O-C-N 123.168 0.293 . . . . 0.0 111.168 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 17.1 m -84.68 118.36 70.85 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 122.327 0.251 . . . . 0.0 111.348 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.54 157.74 28.7 Favored 'Trans proline' 0 C--N 1.368 1.587 0 C-N-CA 122.705 2.27 . . . . 0.0 113.114 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.64 -32.19 5.7 Favored Glycine 0 C--N 1.337 0.59 0 O-C-N 123.669 0.606 . . . . 0.0 112.853 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.7 mt -84.22 -60.2 2.16 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 122.624 0.37 . . . . 0.0 110.991 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.15 36.28 0.31 Allowed Glycine 0 C--N 1.341 0.846 0 O-C-N 123.399 0.437 . . . . 0.0 113.311 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.18 155.7 18.84 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.86 0.33 . . . . 0.0 111.425 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.82 129.08 19.89 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.324 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -84.94 123.72 30.83 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.317 0.386 . . . . 0.0 110.85 179.829 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.2 mm -123.15 120.37 27.38 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.057 -178.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.32 -31.76 4.99 Favored 'Cis proline' 0 C--N 1.371 1.731 0 C-N-CA 124.185 -1.173 . . . . 0.0 113.143 -0.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.642 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.58 -24.88 30.38 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.843 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.65 112.15 48.48 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-N 117.187 0.494 . . . . 0.0 111.012 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -69.88 -25.18 8.23 Favored 'Cis proline' 0 C--N 1.378 2.087 0 C-N-CA 125.036 -0.818 . . . . 0.0 113.34 -0.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.519 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p30 -153.39 150.98 29.41 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.796 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.22 -168.27 11.3 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.4 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.54 134.33 41.65 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.697 0.284 . . . . 0.0 111.518 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 87.1 m -80.27 107.62 13.22 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.344 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -112.4 147.35 36.62 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.789 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.436 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.3 m-85 -78.61 129.46 34.8 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.259 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--O 1.251 1.152 0 CA-C-O 118.533 -0.746 . . . . 0.0 111.389 -179.548 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.272 . . . . . . . 0 C--O 1.235 0.297 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.66 55.6 1.0 Allowed Glycine 0 C--N 1.335 0.523 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.589 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.64 113.3 10.2 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 120.778 0.323 . . . . 0.0 110.416 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.453 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -117.94 148.08 42.53 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.886 179.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -92.2 171.86 8.8 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.059 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.509 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.3 tt0 -64.88 137.24 57.64 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.726 0.298 . . . . 0.0 111.108 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.73 -5.02 80.53 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.949 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -93.72 157.04 16.35 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 122.697 0.399 . . . . 0.0 110.662 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.569 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.4 t -96.89 115.94 28.3 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.984 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.06 153.96 33.91 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.62 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.522 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.2 m-80 -100.75 138.23 38.08 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.79 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.6 m -91.96 20.45 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.961 0.41 . . . . 0.0 111.086 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -112.74 -30.09 7.19 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.736 -178.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.78 -45.02 0.15 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -115.69 74.22 4.66 Favored Pre-proline 0 CA--C 1.548 0.888 0 O-C-N 123.114 0.259 . . . . 0.0 111.294 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.72 -171.84 0.83 Allowed 'Trans proline' 0 C--N 1.368 1.557 0 C-N-CA 122.71 2.273 . . . . 0.0 112.886 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 90.5 m -70.27 -177.55 1.45 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 122.405 0.282 . . . . 0.0 111.069 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.7 m -84.28 118.55 71.47 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 122.249 0.22 . . . . 0.0 111.388 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -78.42 158.18 29.21 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 122.715 2.277 . . . . 0.0 113.094 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.27 -32.1 5.65 Favored Glycine 0 C--N 1.337 0.591 0 O-C-N 123.628 0.58 . . . . 0.0 112.882 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.9 mt -84.34 -61.12 1.88 Allowed 'General case' 0 C--O 1.236 0.36 0 C-N-CA 122.668 0.387 . . . . 0.0 111.024 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.91 36.31 0.28 Allowed Glycine 0 C--N 1.341 0.849 0 O-C-N 123.377 0.423 . . . . 0.0 113.214 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.34 156.2 18.43 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.885 0.343 . . . . 0.0 111.318 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.1 t -143.29 129.61 19.91 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.301 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.34 123.79 31.22 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 123.32 0.388 . . . . 0.0 110.848 179.839 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.3 mm -123.3 120.36 27.22 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.116 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.41 -31.76 5.0 Favored 'Cis proline' 0 C--N 1.372 1.768 0 C-N-CA 124.155 -1.185 . . . . 0.0 113.142 -0.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.643 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.64 -24.71 31.03 Favored Glycine 0 C--N 1.337 0.601 0 CA-C-O 119.386 -0.675 . . . . 0.0 113.874 179.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.62 112.13 48.6 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 117.198 0.499 . . . . 0.0 111.06 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -69.95 -25.18 8.25 Favored 'Cis proline' 0 C--N 1.376 2.026 0 CA-C-N 119.416 0.827 . . . . 0.0 113.244 -0.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.522 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.1 p30 -153.25 151.08 29.65 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.836 179.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.569 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.11 -168.43 11.34 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.46 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.53 134.52 41.37 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 120.77 0.319 . . . . 0.0 111.418 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 80.0 m -80.55 107.78 13.64 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.329 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -112.5 147.73 35.93 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.712 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.445 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.3 m-85 -78.11 128.94 34.57 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.171 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.251 1.18 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.451 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.149 0 N-CA-C 112.602 -0.199 . . . . 0.0 112.602 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.72 113.14 9.99 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 120.803 0.335 . . . . 0.0 110.398 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.462 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -117.8 148.93 41.61 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.918 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -93.19 172.48 8.27 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.981 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 24.5 tt0 -65.35 136.81 56.99 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.813 0.34 . . . . 0.0 111.01 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.04 -5.36 79.96 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.941 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -93.54 156.79 16.53 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 122.721 0.409 . . . . 0.0 110.647 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 51.7 m -96.88 116.23 28.81 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.199 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.26 154.17 33.88 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.646 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.522 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.0 m-80 -100.85 138.27 38.13 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.773 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.644 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -91.98 20.45 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.997 0.427 . . . . 0.0 111.051 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.78 -30.13 7.17 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.823 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.72 -45.02 0.15 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -115.56 74.2 4.43 Favored Pre-proline 0 CA--C 1.547 0.852 0 O-C-N 123.19 0.306 . . . . 0.0 111.367 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.59 -172.18 0.88 Allowed 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 122.762 2.308 . . . . 0.0 112.831 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 92.8 m -70.16 -177.69 1.45 Allowed 'General case' 0 CA--C 1.543 0.686 0 O-C-N 123.107 0.255 . . . . 0.0 111.137 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.6 m -84.11 118.6 71.68 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 122.271 0.228 . . . . 0.0 111.334 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.49 157.62 28.87 Favored 'Trans proline' 0 C--N 1.369 1.629 0 C-N-CA 122.676 2.251 . . . . 0.0 113.065 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.72 -32.27 5.67 Favored Glycine 0 C--N 1.338 0.661 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.862 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.4 mt -84.15 -60.46 2.09 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 122.643 0.377 . . . . 0.0 111.02 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.28 36.36 0.3 Allowed Glycine 0 C--N 1.341 0.837 0 O-C-N 123.459 0.475 . . . . 0.0 113.286 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.58 155.59 18.76 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.8 0.333 . . . . 0.0 111.381 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.63 129.39 20.45 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.333 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.11 123.69 30.92 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 123.265 0.353 . . . . 0.0 110.818 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.8 mm -123.26 120.45 27.23 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.127 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.37 -31.64 5.07 Favored 'Cis proline' 0 C--N 1.372 1.773 0 C-N-CA 124.192 -1.17 . . . . 0.0 113.169 -0.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.644 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.59 -24.74 30.91 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-N 115.766 -0.652 . . . . 0.0 113.868 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -113.66 112.18 48.45 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 117.205 0.502 . . . . 0.0 111.009 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -69.96 -25.12 8.3 Favored 'Cis proline' 0 C--N 1.378 2.111 0 C-N-CA 124.978 -0.842 . . . . 0.0 113.321 -0.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.522 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.1 p-10 -153.25 150.98 29.54 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.79 179.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.562 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -139.91 -168.54 11.36 Favored Glycine 0 C--N 1.335 0.521 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.473 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.5 134.62 41.21 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.729 0.299 . . . . 0.0 111.459 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 77.4 m -80.35 107.73 13.38 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.355 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -112.51 147.51 36.42 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.691 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.44 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.5 m-85 -78.65 129.41 34.7 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.281 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.1 mt . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.473 -0.775 . . . . 0.0 111.475 -179.554 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.153 0 N-CA-C 112.602 -0.199 . . . . 0.0 112.602 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.87 113.26 9.99 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 122.427 0.291 . . . . 0.0 110.462 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.463 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -117.73 148.16 42.28 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.851 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -92.47 172.2 8.54 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.079 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.511 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.5 tt0 -65.17 137.05 57.38 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.51 0.324 . . . . 0.0 111.015 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.93 -5.41 79.4 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.978 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -93.61 156.81 16.5 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 122.772 0.429 . . . . 0.0 110.682 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 52.9 m -96.8 116.23 28.79 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.18 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.29 154.06 34.08 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.591 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.521 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.0 m-80 -100.75 138.2 38.11 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.801 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.644 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.6 m -91.83 20.34 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 120.945 0.402 . . . . 0.0 111.071 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.71 -30.05 7.22 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.8 -178.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.91 -44.97 0.14 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -115.61 74.16 4.5 Favored Pre-proline 0 CA--C 1.548 0.888 0 O-C-N 123.2 0.312 . . . . 0.0 111.408 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.58 -172.05 0.86 Allowed 'Trans proline' 0 C--N 1.366 1.472 0 C-N-CA 122.768 2.312 . . . . 0.0 112.86 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 93.7 m -70.21 -177.62 1.45 Allowed 'General case' 0 CA--C 1.542 0.663 0 O-C-N 123.155 0.284 . . . . 0.0 111.16 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.7 m -84.15 118.46 71.3 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 122.33 0.252 . . . . 0.0 111.325 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -78.49 157.55 28.87 Favored 'Trans proline' 0 C--N 1.369 1.639 0 C-N-CA 122.64 2.227 . . . . 0.0 113.121 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.77 -32.28 5.68 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.845 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.7 mt -84.14 -60.71 2.01 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 122.617 0.367 . . . . 0.0 110.99 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.66 36.4 0.29 Allowed Glycine 0 C--N 1.341 0.848 0 O-C-N 123.442 0.464 . . . . 0.0 113.312 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.71 155.65 18.66 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.866 0.365 . . . . 0.0 111.389 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.73 129.48 20.43 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.305 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.22 123.74 31.06 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.293 0.37 . . . . 0.0 110.796 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.2 mm -123.18 120.4 27.33 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.132 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -73.45 -31.7 5.04 Favored 'Cis proline' 0 C--N 1.372 1.764 0 C-N-CA 124.217 -1.16 . . . . 0.0 113.136 -0.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.644 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.67 -24.84 30.53 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-O 119.432 -0.649 . . . . 0.0 113.79 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.58 112.17 48.67 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 117.22 0.51 . . . . 0.0 111.001 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -69.85 -25.25 8.17 Favored 'Cis proline' 0 C--N 1.378 2.088 0 CA-C-N 119.386 0.817 . . . . 0.0 113.299 -0.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.521 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.27 151.03 29.57 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.832 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.563 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.06 -168.58 11.39 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 115.811 -0.632 . . . . 0.0 112.458 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.4 134.6 41.17 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.723 0.296 . . . . 0.0 111.46 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 78.9 m -80.32 107.73 13.36 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.329 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -112.51 147.68 36.06 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.727 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.44 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.5 m-85 -78.83 129.43 34.58 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.311 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.156 -0.926 . . . . 0.0 111.44 -179.496 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.134 0 N-CA-C 112.558 -0.217 . . . . 0.0 112.558 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.86 112.98 9.75 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 120.843 0.354 . . . . 0.0 110.382 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.466 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -117.66 148.6 41.82 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.843 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -92.81 172.13 8.54 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.983 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.515 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.9 tt0 -65.16 137.0 57.35 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.796 0.331 . . . . 0.0 110.975 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.88 -5.31 79.69 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.987 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -93.7 156.84 16.47 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 122.648 0.379 . . . . 0.0 110.635 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.561 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 52.3 m -96.86 116.45 29.19 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.185 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.57 154.16 34.32 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.588 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.522 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.0 m-80 -100.84 138.2 38.2 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.782 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.6 m -91.87 20.3 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 120.983 0.421 . . . . 0.0 111.064 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -112.68 -30.03 7.23 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.802 -178.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.8 -45.01 0.15 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -115.58 74.21 4.46 Favored Pre-proline 0 CA--C 1.548 0.891 0 O-C-N 123.091 0.244 . . . . 0.0 111.334 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.65 -172.12 0.88 Allowed 'Trans proline' 0 C--N 1.367 1.545 0 C-N-CA 122.704 2.269 . . . . 0.0 112.824 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 91.9 m -70.18 -177.54 1.42 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 122.427 0.291 . . . . 0.0 111.145 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 15.1 m -84.22 118.55 71.51 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 122.272 0.229 . . . . 0.0 111.408 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -78.55 157.69 28.66 Favored 'Trans proline' 0 C--N 1.368 1.563 0 C-N-CA 122.73 2.287 . . . . 0.0 113.04 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.64 -32.21 5.69 Favored Glycine 0 C--N 1.337 0.632 0 O-C-N 123.717 0.636 . . . . 0.0 112.916 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.9 mt -84.22 -60.79 1.98 Allowed 'General case' 0 C--O 1.236 0.385 0 C-N-CA 122.645 0.378 . . . . 0.0 110.962 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.78 36.26 0.29 Allowed Glycine 0 C--N 1.341 0.813 0 O-C-N 123.447 0.467 . . . . 0.0 113.279 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.63 155.77 18.61 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.921 0.361 . . . . 0.0 111.413 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.86 129.4 20.19 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.36 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.17 123.68 30.96 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.299 0.374 . . . . 0.0 110.801 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.4 mm -123.22 120.47 27.28 Favored Pre-proline 0 CA--C 1.542 0.649 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.099 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.39 -31.59 5.1 Favored 'Cis proline' 0 C--N 1.371 1.746 0 C-N-CA 124.192 -1.17 . . . . 0.0 113.19 -0.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.643 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.51 -24.77 30.83 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 115.747 -0.66 . . . . 0.0 113.891 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.67 112.17 48.44 Favored Pre-proline 0 CA--C 1.542 0.673 0 CA-C-N 117.199 0.499 . . . . 0.0 111.025 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -69.87 -25.25 8.18 Favored 'Cis proline' 0 C--N 1.378 2.088 0 C-N-CA 125.069 -0.804 . . . . 0.0 113.298 -0.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.522 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.24 150.98 29.55 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.782 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.561 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.05 -168.43 11.34 Favored Glycine 0 C--N 1.336 0.533 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.461 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.53 134.64 41.21 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.77 0.319 . . . . 0.0 111.436 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 79.9 m -80.28 107.76 13.34 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.334 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -112.59 147.76 36.0 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.654 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.44 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.5 m-85 -78.81 129.36 34.52 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.279 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.134 -0.936 . . . . 0.0 111.45 -179.603 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.169 0 N-CA-C 112.587 -0.205 . . . . 0.0 112.587 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.23 113.69 10.85 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.832 0.349 . . . . 0.0 110.45 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.469 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -119.14 146.71 44.91 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.776 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -92.18 173.67 7.7 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.985 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.5 tt0 -65.22 137.42 57.58 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.792 0.33 . . . . 0.0 111.204 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.84 -5.74 77.57 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 115.254 -0.885 . . . . 0.0 113.085 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -93.47 156.36 16.8 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 122.625 0.37 . . . . 0.0 110.778 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.559 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 53.3 m -96.88 116.2 28.76 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.127 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.17 154.32 33.5 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.673 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.527 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 5.9 m-80 -101.09 138.33 38.28 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.749 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.644 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.6 m -91.9 20.37 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 120.954 0.407 . . . . 0.0 110.99 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -112.58 -29.92 7.3 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.825 -178.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -149.03 -45.2 0.14 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -115.49 74.16 4.3 Favored Pre-proline 0 CA--C 1.548 0.891 0 O-C-N 123.185 0.303 . . . . 0.0 111.369 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.63 -172.03 0.86 Allowed 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 122.73 2.287 . . . . 0.0 112.798 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 95.4 m -70.26 -177.92 1.55 Allowed 'General case' 0 CA--C 1.543 0.701 0 O-C-N 123.128 0.268 . . . . 0.0 111.13 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.6 m -83.94 118.35 71.11 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 122.237 0.215 . . . . 0.0 111.28 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -78.44 157.87 29.11 Favored 'Trans proline' 0 C--N 1.368 1.604 0 C-N-CA 122.679 2.253 . . . . 0.0 113.128 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.49 -32.03 5.75 Favored Glycine 0 C--N 1.338 0.664 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.858 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.2 mt -84.51 -60.59 2.02 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.63 0.372 . . . . 0.0 111.002 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.72 36.04 0.3 Allowed Glycine 0 C--N 1.341 0.813 0 O-C-N 123.425 0.453 . . . . 0.0 113.327 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.67 155.34 18.91 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.866 0.365 . . . . 0.0 111.361 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.9 t -142.29 129.75 21.28 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.357 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.42 123.72 31.19 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.3 0.375 . . . . 0.0 110.808 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.1 mm -123.07 120.48 27.43 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.092 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.5 -31.39 5.24 Favored 'Cis proline' 0 C--N 1.37 1.688 0 C-N-CA 124.166 -1.181 . . . . 0.0 113.175 -0.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.644 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.36 -24.59 31.49 Favored Glycine 0 C--N 1.338 0.656 0 CA-C-N 115.75 -0.659 . . . . 0.0 113.891 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -113.7 112.06 48.42 Favored Pre-proline 0 CA--C 1.543 0.673 0 CA-C-N 117.218 0.509 . . . . 0.0 111.079 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -69.77 -25.35 8.07 Favored 'Cis proline' 0 C--N 1.378 2.106 0 CA-C-N 119.404 0.823 . . . . 0.0 113.313 -0.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.527 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.13 151.18 29.86 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.744 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.22 -168.67 11.43 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.429 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.33 134.67 41.02 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 120.769 0.319 . . . . 0.0 111.489 -179.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 77.9 m -80.24 107.98 13.47 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.3 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -112.82 147.42 36.98 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.769 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.441 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.5 m-85 -78.68 129.75 35.07 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.286 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.137 -0.935 . . . . 0.0 111.429 -179.508 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 0.118 0 N-CA-C 112.578 -0.209 . . . . 0.0 112.578 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.67 113.36 10.23 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 120.77 0.319 . . . . 0.0 110.414 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.459 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -117.99 148.32 42.33 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.887 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -92.4 172.32 8.47 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.971 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.51 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.9 tt0 -65.36 137.07 57.26 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.767 0.318 . . . . 0.0 111.056 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.92 -5.3 79.84 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 115.311 -0.859 . . . . 0.0 113.038 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -93.46 156.97 16.45 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 122.66 0.384 . . . . 0.0 110.656 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.567 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.1 t -96.94 115.91 28.27 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.085 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.507 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.04 154.02 33.78 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.629 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.521 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.1 m-80 -100.8 138.25 38.11 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.784 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -91.99 20.5 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.032 0.444 . . . . 0.0 111.072 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -112.82 -30.0 7.2 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.796 -178.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -148.9 -45.07 0.14 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -178.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -115.57 74.2 4.44 Favored Pre-proline 0 CA--C 1.547 0.852 0 O-C-N 123.053 0.22 . . . . 0.0 111.37 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.67 -172.03 0.86 Allowed 'Trans proline' 0 C--N 1.367 1.535 0 C-N-CA 122.758 2.305 . . . . 0.0 112.8 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.507 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 93.2 m -70.22 -177.62 1.46 Allowed 'General case' 0 CA--C 1.542 0.663 0 O-C-N 123.152 0.282 . . . . 0.0 111.126 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.9 m -84.26 118.56 71.5 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 122.29 0.236 . . . . 0.0 111.379 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.51 157.85 28.85 Favored 'Trans proline' 0 C--N 1.37 1.658 0 C-N-CA 122.606 2.204 . . . . 0.0 113.073 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.53 -32.22 5.65 Favored Glycine 0 C--N 1.338 0.659 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.897 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.5 mt -84.19 -60.42 2.1 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 122.693 0.397 . . . . 0.0 111.023 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.19 36.42 0.3 Allowed Glycine 0 C--N 1.341 0.831 0 O-C-N 123.413 0.445 . . . . 0.0 113.248 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.51 155.72 18.69 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.891 0.345 . . . . 0.0 111.455 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.74 129.39 20.32 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.32 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.21 123.74 31.06 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.253 0.346 . . . . 0.0 110.843 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.2 mm -123.26 120.39 27.25 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.087 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.34 -31.74 5.01 Favored 'Cis proline' 0 C--N 1.371 1.75 0 C-N-CA 124.188 -1.172 . . . . 0.0 113.201 -0.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.643 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.66 -24.85 30.49 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-N 115.747 -0.66 . . . . 0.0 113.805 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -113.61 112.22 48.56 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 117.253 0.527 . . . . 0.0 111.057 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.87 -25.18 8.22 Favored 'Cis proline' 0 C--N 1.378 2.088 0 C-N-CA 125.038 -0.818 . . . . 0.0 113.278 -0.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.521 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.1 p30 -153.34 150.93 29.39 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.814 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -139.95 -168.43 11.33 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.5 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.5 134.56 41.29 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.731 0.3 . . . . 0.0 111.494 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 79.7 m -80.27 107.67 13.26 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.392 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -112.43 147.43 36.48 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.744 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.439 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.67 129.4 34.68 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.322 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--O 1.252 1.189 0 CA-C-O 118.483 -0.77 . . . . 0.0 111.511 -179.539 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.193 0 N-CA-C 112.563 -0.215 . . . . 0.0 112.563 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.62 113.31 10.21 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 120.708 0.29 . . . . 0.0 110.472 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.459 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -117.99 148.33 42.32 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.847 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -92.3 172.33 8.47 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.999 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.7 tt0 -65.42 137.03 57.2 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.771 0.32 . . . . 0.0 111.046 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.89 -5.21 80.15 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.982 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -93.46 157.07 16.4 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 122.711 0.404 . . . . 0.0 110.712 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.567 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.6 t -96.97 115.86 28.18 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.961 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.508 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.04 153.84 34.09 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.601 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.521 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.1 m-80 -100.72 138.24 38.04 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.794 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -91.93 20.46 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.97 0.414 . . . . 0.0 111.086 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.86 -30.01 7.19 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.764 -178.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.84 -45.13 0.15 Allowed 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -178.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -115.55 74.18 4.4 Favored Pre-proline 0 CA--C 1.547 0.855 0 O-C-N 123.088 0.243 . . . . 0.0 111.319 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.5 -171.99 0.84 Allowed 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 122.741 2.294 . . . . 0.0 112.907 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.508 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 93.0 m -70.29 -177.58 1.47 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 122.431 0.293 . . . . 0.0 111.152 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.9 m -84.31 118.48 71.3 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 122.328 0.251 . . . . 0.0 111.384 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -78.46 157.83 29.02 Favored 'Trans proline' 0 C--N 1.368 1.599 0 C-N-CA 122.711 2.274 . . . . 0.0 113.044 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.52 -32.27 5.62 Favored Glycine 0 C--N 1.338 0.669 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.895 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.5 mt -84.12 -60.44 2.09 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 122.706 0.403 . . . . 0.0 111.024 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.22 36.37 0.3 Allowed Glycine 0 C--N 1.341 0.86 0 O-C-N 123.476 0.485 . . . . 0.0 113.251 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -90.54 155.63 18.75 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.903 0.383 . . . . 0.0 111.426 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.9 t -142.53 129.23 20.4 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.345 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.08 123.77 30.99 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 123.217 0.323 . . . . 0.0 110.785 179.852 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.2 mm -123.22 120.41 27.29 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.126 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.38 -31.73 5.01 Favored 'Cis proline' 0 C--N 1.371 1.75 0 C-N-CA 124.159 -1.184 . . . . 0.0 113.146 -0.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.643 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.71 -25.03 29.86 Favored Glycine 0 C--N 1.338 0.677 0 CA-C-N 115.694 -0.685 . . . . 0.0 113.767 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -113.5 112.18 48.9 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 117.235 0.517 . . . . 0.0 111.023 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -69.96 -25.04 8.35 Favored 'Cis proline' 0 C--N 1.379 2.148 0 C-N-CA 124.995 -0.835 . . . . 0.0 113.367 -0.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.521 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.1 p-10 -153.49 150.96 29.29 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.803 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.08 -168.45 11.34 Favored Glycine 0 C--N 1.335 0.519 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.492 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.44 134.63 41.16 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 120.77 0.319 . . . . 0.0 111.446 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 78.2 m -80.39 107.71 13.42 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.319 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -112.38 147.42 36.45 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.693 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.44 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.5 m-85 -78.56 129.5 34.89 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.356 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.5 mt . . . . . 0 C--O 1.252 1.201 0 CA-C-O 118.526 -0.749 . . . . 0.0 111.474 -179.57 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.191 0 CA-C-O 120.263 -0.187 . . . . 0.0 112.73 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -138.84 113.87 9.36 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.777 0.323 . . . . 0.0 110.482 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.477 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -117.17 147.97 42.0 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.904 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -92.67 172.74 8.17 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.027 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.51 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.6 tt0 -65.81 137.3 57.14 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.8 0.334 . . . . 0.0 110.951 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.81 -5.29 79.54 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 115.267 -0.879 . . . . 0.0 113.023 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -93.77 157.01 16.35 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 122.651 0.38 . . . . 0.0 110.733 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.564 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 52.7 m -96.75 116.07 28.51 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.182 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.05 153.93 33.95 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.656 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.522 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.1 m-80 -100.71 138.26 38.0 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.824 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -91.98 20.47 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.912 0.387 . . . . 0.0 110.967 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.85 -29.79 7.27 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.817 -178.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -149.09 -45.01 0.14 Allowed 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -115.67 74.13 4.59 Favored Pre-proline 0 CA--C 1.548 0.884 0 O-C-N 123.193 0.308 . . . . 0.0 111.304 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.65 -171.92 0.84 Allowed 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 122.739 2.293 . . . . 0.0 112.892 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 95.3 m -70.16 -177.84 1.49 Allowed 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.163 0.289 . . . . 0.0 111.082 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.5 m -83.84 118.46 71.45 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 122.294 0.238 . . . . 0.0 111.367 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -78.53 157.25 28.67 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.681 2.254 . . . . 0.0 113.065 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.94 -32.22 5.76 Favored Glycine 0 C--N 1.338 0.64 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.891 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.8 mt -84.17 -60.61 2.04 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 122.674 0.389 . . . . 0.0 110.993 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.49 36.4 0.29 Allowed Glycine 0 C--N 1.34 0.794 0 O-C-N 123.489 0.493 . . . . 0.0 113.249 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.61 155.71 18.66 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.884 0.374 . . . . 0.0 111.379 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.7 129.42 20.41 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.301 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.2 123.74 31.05 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.275 0.359 . . . . 0.0 110.794 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.1 mm -123.23 120.42 27.28 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.149 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.29 -31.84 4.94 Favored 'Cis proline' 0 C--N 1.371 1.717 0 C-N-CA 124.166 -1.181 . . . . 0.0 113.155 -0.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.643 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.69 -24.83 30.56 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-O 119.413 -0.659 . . . . 0.0 113.878 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -113.58 112.13 48.7 Favored Pre-proline 0 CA--C 1.543 0.705 0 CA-C-N 117.239 0.52 . . . . 0.0 111.072 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -69.91 -25.26 8.19 Favored 'Cis proline' 0 C--N 1.377 2.032 0 CA-C-N 119.386 0.816 . . . . 0.0 113.251 -0.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.522 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.28 151.0 29.52 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.84 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -139.89 -168.43 11.32 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.522 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.59 134.62 41.27 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 120.733 0.302 . . . . 0.0 111.38 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 76.5 m -80.38 107.82 13.49 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.398 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -112.51 147.36 36.74 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.72 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.439 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.62 129.5 34.84 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.256 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.08 -0.962 . . . . 0.0 111.466 -179.547 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.187 0 CA-C-O 120.249 -0.195 . . . . 0.0 112.857 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -141.26 113.07 7.74 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 120.724 0.297 . . . . 0.0 110.592 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.498 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -116.57 149.11 40.17 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.846 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -93.8 171.66 8.73 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.514 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.8 tt0 -65.02 136.8 57.21 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 122.482 0.313 . . . . 0.0 111.002 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.9 -5.0 81.13 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.966 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -94.02 157.13 16.24 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 122.673 0.389 . . . . 0.0 110.672 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.56 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 52.3 m -96.85 116.76 29.72 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.194 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.512 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.84 154.03 34.91 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.622 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.521 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.1 m-80 -100.77 138.19 38.15 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.719 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -91.87 20.24 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 120.909 0.385 . . . . 0.0 111.097 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.79 -29.93 7.24 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.842 -178.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -148.91 -44.96 0.14 Allowed 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -115.45 73.99 4.17 Favored Pre-proline 0 CA--C 1.548 0.894 0 O-C-N 123.149 0.281 . . . . 0.0 111.375 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.66 -172.3 0.91 Allowed 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 122.743 2.295 . . . . 0.0 112.918 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.512 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 90.6 m -70.32 -177.1 1.34 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 122.408 0.283 . . . . 0.0 111.137 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 16.0 m -84.56 118.47 71.16 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 122.354 0.262 . . . . 0.0 111.274 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -78.57 157.65 28.59 Favored 'Trans proline' 0 C--N 1.368 1.587 0 C-N-CA 122.711 2.274 . . . . 0.0 113.053 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.6 -32.16 5.7 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.89 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.7 mt -84.1 -60.76 2.0 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.643 0.377 . . . . 0.0 111.025 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.78 36.43 0.28 Allowed Glycine 0 C--N 1.341 0.835 0 O-C-N 123.461 0.476 . . . . 0.0 113.218 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.66 155.71 18.64 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.946 0.373 . . . . 0.0 111.427 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.69 129.34 20.33 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.305 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.11 123.68 30.91 Favored 'General case' 0 C--O 1.236 0.391 0 O-C-N 123.201 0.313 . . . . 0.0 110.825 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.3 mm -123.22 120.37 27.3 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.121 -178.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.34 -31.72 5.02 Favored 'Cis proline' 0 C--N 1.371 1.746 0 C-N-CA 124.223 -1.157 . . . . 0.0 113.226 -0.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.642 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.6 -25.03 29.82 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.854 179.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -113.54 112.1 48.83 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 117.237 0.519 . . . . 0.0 111.025 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -69.94 -25.14 8.28 Favored 'Cis proline' 0 C--N 1.379 2.147 0 C-N-CA 124.993 -0.836 . . . . 0.0 113.359 -0.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.521 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.39 151.0 29.43 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.784 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.56 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.08 -168.44 11.34 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.499 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.5 134.51 41.37 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 120.717 0.294 . . . . 0.0 111.487 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 83.1 m -80.25 107.62 13.2 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.374 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -112.41 147.72 35.85 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.687 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.437 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.5 m-85 -78.82 129.54 34.72 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.308 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.4 mt . . . . . 0 C--O 1.251 1.165 0 CA-C-O 118.46 -0.781 . . . . 0.0 111.474 -179.542 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.234 0 N-CA-C 112.702 -0.159 . . . . 0.0 112.702 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -138.3 113.82 9.64 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 120.764 0.316 . . . . 0.0 110.479 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.473 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -117.29 147.81 42.24 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.828 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -92.43 172.65 8.25 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.023 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.51 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.3 tt0 -65.63 137.44 57.34 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.822 0.344 . . . . 0.0 111.023 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.8 -5.37 79.11 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.941 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -93.84 157.03 16.33 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 122.639 0.376 . . . . 0.0 110.662 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.566 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 52.6 m -96.69 115.91 28.24 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.209 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.504 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -118.95 153.88 33.9 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.614 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.522 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.0 m-80 -100.68 138.15 38.13 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.814 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -91.91 20.42 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.904 0.383 . . . . 0.0 110.982 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.79 -29.93 7.23 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.764 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.95 -45.12 0.14 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -115.64 74.17 4.54 Favored Pre-proline 0 CA--C 1.548 0.884 0 O-C-N 123.152 0.282 . . . . 0.0 111.32 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.68 -171.93 0.85 Allowed 'Trans proline' 0 C--N 1.367 1.543 0 C-N-CA 122.68 2.253 . . . . 0.0 112.829 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.504 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 94.7 m -70.15 -177.78 1.48 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 122.366 0.267 . . . . 0.0 111.151 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.6 m -83.86 118.47 71.45 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 122.267 0.227 . . . . 0.0 111.373 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.54 157.23 28.66 Favored 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 122.715 2.277 . . . . 0.0 113.095 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.98 -32.2 5.79 Favored Glycine 0 C--N 1.339 0.702 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.854 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.8 mt -84.26 -60.53 2.06 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 122.606 0.362 . . . . 0.0 110.964 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.47 36.33 0.3 Allowed Glycine 0 C--N 1.341 0.828 0 O-C-N 123.472 0.482 . . . . 0.0 113.298 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.52 155.68 18.72 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.836 0.35 . . . . 0.0 111.38 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.66 129.43 20.46 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.32 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.22 123.73 31.05 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 123.258 0.349 . . . . 0.0 110.866 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.9 mm -123.22 120.45 27.28 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.145 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.18 -31.84 4.93 Favored 'Cis proline' 0 C--N 1.372 1.781 0 C-N-CA 124.21 -1.162 . . . . 0.0 113.208 -0.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.643 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.7 -24.85 30.51 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-N 115.75 -0.659 . . . . 0.0 113.898 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -113.7 112.2 48.34 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 117.174 0.487 . . . . 0.0 111.003 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -69.85 -25.28 8.15 Favored 'Cis proline' 0 C--N 1.377 2.051 0 C-N-CA 125.071 -0.804 . . . . 0.0 113.327 -0.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.522 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.29 151.0 29.52 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.803 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -139.94 -168.49 11.34 Favored Glycine 0 C--N 1.335 0.521 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.505 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.44 134.63 41.15 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.762 0.315 . . . . 0.0 111.403 -179.924 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 76.6 m -80.36 107.77 13.42 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.333 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -112.55 147.24 37.03 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.745 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.441 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.53 129.51 34.92 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.368 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--O 1.252 1.203 0 CA-C-O 118.526 -0.749 . . . . 0.0 111.425 -179.5 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.177 0 N-CA-C 112.639 -0.184 . . . . 0.0 112.639 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -137.5 113.38 9.72 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.751 0.31 . . . . 0.0 110.408 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.482 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -118.08 148.63 42.1 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.914 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -93.28 173.49 7.69 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.953 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 24.0 tt0 -66.04 136.86 56.6 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.507 0.323 . . . . 0.0 111.053 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.89 -5.23 80.05 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 115.331 -0.85 . . . . 0.0 113.008 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -93.54 156.79 16.54 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 122.715 0.406 . . . . 0.0 110.624 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 16.8 t -97.03 116.61 29.53 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.044 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.5 p -119.72 154.26 34.39 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.647 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.52 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.0 m-80 -100.89 138.28 38.15 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.734 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -91.99 20.33 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.976 0.417 . . . . 0.0 111.06 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.8 -29.92 7.24 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.833 -178.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.82 -45.02 0.15 Allowed 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -115.57 74.27 4.47 Favored Pre-proline 0 CA--C 1.548 0.888 0 O-C-N 123.178 0.299 . . . . 0.0 111.389 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.68 -172.28 0.91 Allowed 'Trans proline' 0 C--N 1.368 1.574 0 C-N-CA 122.753 2.302 . . . . 0.0 112.825 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 92.5 m -69.96 -177.73 1.4 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 122.511 0.324 . . . . 0.0 111.184 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.1 m -84.56 119.06 72.47 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 122.324 0.25 . . . . 0.0 111.342 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -78.6 159.05 28.63 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 122.657 2.238 . . . . 0.0 113.052 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.65 -31.96 5.56 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.864 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.6 mt -84.7 -60.25 2.12 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 122.643 0.377 . . . . 0.0 111.008 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.46 36.78 0.32 Allowed Glycine 0 C--N 1.341 0.859 0 O-C-N 123.379 0.424 . . . . 0.0 113.268 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -90.4 155.87 18.63 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.935 0.368 . . . . 0.0 111.369 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.78 129.18 20.05 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.381 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.0 123.72 30.88 Favored 'General case' 0 C--O 1.235 0.342 0 O-C-N 123.256 0.347 . . . . 0.0 110.84 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.1 mm -123.19 120.32 27.35 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.18 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.39 -31.7 5.03 Favored 'Cis proline' 0 C--N 1.37 1.7 0 C-N-CA 124.242 -1.149 . . . . 0.0 113.105 -0.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.643 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.51 -24.87 30.44 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-N 115.778 -0.646 . . . . 0.0 113.824 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -113.63 112.15 48.54 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 117.17 0.485 . . . . 0.0 111.008 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -69.9 -25.25 8.19 Favored 'Cis proline' 0 C--N 1.378 2.092 0 C-N-CA 125.061 -0.808 . . . . 0.0 113.335 -0.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.52 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.35 151.04 29.51 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.803 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.562 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.11 -168.5 11.36 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.524 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.33 134.58 41.15 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 120.682 0.277 . . . . 0.0 111.506 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 79.2 m -80.29 107.69 13.29 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.366 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -112.59 147.11 37.34 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.761 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.433 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.3 m-85 -78.31 129.5 35.1 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.364 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.7 mt . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.487 -0.768 . . . . 0.0 111.481 -179.519 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.139 0 N-CA-C 112.586 -0.206 . . . . 0.0 112.586 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -137.75 113.08 9.33 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 120.771 0.32 . . . . 0.0 110.406 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.462 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -116.85 148.74 40.99 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.934 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -93.26 169.22 10.55 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.637 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.9 tt0 -62.89 136.94 58.11 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.78 0.324 . . . . 0.0 111.124 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.05 -5.25 80.52 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.993 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -93.83 157.08 16.31 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 122.707 0.403 . . . . 0.0 110.604 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 53.1 m -96.82 116.05 28.48 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.171 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.508 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.18 153.93 34.12 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.618 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.52 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.0 m-80 -100.69 138.23 38.03 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.827 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.6 m -91.87 20.31 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 120.941 0.401 . . . . 0.0 111.081 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -112.78 -29.86 7.26 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.819 -178.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.98 -45.01 0.14 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -115.59 74.2 4.48 Favored Pre-proline 0 CA--C 1.548 0.89 0 O-C-N 123.108 0.255 . . . . 0.0 111.291 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.68 -172.04 0.87 Allowed 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 122.739 2.293 . . . . 0.0 112.83 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.508 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 93.6 m -70.33 -177.44 1.44 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 122.428 0.291 . . . . 0.0 111.08 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 15.9 m -84.04 118.31 70.96 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 122.305 0.242 . . . . 0.0 111.312 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -78.54 157.4 28.67 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 122.668 2.246 . . . . 0.0 113.088 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.79 -32.19 5.74 Favored Glycine 0 C--N 1.338 0.666 0 CA-C-N 115.976 -0.557 . . . . 0.0 112.893 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.6 mt -84.14 -60.52 2.07 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.66 0.384 . . . . 0.0 111.046 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.61 36.19 0.3 Allowed Glycine 0 C--N 1.341 0.828 0 O-C-N 123.408 0.443 . . . . 0.0 113.315 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.52 155.67 18.72 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.869 0.334 . . . . 0.0 111.409 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.71 129.41 20.38 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.317 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.18 123.76 31.06 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 123.264 0.353 . . . . 0.0 110.811 179.853 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.1 mm -123.18 120.32 27.36 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.121 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -73.37 -31.72 5.02 Favored 'Cis proline' 0 C--N 1.371 1.731 0 C-N-CA 124.165 -1.181 . . . . 0.0 113.141 -0.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.642 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.63 -24.92 30.24 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-O 119.381 -0.677 . . . . 0.0 113.841 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.59 112.16 48.66 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 117.241 0.521 . . . . 0.0 111.021 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -69.96 -25.2 8.25 Favored 'Cis proline' 0 C--N 1.376 2.026 0 CA-C-N 119.343 0.801 . . . . 0.0 113.248 -0.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.52 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.34 150.97 29.43 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 123.543 0.527 . . . . 0.0 110.808 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.565 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -139.98 -168.41 11.32 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.424 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.58 134.58 41.32 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 120.758 0.313 . . . . 0.0 111.399 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 80.1 m -80.31 107.85 13.44 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.35 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -112.55 147.5 36.49 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.736 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.44 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.73 129.37 34.6 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.299 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.424 -0.798 . . . . 0.0 111.517 -179.622 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 0.155 0 CA-C-O 120.319 -0.156 . . . . 0.0 112.764 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.4 t -137.1 112.01 8.92 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.912 0.387 . . . . 0.0 110.927 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.443 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -118.41 148.82 42.15 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.668 179.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -91.84 169.85 10.36 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.14 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.514 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 22.5 tt0 -63.98 137.14 57.87 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 120.732 0.301 . . . . 0.0 111.055 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.01 -5.01 81.4 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.959 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -93.95 157.69 15.99 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 122.688 0.395 . . . . 0.0 110.663 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.569 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.9 t -97.16 115.73 28.08 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.999 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.517 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.3 p -118.83 153.66 34.13 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.566 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.519 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 5.7 m-80 -100.73 138.37 37.88 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.754 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.8 m -92.11 20.19 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 120.928 0.394 . . . . 0.0 110.994 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.85 -29.91 7.23 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.807 -178.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -149.03 -44.75 0.14 Allowed 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -115.47 73.92 4.18 Favored Pre-proline 0 CA--C 1.548 0.878 0 O-C-N 123.21 0.319 . . . . 0.0 111.429 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.53 -172.53 0.94 Allowed 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.826 2.351 . . . . 0.0 113.037 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.517 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 87.8 m -70.77 -176.26 1.28 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 122.395 0.278 . . . . 0.0 111.123 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 17.8 m -85.53 118.53 70.86 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 122.361 0.264 . . . . 0.0 111.342 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -78.62 158.34 28.49 Favored 'Trans proline' 0 C--N 1.37 1.662 0 C-N-CA 122.663 2.242 . . . . 0.0 112.939 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.14 -32.57 5.35 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.845 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.8 mt -83.71 -60.34 2.15 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 122.696 0.398 . . . . 0.0 110.978 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.2 36.47 0.3 Allowed Glycine 0 C--N 1.34 0.798 0 O-C-N 123.378 0.424 . . . . 0.0 113.303 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.63 155.61 18.72 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.826 0.346 . . . . 0.0 111.41 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.9 t -142.87 129.26 20.03 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.307 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.09 123.73 30.95 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 123.28 0.362 . . . . 0.0 110.823 179.838 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.8 mm -123.2 120.38 27.32 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.223 -178.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.32 -31.72 5.02 Favored 'Cis proline' 0 C--N 1.37 1.704 0 C-N-CA 124.196 -1.168 . . . . 0.0 113.178 -0.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.643 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.5 -24.88 30.41 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.848 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -113.64 112.21 48.48 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 117.213 0.507 . . . . 0.0 111.005 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.82 -25.25 8.16 Favored 'Cis proline' 0 C--N 1.377 2.05 0 CA-C-N 119.381 0.815 . . . . 0.0 113.328 -0.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.519 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.1 p-10 -153.37 151.05 29.5 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.745 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.569 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.22 -168.44 11.35 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.441 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.7 OUTLIER -98.58 134.51 41.43 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 120.714 0.292 . . . . 0.0 111.501 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 89.4 m -80.16 107.7 13.17 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.287 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -112.41 147.44 36.44 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.86 -1.063 . . . . 0.0 110.698 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.439 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.71 129.63 34.9 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.315 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.1 mt . . . . . 0 C--O 1.25 1.113 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.46 -179.555 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.188 0 CA-C-O 120.298 -0.168 . . . . 0.0 112.773 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.6 t -139.37 112.62 8.18 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 120.735 0.303 . . . . 0.0 110.508 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.475 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -116.38 149.65 39.02 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.947 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -93.92 168.87 10.69 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.695 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.511 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 24.3 tt0 -62.99 136.71 57.98 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.763 0.316 . . . . 0.0 111.082 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.06 -4.99 81.63 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.939 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -93.97 157.19 16.23 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 122.651 0.38 . . . . 0.0 110.634 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.564 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 53.5 m -96.72 116.41 29.09 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.26 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.512 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.48 153.97 34.48 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.607 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.518 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 5.9 m-80 -100.77 138.24 38.09 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.771 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -92.05 20.34 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.973 0.416 . . . . 0.0 111.074 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.77 -30.01 7.21 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.835 -178.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.81 -45.01 0.15 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -115.42 74.05 4.13 Favored Pre-proline 0 CA--C 1.547 0.858 0 O-C-N 123.188 0.305 . . . . 0.0 111.351 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.6 -172.43 0.93 Allowed 'Trans proline' 0 C--N 1.367 1.545 0 C-N-CA 122.839 2.359 . . . . 0.0 112.902 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.512 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 89.7 m -70.22 -177.06 1.31 Allowed 'General case' 0 CA--C 1.542 0.665 0 O-C-N 123.194 0.309 . . . . 0.0 111.166 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 16.5 m -84.42 118.33 70.88 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 122.324 0.25 . . . . 0.0 111.343 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.45 157.61 29.02 Favored 'Trans proline' 0 C--N 1.369 1.634 0 C-N-CA 122.673 2.249 . . . . 0.0 113.117 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.69 -32.09 5.77 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.889 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.6 mt -84.23 -60.47 2.08 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.614 0.366 . . . . 0.0 110.965 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.39 36.33 0.3 Allowed Glycine 0 C--N 1.341 0.857 0 O-C-N 123.458 0.474 . . . . 0.0 113.269 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.39 155.65 18.8 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.908 0.354 . . . . 0.0 111.391 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.74 129.18 20.1 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.341 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.03 123.63 30.8 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 123.273 0.358 . . . . 0.0 110.824 179.865 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.4 mm -123.16 120.36 27.36 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.102 -178.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.35 -31.8 4.97 Favored 'Cis proline' 0 C--N 1.372 1.791 0 C-N-CA 124.169 -1.179 . . . . 0.0 113.129 -0.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.642 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.66 -24.93 30.22 Favored Glycine 0 C--N 1.338 0.69 0 CA-C-N 115.691 -0.686 . . . . 0.0 113.877 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -113.54 112.09 48.85 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 117.209 0.505 . . . . 0.0 111.053 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -69.89 -25.27 8.17 Favored 'Cis proline' 0 C--N 1.378 2.084 0 CA-C-N 119.437 0.835 . . . . 0.0 113.304 -0.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.518 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.24 150.99 29.56 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.821 179.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.05 -168.32 11.3 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.501 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.6 134.45 41.53 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 120.689 0.281 . . . . 0.0 111.452 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 83.4 m -80.35 107.7 13.36 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.292 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -112.47 147.42 36.56 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.689 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.439 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.6 129.41 34.75 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.332 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.122 -0.942 . . . . 0.0 111.507 -179.567 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.127 0 N-CA-C 112.55 -0.22 . . . . 0.0 112.55 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -135.58 113.26 10.89 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 120.734 0.302 . . . . 0.0 110.432 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.445 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -118.12 147.9 42.85 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.835 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -91.63 172.12 8.71 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.041 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.4 tt0 -65.4 137.49 57.51 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.833 0.349 . . . . 0.0 111.024 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.75 -5.2 79.75 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 115.32 -0.855 . . . . 0.0 113.025 -179.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -93.66 157.2 16.29 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 122.719 0.408 . . . . 0.0 110.63 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.571 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.3 t -96.86 115.43 27.41 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.98 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.507 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -118.6 153.73 33.79 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.591 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.52 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.0 m-80 -100.7 138.2 38.07 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.808 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.6 m -91.89 20.32 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 120.9 0.381 . . . . 0.0 111.071 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.76 -29.95 7.24 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.803 -178.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -148.94 -45.0 0.14 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -178.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -115.63 74.22 4.56 Favored Pre-proline 0 CA--C 1.548 0.89 0 O-C-N 123.196 0.31 . . . . 0.0 111.34 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.71 -171.98 0.86 Allowed 'Trans proline' 0 C--N 1.367 1.527 0 C-N-CA 122.745 2.296 . . . . 0.0 112.827 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.507 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 92.7 m -70.32 -177.51 1.46 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 122.39 0.276 . . . . 0.0 111.123 179.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.8 m -84.31 118.49 71.3 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 122.369 0.268 . . . . 0.0 111.373 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.43 157.88 29.13 Favored 'Trans proline' 0 C--N 1.37 1.665 0 C-N-CA 122.695 2.263 . . . . 0.0 113.066 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.52 -32.28 5.61 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.894 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.7 mt -84.18 -60.31 2.13 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 122.685 0.394 . . . . 0.0 110.934 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.01 36.36 0.31 Allowed Glycine 0 C--N 1.341 0.847 0 O-C-N 123.406 0.441 . . . . 0.0 113.321 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.39 155.69 18.77 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.868 0.366 . . . . 0.0 111.418 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.77 129.28 20.17 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.325 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.08 123.77 30.98 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 123.291 0.369 . . . . 0.0 110.785 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.3 mm -123.3 120.39 27.22 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.104 -178.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.3 -31.84 4.94 Favored 'Cis proline' 0 C--N 1.371 1.75 0 C-N-CA 124.222 -1.158 . . . . 0.0 113.148 -0.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.643 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.73 -24.85 30.51 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-O 119.412 -0.66 . . . . 0.0 113.852 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -113.65 112.16 48.49 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 117.158 0.479 . . . . 0.0 110.982 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -69.95 -25.13 8.29 Favored 'Cis proline' 0 C--N 1.379 2.152 0 C-N-CA 125.024 -0.823 . . . . 0.0 113.249 -0.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.52 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p30 -153.39 151.03 29.45 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.767 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.571 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.02 -168.42 11.33 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.484 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.51 134.6 41.25 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.726 0.298 . . . . 0.0 111.359 -179.864 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 81.3 m -80.3 107.66 13.28 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.361 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -112.46 147.12 37.17 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.733 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.44 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.47 129.45 34.9 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.24 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.129 -0.938 . . . . 0.0 111.498 -179.597 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.135 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -137.45 113.08 9.5 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 120.815 0.34 . . . . 0.0 110.425 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.463 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -117.07 148.65 41.33 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.895 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -93.38 169.54 10.29 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.727 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.7 tt0 -62.94 137.05 58.16 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 120.87 0.367 . . . . 0.0 111.078 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.06 -5.44 79.71 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.956 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -93.53 157.01 16.41 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 122.702 0.401 . . . . 0.0 110.635 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.566 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.2 t -97.03 115.99 28.43 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.995 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.509 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.07 154.03 33.81 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.631 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.521 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.1 m-80 -100.78 138.27 38.05 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.823 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.644 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -91.95 20.39 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.015 0.436 . . . . 0.0 111.064 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -112.67 -29.9 7.28 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.818 -178.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -149.02 -45.05 0.14 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -115.58 74.1 4.42 Favored Pre-proline 0 CA--C 1.548 0.888 0 O-C-N 123.126 0.266 . . . . 0.0 111.362 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.65 -172.04 0.86 Allowed 'Trans proline' 0 C--N 1.368 1.557 0 C-N-CA 122.743 2.295 . . . . 0.0 112.795 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.509 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 92.4 m -70.23 -177.41 1.4 Allowed 'General case' 0 CA--C 1.543 0.676 0 O-C-N 123.142 0.276 . . . . 0.0 111.161 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 15.6 m -84.11 118.29 70.88 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 122.345 0.258 . . . . 0.0 111.277 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -78.49 157.51 28.86 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 122.593 2.195 . . . . 0.0 113.081 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.77 -32.15 5.75 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.875 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.6 mt -84.26 -60.76 1.99 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 122.607 0.363 . . . . 0.0 110.992 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 133.0 36.15 0.28 Allowed Glycine 0 C--N 1.34 0.779 0 O-C-N 123.475 0.484 . . . . 0.0 113.271 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.63 155.45 18.84 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.91 0.355 . . . . 0.0 111.366 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.9 t -142.55 129.56 20.73 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.384 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.2 123.72 31.03 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.227 0.329 . . . . 0.0 110.807 179.853 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.0 mm -123.23 120.46 27.27 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.062 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.23 -31.83 4.94 Favored 'Cis proline' 0 C--N 1.372 1.781 0 C-N-CA 124.131 -1.196 . . . . 0.0 113.208 -0.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.644 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.76 -24.89 30.37 Favored Glycine 0 C--N 1.338 0.667 0 CA-C-N 115.712 -0.677 . . . . 0.0 113.844 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.58 112.16 48.69 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 117.209 0.504 . . . . 0.0 111.026 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -69.85 -25.25 8.17 Favored 'Cis proline' 0 C--N 1.378 2.088 0 CA-C-N 119.372 0.811 . . . . 0.0 113.347 -0.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.521 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.3 151.01 29.52 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.774 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.02 -168.52 11.36 Favored Glycine 0 C--N 1.336 0.545 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.393 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.41 134.72 41.02 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 120.719 0.295 . . . . 0.0 111.499 -179.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 79.4 m -80.44 107.84 13.57 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.325 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -112.54 147.65 36.15 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.758 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.44 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.84 129.44 34.59 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.274 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.485 -0.769 . . . . 0.0 111.473 -179.575 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.2 0 CA-C-O 120.302 -0.166 . . . . 0.0 112.789 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.6 t -139.76 112.66 8.06 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 120.766 0.317 . . . . 0.0 110.517 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.474 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -116.45 149.63 39.15 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.866 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -94.05 168.78 10.73 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.65 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.509 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 24.1 tt0 -62.76 136.54 57.91 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.785 0.326 . . . . 0.0 111.053 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.31 -5.1 81.95 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.956 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -93.71 157.26 16.25 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 122.745 0.418 . . . . 0.0 110.693 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.566 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.1 t -96.95 116.07 28.54 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.082 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.511 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.3 153.95 34.26 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.627 179.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.519 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.0 m-80 -100.76 138.28 38.02 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.766 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.6 m -91.99 20.3 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 120.914 0.388 . . . . 0.0 111.083 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.79 -30.05 7.2 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.835 -178.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.8 -44.97 0.15 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -115.44 74.07 4.18 Favored Pre-proline 0 CA--C 1.548 0.893 0 O-C-N 123.177 0.298 . . . . 0.0 111.379 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.61 -172.31 0.91 Allowed 'Trans proline' 0 C--N 1.368 1.567 0 C-N-CA 122.792 2.328 . . . . 0.0 112.906 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.511 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 88.8 m -70.21 -177.01 1.29 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 122.414 0.286 . . . . 0.0 111.218 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 16.5 m -84.49 118.36 70.93 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 122.346 0.258 . . . . 0.0 111.321 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -78.58 157.66 28.55 Favored 'Trans proline' 0 C--N 1.368 1.568 0 C-N-CA 122.727 2.285 . . . . 0.0 113.071 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.66 -32.2 5.7 Favored Glycine 0 C--N 1.338 0.67 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.842 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.5 mt -84.11 -60.92 1.95 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 122.64 0.376 . . . . 0.0 111.016 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 133.03 36.26 0.28 Allowed Glycine 0 C--N 1.342 0.869 0 O-C-N 123.414 0.446 . . . . 0.0 113.217 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.56 155.58 18.77 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.919 0.36 . . . . 0.0 111.392 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.9 t -142.68 129.28 20.27 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.363 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.12 123.77 31.02 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 123.278 0.361 . . . . 0.0 110.785 179.857 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.3 mm -123.28 120.39 27.24 Favored Pre-proline 0 CA--C 1.541 0.629 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.062 -178.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.32 -31.8 4.97 Favored 'Cis proline' 0 C--N 1.372 1.764 0 C-N-CA 124.231 -1.154 . . . . 0.0 113.148 -0.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.642 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.6 -24.86 30.48 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-O 119.358 -0.69 . . . . 0.0 113.815 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -113.65 112.18 48.47 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-N 117.212 0.506 . . . . 0.0 111.035 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.92 -25.17 8.25 Favored 'Cis proline' 0 C--N 1.378 2.084 0 C-N-CA 125.016 -0.827 . . . . 0.0 113.303 -0.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.519 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.35 151.03 29.5 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.798 179.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.17 -168.41 11.34 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.453 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.57 134.47 41.48 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 120.765 0.317 . . . . 0.0 111.476 -179.909 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 85.4 m -80.36 107.72 13.39 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.327 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -112.4 147.79 35.7 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.714 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.439 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.5 m-85 -78.89 129.52 34.63 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.284 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.103 -0.951 . . . . 0.0 111.429 -179.526 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.119 0 N-CA-C 112.526 -0.23 . . . . 0.0 112.526 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.89 113.15 9.89 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.755 0.312 . . . . 0.0 110.431 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.455 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -117.78 148.17 42.31 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.805 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -92.26 172.09 8.64 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.034 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 24.2 tt0 -65.15 136.92 57.26 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.521 0.328 . . . . 0.0 111.021 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.88 -5.09 80.69 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.983 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -93.66 157.06 16.36 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 122.729 0.412 . . . . 0.0 110.669 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.566 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 52.6 m -96.93 116.09 28.57 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.211 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.505 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.16 155.01 32.4 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.658 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.527 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.5 m-80 -101.7 138.53 38.56 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.78 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.646 HG22 ' O ' ' A' ' 28' ' ' GLY . 35.7 m -91.86 21.22 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 120.91 0.386 . . . . 0.0 111.216 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -113.81 -31.05 6.56 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.931 -178.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -147.54 -44.94 0.17 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -115.69 74.2 4.65 Favored Pre-proline 0 CA--C 1.547 0.864 0 O-C-N 123.175 0.297 . . . . 0.0 111.304 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.67 -172.21 0.9 Allowed 'Trans proline' 0 C--N 1.367 1.537 0 C-N-CA 122.77 2.313 . . . . 0.0 112.8 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.505 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 93.0 m -70.17 -177.5 1.41 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 122.394 0.278 . . . . 0.0 111.152 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.9 m -84.36 118.38 71.03 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 122.222 0.209 . . . . 0.0 111.372 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.5 157.82 28.88 Favored 'Trans proline' 0 C--N 1.369 1.658 0 C-N-CA 122.654 2.236 . . . . 0.0 113.087 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.56 -32.17 5.69 Favored Glycine 0 C--N 1.337 0.598 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.882 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.5 mt -84.25 -60.39 2.1 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.671 0.388 . . . . 0.0 110.97 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.24 36.45 0.3 Allowed Glycine 0 C--N 1.342 0.884 0 O-C-N 123.393 0.433 . . . . 0.0 113.269 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.49 155.8 18.64 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.88 0.372 . . . . 0.0 111.356 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.66 128.79 19.75 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.316 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -84.87 123.76 30.84 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 123.226 0.329 . . . . 0.0 110.792 179.853 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.4 mm -122.98 119.84 27.72 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.236 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.12 -31.29 5.28 Favored 'Cis proline' 0 C--N 1.371 1.757 0 C-N-CA 124.147 -1.189 . . . . 0.0 113.129 -0.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.646 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.02 -26.07 25.88 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 115.683 -0.69 . . . . 0.0 113.88 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -115.72 113.37 42.49 Favored Pre-proline 0 CA--C 1.546 0.797 0 CA-C-N 117.211 0.505 . . . . 0.0 111.156 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.59 -27.34 5.92 Favored 'Cis proline' 0 C--N 1.377 2.059 0 CA-C-N 119.323 0.794 . . . . 0.0 113.586 -0.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.527 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.63 151.44 29.71 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.783 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -141.37 -168.91 11.68 Favored Glycine 0 C--N 1.336 0.555 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.484 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.51 134.48 41.42 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 120.74 0.305 . . . . 0.0 111.561 -179.839 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 82.8 m -80.3 107.88 13.45 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.361 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -112.55 147.38 36.73 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.693 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.438 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.5 m-85 -78.61 129.62 34.99 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.341 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.057 -0.973 . . . . 0.0 111.45 -179.557 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.196 0 N-CA-C 112.644 -0.182 . . . . 0.0 112.644 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -138.82 113.47 9.05 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 122.451 0.301 . . . . 0.0 110.411 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.469 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -116.26 148.42 40.5 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.927 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -93.32 169.18 10.57 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.691 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.8 tt0 -62.99 137.21 58.2 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.872 0.368 . . . . 0.0 111.066 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.95 -5.19 80.43 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.999 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -93.66 157.26 16.26 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 122.707 0.403 . . . . 0.0 110.73 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.569 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.1 t -96.89 115.65 27.79 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.074 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -118.8 153.82 33.84 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.604 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.52 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.2 m-80 -100.66 138.25 37.98 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.794 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -92.01 20.48 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.971 0.415 . . . . 0.0 111.044 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.82 -29.82 7.27 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.857 -178.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -149.06 -45.13 0.14 Allowed 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -115.58 74.15 4.44 Favored Pre-proline 0 CA--C 1.547 0.843 0 O-C-N 123.09 0.244 . . . . 0.0 111.34 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.73 -171.95 0.85 Allowed 'Trans proline' 0 C--N 1.368 1.562 0 C-N-CA 122.769 2.313 . . . . 0.0 112.826 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 94.5 m -70.2 -177.53 1.42 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 122.382 0.273 . . . . 0.0 111.145 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 15.2 m -83.83 118.27 70.91 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 122.231 0.212 . . . . 0.0 111.298 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -78.53 156.95 28.62 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.623 2.215 . . . . 0.0 113.133 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.18 -32.02 5.95 Favored Glycine 0 C--N 1.338 0.657 0 O-C-N 123.682 0.614 . . . . 0.0 112.872 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.7 mt -84.31 -60.84 1.96 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.664 0.386 . . . . 0.0 111.045 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 133.09 36.2 0.28 Allowed Glycine 0 C--N 1.342 0.87 0 O-C-N 123.511 0.507 . . . . 0.0 113.243 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.6 155.71 18.67 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.838 0.351 . . . . 0.0 111.346 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.79 129.46 20.33 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.28 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.24 123.79 31.13 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 123.237 0.335 . . . . 0.0 110.785 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.7 mm -123.28 120.49 27.21 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.11 -178.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.29 -31.73 5.01 Favored 'Cis proline' 0 C--N 1.371 1.74 0 C-N-CA 124.182 -1.174 . . . . 0.0 113.117 -0.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.643 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.67 -24.9 30.3 Favored Glycine 0 C--N 1.338 0.662 0 CA-C-N 115.788 -0.642 . . . . 0.0 113.859 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.65 112.19 48.46 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 117.225 0.513 . . . . 0.0 111.008 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -69.94 -25.17 8.26 Favored 'Cis proline' 0 C--N 1.378 2.095 0 C-N-CA 125.062 -0.807 . . . . 0.0 113.292 -0.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.52 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p30 -153.4 150.94 29.36 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.811 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.569 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -139.94 -168.34 11.3 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.498 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.46 134.65 41.15 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.76 0.314 . . . . 0.0 111.437 -179.917 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 78.5 m -80.51 107.82 13.63 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.358 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -112.54 147.61 36.25 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.709 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.444 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.81 129.43 34.59 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.269 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.555 -0.736 . . . . 0.0 111.452 -179.552 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.274 0 CA-C-O 120.236 -0.202 . . . . 0.0 112.915 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.6 t -141.96 112.86 7.37 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 120.743 0.306 . . . . 0.0 110.623 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.488 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -115.99 149.82 38.2 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.877 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -94.24 168.67 10.77 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.64 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 24.6 tt0 -63.07 136.73 57.97 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.747 0.308 . . . . 0.0 111.088 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.02 -4.83 81.95 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.913 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -93.88 157.63 16.04 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 122.725 0.41 . . . . 0.0 110.705 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.567 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.1 t -96.92 116.1 28.59 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.066 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.514 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.3 p -119.39 153.75 34.7 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.609 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.519 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.1 m-80 -100.72 138.22 38.06 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.775 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.5 m -92.03 20.31 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.926 0.394 . . . . 0.0 111.04 -179.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.86 -29.9 7.23 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.849 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -148.97 -44.86 0.14 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -115.38 74.07 4.08 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 122.259 0.223 . . . . 0.0 111.36 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.71 -172.41 0.94 Allowed 'Trans proline' 0 C--N 1.367 1.505 0 C-N-CA 122.821 2.347 . . . . 0.0 112.921 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.514 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 88.8 m -70.38 -176.86 1.31 Allowed 'General case' 0 CA--C 1.543 0.692 0 O-C-N 123.168 0.293 . . . . 0.0 111.168 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 17.1 m -84.68 118.36 70.85 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 122.327 0.251 . . . . 0.0 111.348 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.54 157.74 28.7 Favored 'Trans proline' 0 C--N 1.368 1.587 0 C-N-CA 122.705 2.27 . . . . 0.0 113.114 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.64 -32.19 5.7 Favored Glycine 0 C--N 1.337 0.59 0 O-C-N 123.669 0.606 . . . . 0.0 112.853 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.7 mt -84.22 -60.2 2.16 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 122.624 0.37 . . . . 0.0 110.991 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.15 36.28 0.31 Allowed Glycine 0 C--N 1.341 0.846 0 O-C-N 123.399 0.437 . . . . 0.0 113.311 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.18 155.7 18.84 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.86 0.33 . . . . 0.0 111.425 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.82 129.08 19.89 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.324 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -84.94 123.72 30.83 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.317 0.386 . . . . 0.0 110.85 179.829 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.2 mm -123.15 120.37 27.38 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.057 -178.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.32 -31.76 4.99 Favored 'Cis proline' 0 C--N 1.371 1.731 0 C-N-CA 124.185 -1.173 . . . . 0.0 113.143 -0.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.642 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.58 -24.88 30.38 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.843 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.65 112.15 48.48 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-N 117.187 0.494 . . . . 0.0 111.012 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -69.88 -25.18 8.23 Favored 'Cis proline' 0 C--N 1.378 2.087 0 C-N-CA 125.036 -0.818 . . . . 0.0 113.34 -0.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.519 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p30 -153.39 150.98 29.41 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.796 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.22 -168.27 11.3 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.4 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.54 134.33 41.65 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.697 0.284 . . . . 0.0 111.518 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 87.1 m -80.27 107.62 13.22 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.344 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -112.4 147.35 36.62 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.789 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.436 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.3 m-85 -78.61 129.46 34.8 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.259 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--O 1.251 1.152 0 CA-C-O 118.533 -0.746 . . . . 0.0 111.389 -179.548 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.189 0 N-CA-C 112.589 -0.205 . . . . 0.0 112.589 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.64 113.3 10.2 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 120.778 0.323 . . . . 0.0 110.416 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.453 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -117.94 148.08 42.53 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.886 179.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -92.2 171.86 8.8 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.059 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.509 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.3 tt0 -64.88 137.24 57.64 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.726 0.298 . . . . 0.0 111.108 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.73 -5.02 80.53 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.949 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -93.72 157.04 16.35 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 122.697 0.399 . . . . 0.0 110.662 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.569 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.4 t -96.89 115.94 28.3 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.984 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.06 153.96 33.91 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.62 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.522 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.2 m-80 -100.75 138.23 38.08 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.79 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.6 m -91.96 20.45 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.961 0.41 . . . . 0.0 111.086 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -112.74 -30.09 7.19 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.736 -178.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.78 -45.02 0.15 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -115.69 74.22 4.66 Favored Pre-proline 0 CA--C 1.548 0.888 0 O-C-N 123.114 0.259 . . . . 0.0 111.294 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.72 -171.84 0.83 Allowed 'Trans proline' 0 C--N 1.368 1.557 0 C-N-CA 122.71 2.273 . . . . 0.0 112.886 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 90.5 m -70.27 -177.55 1.45 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 122.405 0.282 . . . . 0.0 111.069 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.7 m -84.28 118.55 71.47 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 122.249 0.22 . . . . 0.0 111.388 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -78.42 158.18 29.21 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 122.715 2.277 . . . . 0.0 113.094 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.27 -32.1 5.65 Favored Glycine 0 C--N 1.337 0.591 0 O-C-N 123.628 0.58 . . . . 0.0 112.882 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.9 mt -84.34 -61.12 1.88 Allowed 'General case' 0 C--O 1.236 0.36 0 C-N-CA 122.668 0.387 . . . . 0.0 111.024 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.91 36.31 0.28 Allowed Glycine 0 C--N 1.341 0.849 0 O-C-N 123.377 0.423 . . . . 0.0 113.214 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.34 156.2 18.43 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.885 0.343 . . . . 0.0 111.318 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.1 t -143.29 129.61 19.91 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.301 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.34 123.79 31.22 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 123.32 0.388 . . . . 0.0 110.848 179.839 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.3 mm -123.3 120.36 27.22 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.116 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.41 -31.76 5.0 Favored 'Cis proline' 0 C--N 1.372 1.768 0 C-N-CA 124.155 -1.185 . . . . 0.0 113.142 -0.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.643 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.64 -24.71 31.03 Favored Glycine 0 C--N 1.337 0.601 0 CA-C-O 119.386 -0.675 . . . . 0.0 113.874 179.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.62 112.13 48.6 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 117.198 0.499 . . . . 0.0 111.06 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -69.95 -25.18 8.25 Favored 'Cis proline' 0 C--N 1.376 2.026 0 CA-C-N 119.416 0.827 . . . . 0.0 113.244 -0.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.522 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.1 p30 -153.25 151.08 29.65 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.836 179.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.569 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.11 -168.43 11.34 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.46 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.53 134.52 41.37 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 120.77 0.319 . . . . 0.0 111.418 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 80.0 m -80.55 107.78 13.64 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.329 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -112.5 147.73 35.93 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.712 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.445 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.3 m-85 -78.11 128.94 34.57 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.171 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.251 1.18 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.451 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.271 . . . . . . . 0 C--O 1.235 0.341 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 101.37 56.44 0.87 Allowed Glycine 0 C--N 1.336 0.532 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.602 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.72 113.14 9.99 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 120.803 0.335 . . . . 0.0 110.398 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.462 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -117.8 148.93 41.61 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.918 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -93.19 172.48 8.27 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.981 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 24.5 tt0 -65.35 136.81 56.99 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.813 0.34 . . . . 0.0 111.01 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.04 -5.36 79.96 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.941 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -93.54 156.79 16.53 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 122.721 0.409 . . . . 0.0 110.647 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 51.7 m -96.88 116.23 28.81 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.199 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.26 154.17 33.88 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.646 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.522 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.0 m-80 -100.85 138.27 38.13 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.773 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.644 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -91.98 20.45 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.997 0.427 . . . . 0.0 111.051 -179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.78 -30.13 7.17 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.823 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.72 -45.02 0.15 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -115.56 74.2 4.43 Favored Pre-proline 0 CA--C 1.547 0.852 0 O-C-N 123.19 0.306 . . . . 0.0 111.367 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.59 -172.18 0.88 Allowed 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 122.762 2.308 . . . . 0.0 112.831 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 92.8 m -70.16 -177.69 1.45 Allowed 'General case' 0 CA--C 1.543 0.686 0 O-C-N 123.107 0.255 . . . . 0.0 111.137 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.6 m -84.11 118.6 71.68 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 122.271 0.228 . . . . 0.0 111.334 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.49 157.62 28.87 Favored 'Trans proline' 0 C--N 1.369 1.629 0 C-N-CA 122.676 2.251 . . . . 0.0 113.065 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.72 -32.27 5.67 Favored Glycine 0 C--N 1.338 0.661 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.862 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.4 mt -84.15 -60.46 2.09 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 122.643 0.377 . . . . 0.0 111.02 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.28 36.36 0.3 Allowed Glycine 0 C--N 1.341 0.837 0 O-C-N 123.459 0.475 . . . . 0.0 113.286 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.58 155.59 18.76 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.8 0.333 . . . . 0.0 111.381 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.63 129.39 20.45 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.333 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.11 123.69 30.92 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 123.265 0.353 . . . . 0.0 110.818 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.8 mm -123.26 120.45 27.23 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.127 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.37 -31.64 5.07 Favored 'Cis proline' 0 C--N 1.372 1.773 0 C-N-CA 124.192 -1.17 . . . . 0.0 113.169 -0.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.644 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.59 -24.74 30.91 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-N 115.766 -0.652 . . . . 0.0 113.868 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -113.66 112.18 48.45 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 117.205 0.502 . . . . 0.0 111.009 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -69.96 -25.12 8.3 Favored 'Cis proline' 0 C--N 1.378 2.111 0 C-N-CA 124.978 -0.842 . . . . 0.0 113.321 -0.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.522 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.1 p-10 -153.25 150.98 29.54 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.79 179.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.562 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -139.91 -168.54 11.36 Favored Glycine 0 C--N 1.335 0.521 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.473 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.5 134.62 41.21 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.729 0.299 . . . . 0.0 111.459 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 77.4 m -80.35 107.73 13.38 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.355 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -112.51 147.51 36.42 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.691 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.44 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.5 m-85 -78.65 129.41 34.7 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.281 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.1 mt . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.473 -0.775 . . . . 0.0 111.475 -179.554 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.272 . . . . . . . 0 C--O 1.235 0.321 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 100.15 54.31 1.04 Allowed Glycine 0 C--N 1.336 0.543 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.602 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.87 113.26 9.99 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 122.427 0.291 . . . . 0.0 110.462 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.463 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -117.73 148.16 42.28 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.851 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -92.47 172.2 8.54 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.079 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.511 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.5 tt0 -65.17 137.05 57.38 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.51 0.324 . . . . 0.0 111.015 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.93 -5.41 79.4 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.978 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -93.61 156.81 16.5 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 122.772 0.429 . . . . 0.0 110.682 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 52.9 m -96.8 116.23 28.79 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.18 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.29 154.06 34.08 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.591 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.521 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.0 m-80 -100.75 138.2 38.11 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.801 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.644 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.6 m -91.83 20.34 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 120.945 0.402 . . . . 0.0 111.071 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.71 -30.05 7.22 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.8 -178.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.91 -44.97 0.14 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -115.61 74.16 4.5 Favored Pre-proline 0 CA--C 1.548 0.888 0 O-C-N 123.2 0.312 . . . . 0.0 111.408 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.58 -172.05 0.86 Allowed 'Trans proline' 0 C--N 1.366 1.472 0 C-N-CA 122.768 2.312 . . . . 0.0 112.86 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 93.7 m -70.21 -177.62 1.45 Allowed 'General case' 0 CA--C 1.542 0.663 0 O-C-N 123.155 0.284 . . . . 0.0 111.16 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.7 m -84.15 118.46 71.3 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 122.33 0.252 . . . . 0.0 111.325 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -78.49 157.55 28.87 Favored 'Trans proline' 0 C--N 1.369 1.639 0 C-N-CA 122.64 2.227 . . . . 0.0 113.121 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.77 -32.28 5.68 Favored Glycine 0 C--N 1.337 0.59 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.845 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.7 mt -84.14 -60.71 2.01 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 122.617 0.367 . . . . 0.0 110.99 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.66 36.4 0.29 Allowed Glycine 0 C--N 1.341 0.848 0 O-C-N 123.442 0.464 . . . . 0.0 113.312 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.71 155.65 18.66 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.866 0.365 . . . . 0.0 111.389 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.73 129.48 20.43 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.305 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.22 123.74 31.06 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.293 0.37 . . . . 0.0 110.796 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.2 mm -123.18 120.4 27.33 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.132 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -73.45 -31.7 5.04 Favored 'Cis proline' 0 C--N 1.372 1.764 0 C-N-CA 124.217 -1.16 . . . . 0.0 113.136 -0.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.644 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.67 -24.84 30.53 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-O 119.432 -0.649 . . . . 0.0 113.79 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.58 112.17 48.67 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 117.22 0.51 . . . . 0.0 111.001 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -69.85 -25.25 8.17 Favored 'Cis proline' 0 C--N 1.378 2.088 0 CA-C-N 119.386 0.817 . . . . 0.0 113.299 -0.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.521 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.27 151.03 29.57 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.832 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.563 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.06 -168.58 11.39 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 115.811 -0.632 . . . . 0.0 112.458 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.4 134.6 41.17 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.723 0.296 . . . . 0.0 111.46 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 78.9 m -80.32 107.73 13.36 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.329 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -112.51 147.68 36.06 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.727 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.44 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.5 m-85 -78.83 129.43 34.58 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.311 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.156 -0.926 . . . . 0.0 111.44 -179.496 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.271 . . . . . . . 0 C--O 1.236 0.346 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 103.04 55.67 0.81 Allowed Glycine 0 C--N 1.335 0.517 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.558 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.86 112.98 9.75 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 120.843 0.354 . . . . 0.0 110.382 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.466 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -117.66 148.6 41.82 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.843 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -92.81 172.13 8.54 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.983 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.515 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.9 tt0 -65.16 137.0 57.35 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.796 0.331 . . . . 0.0 110.975 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.88 -5.31 79.69 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.987 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -93.7 156.84 16.47 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 122.648 0.379 . . . . 0.0 110.635 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.561 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 52.3 m -96.86 116.45 29.19 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.185 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.57 154.16 34.32 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.588 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.522 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.0 m-80 -100.84 138.2 38.2 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.782 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.6 m -91.87 20.3 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 120.983 0.421 . . . . 0.0 111.064 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -112.68 -30.03 7.23 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.802 -178.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.8 -45.01 0.15 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -115.58 74.21 4.46 Favored Pre-proline 0 CA--C 1.548 0.891 0 O-C-N 123.091 0.244 . . . . 0.0 111.334 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.65 -172.12 0.88 Allowed 'Trans proline' 0 C--N 1.367 1.545 0 C-N-CA 122.704 2.269 . . . . 0.0 112.824 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 91.9 m -70.18 -177.54 1.42 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 122.427 0.291 . . . . 0.0 111.145 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 15.1 m -84.22 118.55 71.51 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 122.272 0.229 . . . . 0.0 111.408 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -78.55 157.69 28.66 Favored 'Trans proline' 0 C--N 1.368 1.563 0 C-N-CA 122.73 2.287 . . . . 0.0 113.04 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.64 -32.21 5.69 Favored Glycine 0 C--N 1.337 0.632 0 O-C-N 123.717 0.636 . . . . 0.0 112.916 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.9 mt -84.22 -60.79 1.98 Allowed 'General case' 0 C--O 1.236 0.385 0 C-N-CA 122.645 0.378 . . . . 0.0 110.962 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.78 36.26 0.29 Allowed Glycine 0 C--N 1.341 0.813 0 O-C-N 123.447 0.467 . . . . 0.0 113.279 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.63 155.77 18.61 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.921 0.361 . . . . 0.0 111.413 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.86 129.4 20.19 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.36 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.17 123.68 30.96 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.299 0.374 . . . . 0.0 110.801 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.4 mm -123.22 120.47 27.28 Favored Pre-proline 0 CA--C 1.542 0.649 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.099 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.39 -31.59 5.1 Favored 'Cis proline' 0 C--N 1.371 1.746 0 C-N-CA 124.192 -1.17 . . . . 0.0 113.19 -0.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.643 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.51 -24.77 30.83 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 115.747 -0.66 . . . . 0.0 113.891 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.67 112.17 48.44 Favored Pre-proline 0 CA--C 1.542 0.673 0 CA-C-N 117.199 0.499 . . . . 0.0 111.025 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -69.87 -25.25 8.18 Favored 'Cis proline' 0 C--N 1.378 2.088 0 C-N-CA 125.069 -0.804 . . . . 0.0 113.298 -0.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.522 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.24 150.98 29.55 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.782 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.561 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.05 -168.43 11.34 Favored Glycine 0 C--N 1.336 0.533 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.461 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.53 134.64 41.21 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.77 0.319 . . . . 0.0 111.436 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 79.9 m -80.28 107.76 13.34 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.334 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -112.59 147.76 36.0 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.654 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.44 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.5 m-85 -78.81 129.36 34.52 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.279 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.134 -0.936 . . . . 0.0 111.45 -179.603 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.273 . . . . . . . 0 C--O 1.235 0.31 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.9 56.44 0.95 Allowed Glycine 0 C--N 1.336 0.554 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.587 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.23 113.69 10.85 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.832 0.349 . . . . 0.0 110.45 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.469 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -119.14 146.71 44.91 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.776 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -92.18 173.67 7.7 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.985 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.5 tt0 -65.22 137.42 57.58 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.792 0.33 . . . . 0.0 111.204 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.84 -5.74 77.57 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 115.254 -0.885 . . . . 0.0 113.085 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -93.47 156.36 16.8 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 122.625 0.37 . . . . 0.0 110.778 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.559 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 53.3 m -96.88 116.2 28.76 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.127 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.17 154.32 33.5 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.673 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.527 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 5.9 m-80 -101.09 138.33 38.28 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.749 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.644 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.6 m -91.9 20.37 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 120.954 0.407 . . . . 0.0 110.99 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -112.58 -29.92 7.3 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.825 -178.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -149.03 -45.2 0.14 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -115.49 74.16 4.3 Favored Pre-proline 0 CA--C 1.548 0.891 0 O-C-N 123.185 0.303 . . . . 0.0 111.369 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.63 -172.03 0.86 Allowed 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 122.73 2.287 . . . . 0.0 112.798 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 95.4 m -70.26 -177.92 1.55 Allowed 'General case' 0 CA--C 1.543 0.701 0 O-C-N 123.128 0.268 . . . . 0.0 111.13 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.6 m -83.94 118.35 71.11 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 122.237 0.215 . . . . 0.0 111.28 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -78.44 157.87 29.11 Favored 'Trans proline' 0 C--N 1.368 1.604 0 C-N-CA 122.679 2.253 . . . . 0.0 113.128 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.49 -32.03 5.75 Favored Glycine 0 C--N 1.338 0.664 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.858 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.2 mt -84.51 -60.59 2.02 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.63 0.372 . . . . 0.0 111.002 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.72 36.04 0.3 Allowed Glycine 0 C--N 1.341 0.813 0 O-C-N 123.425 0.453 . . . . 0.0 113.327 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.67 155.34 18.91 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.866 0.365 . . . . 0.0 111.361 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.9 t -142.29 129.75 21.28 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.357 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.42 123.72 31.19 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.3 0.375 . . . . 0.0 110.808 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.1 mm -123.07 120.48 27.43 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.092 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.5 -31.39 5.24 Favored 'Cis proline' 0 C--N 1.37 1.688 0 C-N-CA 124.166 -1.181 . . . . 0.0 113.175 -0.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.644 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.36 -24.59 31.49 Favored Glycine 0 C--N 1.338 0.656 0 CA-C-N 115.75 -0.659 . . . . 0.0 113.891 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -113.7 112.06 48.42 Favored Pre-proline 0 CA--C 1.543 0.673 0 CA-C-N 117.218 0.509 . . . . 0.0 111.079 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -69.77 -25.35 8.07 Favored 'Cis proline' 0 C--N 1.378 2.106 0 CA-C-N 119.404 0.823 . . . . 0.0 113.313 -0.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.527 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.13 151.18 29.86 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.744 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.22 -168.67 11.43 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.429 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.33 134.67 41.02 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 120.769 0.319 . . . . 0.0 111.489 -179.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 77.9 m -80.24 107.98 13.47 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.3 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -112.82 147.42 36.98 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.769 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.441 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.5 m-85 -78.68 129.75 35.07 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.286 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.137 -0.935 . . . . 0.0 111.429 -179.508 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.271 . . . . . . . 0 C--O 1.236 0.346 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.75 55.6 1.0 Allowed Glycine 0 C--N 1.336 0.544 0 O-C-N 123.763 0.664 . . . . 0.0 112.578 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.67 113.36 10.23 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 120.77 0.319 . . . . 0.0 110.414 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.459 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -117.99 148.32 42.33 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.887 179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -92.4 172.32 8.47 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.971 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.51 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.9 tt0 -65.36 137.07 57.26 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.767 0.318 . . . . 0.0 111.056 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.92 -5.3 79.84 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 115.311 -0.859 . . . . 0.0 113.038 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -93.46 156.97 16.45 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 122.66 0.384 . . . . 0.0 110.656 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.567 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.1 t -96.94 115.91 28.27 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.085 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.507 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.04 154.02 33.78 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.629 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.521 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.1 m-80 -100.8 138.25 38.11 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.784 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -91.99 20.5 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.032 0.444 . . . . 0.0 111.072 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -112.82 -30.0 7.2 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.796 -178.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -148.9 -45.07 0.14 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -178.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -115.57 74.2 4.44 Favored Pre-proline 0 CA--C 1.547 0.852 0 O-C-N 123.053 0.22 . . . . 0.0 111.37 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.67 -172.03 0.86 Allowed 'Trans proline' 0 C--N 1.367 1.535 0 C-N-CA 122.758 2.305 . . . . 0.0 112.8 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.507 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 93.2 m -70.22 -177.62 1.46 Allowed 'General case' 0 CA--C 1.542 0.663 0 O-C-N 123.152 0.282 . . . . 0.0 111.126 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.9 m -84.26 118.56 71.5 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 122.29 0.236 . . . . 0.0 111.379 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.51 157.85 28.85 Favored 'Trans proline' 0 C--N 1.37 1.658 0 C-N-CA 122.606 2.204 . . . . 0.0 113.073 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.53 -32.22 5.65 Favored Glycine 0 C--N 1.338 0.659 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.897 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.5 mt -84.19 -60.42 2.1 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 122.693 0.397 . . . . 0.0 111.023 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.19 36.42 0.3 Allowed Glycine 0 C--N 1.341 0.831 0 O-C-N 123.413 0.445 . . . . 0.0 113.248 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.51 155.72 18.69 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.891 0.345 . . . . 0.0 111.455 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.74 129.39 20.32 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.32 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.21 123.74 31.06 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.253 0.346 . . . . 0.0 110.843 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.2 mm -123.26 120.39 27.25 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.087 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.34 -31.74 5.01 Favored 'Cis proline' 0 C--N 1.371 1.75 0 C-N-CA 124.188 -1.172 . . . . 0.0 113.201 -0.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.643 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.66 -24.85 30.49 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-N 115.747 -0.66 . . . . 0.0 113.805 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -113.61 112.22 48.56 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 117.253 0.527 . . . . 0.0 111.057 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.87 -25.18 8.22 Favored 'Cis proline' 0 C--N 1.378 2.088 0 C-N-CA 125.038 -0.818 . . . . 0.0 113.278 -0.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.521 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.1 p30 -153.34 150.93 29.39 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.814 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -139.95 -168.43 11.33 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.5 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.5 134.56 41.29 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-O 120.731 0.3 . . . . 0.0 111.494 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 79.7 m -80.27 107.67 13.26 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.392 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -112.43 147.43 36.48 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.744 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.439 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.67 129.4 34.68 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.322 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--O 1.252 1.189 0 CA-C-O 118.483 -0.77 . . . . 0.0 111.511 -179.539 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.271 . . . . . . . 0 C--O 1.236 0.349 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 100.37 54.97 0.98 Allowed Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.563 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.62 113.31 10.21 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 120.708 0.29 . . . . 0.0 110.472 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.459 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -117.99 148.33 42.32 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.847 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -92.3 172.33 8.47 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.999 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.7 tt0 -65.42 137.03 57.2 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.771 0.32 . . . . 0.0 111.046 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.89 -5.21 80.15 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.982 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -93.46 157.07 16.4 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 122.711 0.404 . . . . 0.0 110.712 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.567 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.6 t -96.97 115.86 28.18 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.961 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.508 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.04 153.84 34.09 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.601 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.521 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.1 m-80 -100.72 138.24 38.04 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.794 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -91.93 20.46 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.97 0.414 . . . . 0.0 111.086 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.86 -30.01 7.19 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.764 -178.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.84 -45.13 0.15 Allowed 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -178.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -115.55 74.18 4.4 Favored Pre-proline 0 CA--C 1.547 0.855 0 O-C-N 123.088 0.243 . . . . 0.0 111.319 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.5 -171.99 0.84 Allowed 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 122.741 2.294 . . . . 0.0 112.907 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.508 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 93.0 m -70.29 -177.58 1.47 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 122.431 0.293 . . . . 0.0 111.152 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.9 m -84.31 118.48 71.3 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 122.328 0.251 . . . . 0.0 111.384 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -78.46 157.83 29.02 Favored 'Trans proline' 0 C--N 1.368 1.599 0 C-N-CA 122.711 2.274 . . . . 0.0 113.044 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.52 -32.27 5.62 Favored Glycine 0 C--N 1.338 0.669 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.895 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.5 mt -84.12 -60.44 2.09 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 122.706 0.403 . . . . 0.0 111.024 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.22 36.37 0.3 Allowed Glycine 0 C--N 1.341 0.86 0 O-C-N 123.476 0.485 . . . . 0.0 113.251 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -90.54 155.63 18.75 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.903 0.383 . . . . 0.0 111.426 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.9 t -142.53 129.23 20.4 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.345 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.08 123.77 30.99 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 123.217 0.323 . . . . 0.0 110.785 179.852 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.2 mm -123.22 120.41 27.29 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.126 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.38 -31.73 5.01 Favored 'Cis proline' 0 C--N 1.371 1.75 0 C-N-CA 124.159 -1.184 . . . . 0.0 113.146 -0.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.643 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.71 -25.03 29.86 Favored Glycine 0 C--N 1.338 0.677 0 CA-C-N 115.694 -0.685 . . . . 0.0 113.767 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -113.5 112.18 48.9 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 117.235 0.517 . . . . 0.0 111.023 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -69.96 -25.04 8.35 Favored 'Cis proline' 0 C--N 1.379 2.148 0 C-N-CA 124.995 -0.835 . . . . 0.0 113.367 -0.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.521 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.1 p-10 -153.49 150.96 29.29 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.803 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.08 -168.45 11.34 Favored Glycine 0 C--N 1.335 0.519 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.492 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.44 134.63 41.16 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 120.77 0.319 . . . . 0.0 111.446 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 78.2 m -80.39 107.71 13.42 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.319 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -112.38 147.42 36.45 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.693 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.44 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.5 m-85 -78.56 129.5 34.89 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.356 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.5 mt . . . . . 0 C--O 1.252 1.201 0 CA-C-O 118.526 -0.749 . . . . 0.0 111.474 -179.57 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.271 . . . . . . . 0 N--CA 1.465 0.322 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 96.5 49.77 1.95 Allowed Glycine 0 C--N 1.34 0.754 0 O-C-N 123.456 0.473 . . . . 0.0 112.73 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -138.84 113.87 9.36 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.777 0.323 . . . . 0.0 110.482 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.477 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -117.17 147.97 42.0 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.904 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -92.67 172.74 8.17 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.027 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.51 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.6 tt0 -65.81 137.3 57.14 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.8 0.334 . . . . 0.0 110.951 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.81 -5.29 79.54 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 115.267 -0.879 . . . . 0.0 113.023 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -93.77 157.01 16.35 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 122.651 0.38 . . . . 0.0 110.733 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.564 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 52.7 m -96.75 116.07 28.51 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.182 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.05 153.93 33.95 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.656 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.522 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.1 m-80 -100.71 138.26 38.0 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.824 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -91.98 20.47 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.912 0.387 . . . . 0.0 110.967 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.85 -29.79 7.27 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.817 -178.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -149.09 -45.01 0.14 Allowed 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -115.67 74.13 4.59 Favored Pre-proline 0 CA--C 1.548 0.884 0 O-C-N 123.193 0.308 . . . . 0.0 111.304 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.65 -171.92 0.84 Allowed 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 122.739 2.293 . . . . 0.0 112.892 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 95.3 m -70.16 -177.84 1.49 Allowed 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.163 0.289 . . . . 0.0 111.082 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.5 m -83.84 118.46 71.45 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 122.294 0.238 . . . . 0.0 111.367 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -78.53 157.25 28.67 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.681 2.254 . . . . 0.0 113.065 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.94 -32.22 5.76 Favored Glycine 0 C--N 1.338 0.64 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.891 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.8 mt -84.17 -60.61 2.04 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 122.674 0.389 . . . . 0.0 110.993 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.49 36.4 0.29 Allowed Glycine 0 C--N 1.34 0.794 0 O-C-N 123.489 0.493 . . . . 0.0 113.249 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.61 155.71 18.66 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.884 0.374 . . . . 0.0 111.379 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.7 129.42 20.41 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.301 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.2 123.74 31.05 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.275 0.359 . . . . 0.0 110.794 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.1 mm -123.23 120.42 27.28 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.149 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.29 -31.84 4.94 Favored 'Cis proline' 0 C--N 1.371 1.717 0 C-N-CA 124.166 -1.181 . . . . 0.0 113.155 -0.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.643 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.69 -24.83 30.56 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-O 119.413 -0.659 . . . . 0.0 113.878 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -113.58 112.13 48.7 Favored Pre-proline 0 CA--C 1.543 0.705 0 CA-C-N 117.239 0.52 . . . . 0.0 111.072 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -69.91 -25.26 8.19 Favored 'Cis proline' 0 C--N 1.377 2.032 0 CA-C-N 119.386 0.816 . . . . 0.0 113.251 -0.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.522 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.28 151.0 29.52 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.84 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -139.89 -168.43 11.32 Favored Glycine 0 C--N 1.336 0.549 0 CA-C-N 115.814 -0.63 . . . . 0.0 112.522 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.59 134.62 41.27 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-O 120.733 0.302 . . . . 0.0 111.38 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 76.5 m -80.38 107.82 13.49 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.398 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -112.51 147.36 36.74 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.72 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.439 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.62 129.5 34.84 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.256 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.08 -0.962 . . . . 0.0 111.466 -179.547 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.273 . . . . . . . 0 C--O 1.235 0.33 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 118.79 45.26 0.47 Allowed Glycine 0 C--N 1.337 0.627 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.857 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -141.26 113.07 7.74 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 120.724 0.297 . . . . 0.0 110.592 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.498 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -116.57 149.11 40.17 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.846 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -93.8 171.66 8.73 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.514 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.8 tt0 -65.02 136.8 57.21 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 122.482 0.313 . . . . 0.0 111.002 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.9 -5.0 81.13 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.966 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -94.02 157.13 16.24 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 122.673 0.389 . . . . 0.0 110.672 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.56 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 52.3 m -96.85 116.76 29.72 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.194 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.512 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.84 154.03 34.91 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.622 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.521 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.1 m-80 -100.77 138.19 38.15 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.719 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -91.87 20.24 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 120.909 0.385 . . . . 0.0 111.097 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.79 -29.93 7.24 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.842 -178.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -148.91 -44.96 0.14 Allowed 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -115.45 73.99 4.17 Favored Pre-proline 0 CA--C 1.548 0.894 0 O-C-N 123.149 0.281 . . . . 0.0 111.375 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.66 -172.3 0.91 Allowed 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 122.743 2.295 . . . . 0.0 112.918 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.512 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 90.6 m -70.32 -177.1 1.34 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 122.408 0.283 . . . . 0.0 111.137 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 16.0 m -84.56 118.47 71.16 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 122.354 0.262 . . . . 0.0 111.274 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -78.57 157.65 28.59 Favored 'Trans proline' 0 C--N 1.368 1.587 0 C-N-CA 122.711 2.274 . . . . 0.0 113.053 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.6 -32.16 5.7 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.89 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.7 mt -84.1 -60.76 2.0 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.643 0.377 . . . . 0.0 111.025 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.78 36.43 0.28 Allowed Glycine 0 C--N 1.341 0.835 0 O-C-N 123.461 0.476 . . . . 0.0 113.218 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.66 155.71 18.64 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.946 0.373 . . . . 0.0 111.427 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.69 129.34 20.33 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.305 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.11 123.68 30.91 Favored 'General case' 0 C--O 1.236 0.391 0 O-C-N 123.201 0.313 . . . . 0.0 110.825 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.3 mm -123.22 120.37 27.3 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.121 -178.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.34 -31.72 5.02 Favored 'Cis proline' 0 C--N 1.371 1.746 0 C-N-CA 124.223 -1.157 . . . . 0.0 113.226 -0.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.642 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.6 -25.03 29.82 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 115.728 -0.669 . . . . 0.0 113.854 179.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -113.54 112.1 48.83 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 117.237 0.519 . . . . 0.0 111.025 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -69.94 -25.14 8.28 Favored 'Cis proline' 0 C--N 1.379 2.147 0 C-N-CA 124.993 -0.836 . . . . 0.0 113.359 -0.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.521 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.39 151.0 29.43 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.784 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.56 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.08 -168.44 11.34 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.499 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.5 134.51 41.37 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 120.717 0.294 . . . . 0.0 111.487 -179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 83.1 m -80.25 107.62 13.2 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.374 -179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -112.41 147.72 35.85 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.687 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.437 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.5 m-85 -78.82 129.54 34.72 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.308 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.4 mt . . . . . 0 C--O 1.251 1.165 0 CA-C-O 118.46 -0.781 . . . . 0.0 111.474 -179.542 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.27 . . . . . . . 0 C--O 1.235 0.331 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 96.38 49.85 1.96 Allowed Glycine 0 C--N 1.342 0.868 0 O-C-N 123.38 0.425 . . . . 0.0 112.702 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -138.3 113.82 9.64 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 120.764 0.316 . . . . 0.0 110.479 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.473 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -117.29 147.81 42.24 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.828 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -92.43 172.65 8.25 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.023 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.51 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.3 tt0 -65.63 137.44 57.34 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.822 0.344 . . . . 0.0 111.023 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.8 -5.37 79.11 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.941 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -93.84 157.03 16.33 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 122.639 0.376 . . . . 0.0 110.662 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.566 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 52.6 m -96.69 115.91 28.24 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.209 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.504 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -118.95 153.88 33.9 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.614 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.522 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.0 m-80 -100.68 138.15 38.13 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.814 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -91.91 20.42 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.904 0.383 . . . . 0.0 110.982 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.79 -29.93 7.23 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.764 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.95 -45.12 0.14 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -115.64 74.17 4.54 Favored Pre-proline 0 CA--C 1.548 0.884 0 O-C-N 123.152 0.282 . . . . 0.0 111.32 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.68 -171.93 0.85 Allowed 'Trans proline' 0 C--N 1.367 1.543 0 C-N-CA 122.68 2.253 . . . . 0.0 112.829 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.504 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 94.7 m -70.15 -177.78 1.48 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 122.366 0.267 . . . . 0.0 111.151 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.6 m -83.86 118.47 71.45 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 122.267 0.227 . . . . 0.0 111.373 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.54 157.23 28.66 Favored 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 122.715 2.277 . . . . 0.0 113.095 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.98 -32.2 5.79 Favored Glycine 0 C--N 1.339 0.702 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.854 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.8 mt -84.26 -60.53 2.06 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 122.606 0.362 . . . . 0.0 110.964 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.47 36.33 0.3 Allowed Glycine 0 C--N 1.341 0.828 0 O-C-N 123.472 0.482 . . . . 0.0 113.298 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.52 155.68 18.72 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.836 0.35 . . . . 0.0 111.38 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.66 129.43 20.46 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.32 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.22 123.73 31.05 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 123.258 0.349 . . . . 0.0 110.866 179.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.9 mm -123.22 120.45 27.28 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.145 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.18 -31.84 4.93 Favored 'Cis proline' 0 C--N 1.372 1.781 0 C-N-CA 124.21 -1.162 . . . . 0.0 113.208 -0.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.643 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.7 -24.85 30.51 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-N 115.75 -0.659 . . . . 0.0 113.898 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -113.7 112.2 48.34 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 117.174 0.487 . . . . 0.0 111.003 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -69.85 -25.28 8.15 Favored 'Cis proline' 0 C--N 1.377 2.051 0 C-N-CA 125.071 -0.804 . . . . 0.0 113.327 -0.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.522 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.29 151.0 29.52 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.803 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -139.94 -168.49 11.34 Favored Glycine 0 C--N 1.335 0.521 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.505 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.44 134.63 41.15 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.762 0.315 . . . . 0.0 111.403 -179.924 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 76.6 m -80.36 107.77 13.42 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.333 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -112.55 147.24 37.03 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.745 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.441 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.53 129.51 34.92 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.368 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--O 1.252 1.203 0 CA-C-O 118.526 -0.749 . . . . 0.0 111.425 -179.5 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.271 . . . . . . . 0 C--O 1.235 0.306 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 104.19 55.56 0.76 Allowed Glycine 0 C--N 1.336 0.55 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.639 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -137.5 113.38 9.72 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.751 0.31 . . . . 0.0 110.408 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.482 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -118.08 148.63 42.1 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.914 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -93.28 173.49 7.69 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.953 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 24.0 tt0 -66.04 136.86 56.6 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.507 0.323 . . . . 0.0 111.053 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.89 -5.23 80.05 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 115.331 -0.85 . . . . 0.0 113.008 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -93.54 156.79 16.54 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 122.715 0.406 . . . . 0.0 110.624 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 16.8 t -97.03 116.61 29.53 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.044 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.5 p -119.72 154.26 34.39 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.647 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.52 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.0 m-80 -100.89 138.28 38.15 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.734 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -91.99 20.33 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.976 0.417 . . . . 0.0 111.06 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.8 -29.92 7.24 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.833 -178.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.82 -45.02 0.15 Allowed 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -115.57 74.27 4.47 Favored Pre-proline 0 CA--C 1.548 0.888 0 O-C-N 123.178 0.299 . . . . 0.0 111.389 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.68 -172.28 0.91 Allowed 'Trans proline' 0 C--N 1.368 1.574 0 C-N-CA 122.753 2.302 . . . . 0.0 112.825 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 92.5 m -69.96 -177.73 1.4 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 122.511 0.324 . . . . 0.0 111.184 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.1 m -84.56 119.06 72.47 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 122.324 0.25 . . . . 0.0 111.342 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -78.6 159.05 28.63 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 122.657 2.238 . . . . 0.0 113.052 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.65 -31.96 5.56 Favored Glycine 0 C--N 1.338 0.665 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.864 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.6 mt -84.7 -60.25 2.12 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 122.643 0.377 . . . . 0.0 111.008 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 131.46 36.78 0.32 Allowed Glycine 0 C--N 1.341 0.859 0 O-C-N 123.379 0.424 . . . . 0.0 113.268 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -90.4 155.87 18.63 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.935 0.368 . . . . 0.0 111.369 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.78 129.18 20.05 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.381 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.0 123.72 30.88 Favored 'General case' 0 C--O 1.235 0.342 0 O-C-N 123.256 0.347 . . . . 0.0 110.84 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.1 mm -123.19 120.32 27.35 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.18 -178.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.39 -31.7 5.03 Favored 'Cis proline' 0 C--N 1.37 1.7 0 C-N-CA 124.242 -1.149 . . . . 0.0 113.105 -0.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.643 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.51 -24.87 30.44 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-N 115.778 -0.646 . . . . 0.0 113.824 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -113.63 112.15 48.54 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 117.17 0.485 . . . . 0.0 111.008 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -69.9 -25.25 8.19 Favored 'Cis proline' 0 C--N 1.378 2.092 0 C-N-CA 125.061 -0.808 . . . . 0.0 113.335 -0.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.52 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.35 151.04 29.51 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.803 179.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.562 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.11 -168.5 11.36 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.524 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.33 134.58 41.15 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 120.682 0.277 . . . . 0.0 111.506 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 79.2 m -80.29 107.69 13.29 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.366 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -112.59 147.11 37.34 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.761 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.433 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.3 m-85 -78.31 129.5 35.1 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.364 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.7 mt . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.487 -0.768 . . . . 0.0 111.481 -179.519 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.271 . . . . . . . 0 C--O 1.234 0.276 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 100.0 53.97 1.07 Allowed Glycine 0 C--N 1.335 0.524 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.586 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -137.75 113.08 9.33 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 120.771 0.32 . . . . 0.0 110.406 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.462 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -116.85 148.74 40.99 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.934 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -93.26 169.22 10.55 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.637 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.9 tt0 -62.89 136.94 58.11 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.78 0.324 . . . . 0.0 111.124 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.05 -5.25 80.52 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.993 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -93.83 157.08 16.31 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 122.707 0.403 . . . . 0.0 110.604 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 53.1 m -96.82 116.05 28.48 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.171 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.508 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.18 153.93 34.12 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.618 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.52 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.0 m-80 -100.69 138.23 38.03 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.827 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.6 m -91.87 20.31 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 120.941 0.401 . . . . 0.0 111.081 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -112.78 -29.86 7.26 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.819 -178.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.98 -45.01 0.14 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -115.59 74.2 4.48 Favored Pre-proline 0 CA--C 1.548 0.89 0 O-C-N 123.108 0.255 . . . . 0.0 111.291 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.68 -172.04 0.87 Allowed 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 122.739 2.293 . . . . 0.0 112.83 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.508 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 93.6 m -70.33 -177.44 1.44 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 122.428 0.291 . . . . 0.0 111.08 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 15.9 m -84.04 118.31 70.96 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 122.305 0.242 . . . . 0.0 111.312 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -78.54 157.4 28.67 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 122.668 2.246 . . . . 0.0 113.088 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.79 -32.19 5.74 Favored Glycine 0 C--N 1.338 0.666 0 CA-C-N 115.976 -0.557 . . . . 0.0 112.893 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.6 mt -84.14 -60.52 2.07 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.66 0.384 . . . . 0.0 111.046 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.61 36.19 0.3 Allowed Glycine 0 C--N 1.341 0.828 0 O-C-N 123.408 0.443 . . . . 0.0 113.315 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.52 155.67 18.72 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.869 0.334 . . . . 0.0 111.409 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.71 129.41 20.38 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.317 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.18 123.76 31.06 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 123.264 0.353 . . . . 0.0 110.811 179.853 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.1 mm -123.18 120.32 27.36 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.121 -178.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -73.37 -31.72 5.02 Favored 'Cis proline' 0 C--N 1.371 1.731 0 C-N-CA 124.165 -1.181 . . . . 0.0 113.141 -0.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.642 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.63 -24.92 30.24 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-O 119.381 -0.677 . . . . 0.0 113.841 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.59 112.16 48.66 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 117.241 0.521 . . . . 0.0 111.021 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -69.96 -25.2 8.25 Favored 'Cis proline' 0 C--N 1.376 2.026 0 CA-C-N 119.343 0.801 . . . . 0.0 113.248 -0.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.52 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.34 150.97 29.43 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 123.543 0.527 . . . . 0.0 110.808 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.565 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -139.98 -168.41 11.32 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.424 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.58 134.58 41.32 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 120.758 0.313 . . . . 0.0 111.399 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 80.1 m -80.31 107.85 13.44 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.35 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -112.55 147.5 36.49 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.736 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.44 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.73 129.37 34.6 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.299 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.424 -0.798 . . . . 0.0 111.517 -179.622 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.27 . . . . . . . 0 C--O 1.236 0.369 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 133.78 43.49 0.14 Allowed Glycine 0 C--N 1.339 0.71 0 O-C-N 123.494 0.496 . . . . 0.0 112.764 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.4 t -137.1 112.01 8.92 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.912 0.387 . . . . 0.0 110.927 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.443 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -118.41 148.82 42.15 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.668 179.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -91.84 169.85 10.36 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.14 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.514 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 22.5 tt0 -63.98 137.14 57.87 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 120.732 0.301 . . . . 0.0 111.055 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.01 -5.01 81.4 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.959 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -93.95 157.69 15.99 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 122.688 0.395 . . . . 0.0 110.663 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.569 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.9 t -97.16 115.73 28.08 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.999 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.517 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.3 p -118.83 153.66 34.13 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.566 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.519 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 5.7 m-80 -100.73 138.37 37.88 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.754 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.8 m -92.11 20.19 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 120.928 0.394 . . . . 0.0 110.994 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.85 -29.91 7.23 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.807 -178.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -149.03 -44.75 0.14 Allowed 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -115.47 73.92 4.18 Favored Pre-proline 0 CA--C 1.548 0.878 0 O-C-N 123.21 0.319 . . . . 0.0 111.429 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.53 -172.53 0.94 Allowed 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.826 2.351 . . . . 0.0 113.037 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.517 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 87.8 m -70.77 -176.26 1.28 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 122.395 0.278 . . . . 0.0 111.123 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 17.8 m -85.53 118.53 70.86 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 122.361 0.264 . . . . 0.0 111.342 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -78.62 158.34 28.49 Favored 'Trans proline' 0 C--N 1.37 1.662 0 C-N-CA 122.663 2.242 . . . . 0.0 112.939 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.14 -32.57 5.35 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.845 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.8 mt -83.71 -60.34 2.15 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 122.696 0.398 . . . . 0.0 110.978 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.2 36.47 0.3 Allowed Glycine 0 C--N 1.34 0.798 0 O-C-N 123.378 0.424 . . . . 0.0 113.303 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.63 155.61 18.72 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.826 0.346 . . . . 0.0 111.41 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.9 t -142.87 129.26 20.03 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.307 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.09 123.73 30.95 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 123.28 0.362 . . . . 0.0 110.823 179.838 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.8 mm -123.2 120.38 27.32 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.223 -178.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.32 -31.72 5.02 Favored 'Cis proline' 0 C--N 1.37 1.704 0 C-N-CA 124.196 -1.168 . . . . 0.0 113.178 -0.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.643 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.5 -24.88 30.41 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.848 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -113.64 112.21 48.48 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 117.213 0.507 . . . . 0.0 111.005 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.82 -25.25 8.16 Favored 'Cis proline' 0 C--N 1.377 2.05 0 CA-C-N 119.381 0.815 . . . . 0.0 113.328 -0.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.519 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.1 p-10 -153.37 151.05 29.5 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.745 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.569 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.22 -168.44 11.35 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.441 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.7 OUTLIER -98.58 134.51 41.43 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 120.714 0.292 . . . . 0.0 111.501 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 89.4 m -80.16 107.7 13.17 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.287 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -112.41 147.44 36.44 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.86 -1.063 . . . . 0.0 110.698 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.439 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.71 129.63 34.9 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.315 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.1 mt . . . . . 0 C--O 1.25 1.113 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.46 -179.555 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.272 . . . . . . . 0 C--O 1.235 0.316 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 110.41 52.0 0.6 Allowed Glycine 0 C--N 1.337 0.607 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.773 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.6 t -139.37 112.62 8.18 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 120.735 0.303 . . . . 0.0 110.508 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.475 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -116.38 149.65 39.02 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.947 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -93.92 168.87 10.69 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.695 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.511 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 24.3 tt0 -62.99 136.71 57.98 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.763 0.316 . . . . 0.0 111.082 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.06 -4.99 81.63 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.939 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -93.97 157.19 16.23 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 122.651 0.38 . . . . 0.0 110.634 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.564 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 53.5 m -96.72 116.41 29.09 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.26 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.512 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.48 153.97 34.48 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.607 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.518 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 5.9 m-80 -100.77 138.24 38.09 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.771 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -92.05 20.34 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.973 0.416 . . . . 0.0 111.074 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.77 -30.01 7.21 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.835 -178.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.81 -45.01 0.15 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -115.42 74.05 4.13 Favored Pre-proline 0 CA--C 1.547 0.858 0 O-C-N 123.188 0.305 . . . . 0.0 111.351 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.6 -172.43 0.93 Allowed 'Trans proline' 0 C--N 1.367 1.545 0 C-N-CA 122.839 2.359 . . . . 0.0 112.902 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.512 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 89.7 m -70.22 -177.06 1.31 Allowed 'General case' 0 CA--C 1.542 0.665 0 O-C-N 123.194 0.309 . . . . 0.0 111.166 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 16.5 m -84.42 118.33 70.88 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 122.324 0.25 . . . . 0.0 111.343 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.45 157.61 29.02 Favored 'Trans proline' 0 C--N 1.369 1.634 0 C-N-CA 122.673 2.249 . . . . 0.0 113.117 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.69 -32.09 5.77 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.889 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.6 mt -84.23 -60.47 2.08 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.614 0.366 . . . . 0.0 110.965 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.39 36.33 0.3 Allowed Glycine 0 C--N 1.341 0.857 0 O-C-N 123.458 0.474 . . . . 0.0 113.269 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.39 155.65 18.8 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.908 0.354 . . . . 0.0 111.391 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.74 129.18 20.1 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.341 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.03 123.63 30.8 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 123.273 0.358 . . . . 0.0 110.824 179.865 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.4 mm -123.16 120.36 27.36 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.102 -178.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.35 -31.8 4.97 Favored 'Cis proline' 0 C--N 1.372 1.791 0 C-N-CA 124.169 -1.179 . . . . 0.0 113.129 -0.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.642 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.66 -24.93 30.22 Favored Glycine 0 C--N 1.338 0.69 0 CA-C-N 115.691 -0.686 . . . . 0.0 113.877 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -113.54 112.09 48.85 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 117.209 0.505 . . . . 0.0 111.053 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -69.89 -25.27 8.17 Favored 'Cis proline' 0 C--N 1.378 2.084 0 CA-C-N 119.437 0.835 . . . . 0.0 113.304 -0.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.518 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.24 150.99 29.56 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.821 179.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.05 -168.32 11.3 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-N 115.848 -0.614 . . . . 0.0 112.501 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.6 134.45 41.53 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 120.689 0.281 . . . . 0.0 111.452 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 83.4 m -80.35 107.7 13.36 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.292 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -112.47 147.42 36.56 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.689 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.439 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.6 129.41 34.75 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.332 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.122 -0.942 . . . . 0.0 111.507 -179.567 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.275 . . . . . . . 0 N--CA 1.467 0.398 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 98.86 53.85 1.16 Allowed Glycine 0 C--N 1.339 0.708 0 O-C-N 123.348 0.405 . . . . 0.0 112.55 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -135.58 113.26 10.89 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 120.734 0.302 . . . . 0.0 110.432 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.445 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -118.12 147.9 42.85 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.835 179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -91.63 172.12 8.71 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.041 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.4 tt0 -65.4 137.49 57.51 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.833 0.349 . . . . 0.0 111.024 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.75 -5.2 79.75 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-N 115.32 -0.855 . . . . 0.0 113.025 -179.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -93.66 157.2 16.29 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 122.719 0.408 . . . . 0.0 110.63 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.571 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.3 t -96.86 115.43 27.41 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.98 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.507 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -118.6 153.73 33.79 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.591 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.52 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.0 m-80 -100.7 138.2 38.07 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.808 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.6 m -91.89 20.32 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 120.9 0.381 . . . . 0.0 111.071 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.76 -29.95 7.24 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.803 -178.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -148.94 -45.0 0.14 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -178.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -115.63 74.22 4.56 Favored Pre-proline 0 CA--C 1.548 0.89 0 O-C-N 123.196 0.31 . . . . 0.0 111.34 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.71 -171.98 0.86 Allowed 'Trans proline' 0 C--N 1.367 1.527 0 C-N-CA 122.745 2.296 . . . . 0.0 112.827 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.507 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 92.7 m -70.32 -177.51 1.46 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 122.39 0.276 . . . . 0.0 111.123 179.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.8 m -84.31 118.49 71.3 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 122.369 0.268 . . . . 0.0 111.373 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.43 157.88 29.13 Favored 'Trans proline' 0 C--N 1.37 1.665 0 C-N-CA 122.695 2.263 . . . . 0.0 113.066 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.52 -32.28 5.61 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.894 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.7 mt -84.18 -60.31 2.13 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 122.685 0.394 . . . . 0.0 110.934 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.01 36.36 0.31 Allowed Glycine 0 C--N 1.341 0.847 0 O-C-N 123.406 0.441 . . . . 0.0 113.321 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.39 155.69 18.77 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.868 0.366 . . . . 0.0 111.418 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.77 129.28 20.17 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.325 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.08 123.77 30.98 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 123.291 0.369 . . . . 0.0 110.785 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.3 mm -123.3 120.39 27.22 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.104 -178.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.3 -31.84 4.94 Favored 'Cis proline' 0 C--N 1.371 1.75 0 C-N-CA 124.222 -1.158 . . . . 0.0 113.148 -0.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.643 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.73 -24.85 30.51 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-O 119.412 -0.66 . . . . 0.0 113.852 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -113.65 112.16 48.49 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 117.158 0.479 . . . . 0.0 110.982 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -69.95 -25.13 8.29 Favored 'Cis proline' 0 C--N 1.379 2.152 0 C-N-CA 125.024 -0.823 . . . . 0.0 113.249 -0.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.52 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p30 -153.39 151.03 29.45 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.767 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.571 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.02 -168.42 11.33 Favored Glycine 0 C--N 1.336 0.547 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.484 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.51 134.6 41.25 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.726 0.298 . . . . 0.0 111.359 -179.864 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 81.3 m -80.3 107.66 13.28 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.361 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -112.46 147.12 37.17 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.733 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.44 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.47 129.45 34.9 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.24 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.129 -0.938 . . . . 0.0 111.498 -179.597 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.271 . . . . . . . 0 C--O 1.235 0.315 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.71 55.27 1.02 Allowed Glycine 0 C--N 1.337 0.586 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.536 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -137.45 113.08 9.5 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 120.815 0.34 . . . . 0.0 110.425 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.463 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -117.07 148.65 41.33 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.895 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -93.38 169.54 10.29 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.727 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.7 tt0 -62.94 137.05 58.16 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 120.87 0.367 . . . . 0.0 111.078 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.06 -5.44 79.71 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 115.288 -0.869 . . . . 0.0 112.956 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -93.53 157.01 16.41 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 122.702 0.401 . . . . 0.0 110.635 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.566 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.2 t -97.03 115.99 28.43 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.995 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.509 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.07 154.03 33.81 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.631 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.521 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.1 m-80 -100.78 138.27 38.05 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.823 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.644 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -91.95 20.39 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 121.015 0.436 . . . . 0.0 111.064 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -112.67 -29.9 7.28 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.818 -178.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -149.02 -45.05 0.14 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -115.58 74.1 4.42 Favored Pre-proline 0 CA--C 1.548 0.888 0 O-C-N 123.126 0.266 . . . . 0.0 111.362 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.65 -172.04 0.86 Allowed 'Trans proline' 0 C--N 1.368 1.557 0 C-N-CA 122.743 2.295 . . . . 0.0 112.795 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.509 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 92.4 m -70.23 -177.41 1.4 Allowed 'General case' 0 CA--C 1.543 0.676 0 O-C-N 123.142 0.276 . . . . 0.0 111.161 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 15.6 m -84.11 118.29 70.88 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 122.345 0.258 . . . . 0.0 111.277 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -78.49 157.51 28.86 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 122.593 2.195 . . . . 0.0 113.081 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.77 -32.15 5.75 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.875 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.6 mt -84.26 -60.76 1.99 Allowed 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 122.607 0.363 . . . . 0.0 110.992 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 133.0 36.15 0.28 Allowed Glycine 0 C--N 1.34 0.779 0 O-C-N 123.475 0.484 . . . . 0.0 113.271 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.63 155.45 18.84 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.91 0.355 . . . . 0.0 111.366 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.9 t -142.55 129.56 20.73 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.384 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.2 123.72 31.03 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.227 0.329 . . . . 0.0 110.807 179.853 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.0 mm -123.23 120.46 27.27 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.062 -178.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.23 -31.83 4.94 Favored 'Cis proline' 0 C--N 1.372 1.781 0 C-N-CA 124.131 -1.196 . . . . 0.0 113.208 -0.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.644 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.76 -24.89 30.37 Favored Glycine 0 C--N 1.338 0.667 0 CA-C-N 115.712 -0.677 . . . . 0.0 113.844 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.58 112.16 48.69 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 117.209 0.504 . . . . 0.0 111.026 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -69.85 -25.25 8.17 Favored 'Cis proline' 0 C--N 1.378 2.088 0 CA-C-N 119.372 0.811 . . . . 0.0 113.347 -0.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.521 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.3 151.01 29.52 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.774 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.02 -168.52 11.36 Favored Glycine 0 C--N 1.336 0.545 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.393 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.41 134.72 41.02 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 120.719 0.295 . . . . 0.0 111.499 -179.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 79.4 m -80.44 107.84 13.57 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.325 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -112.54 147.65 36.15 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.758 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.44 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.84 129.44 34.59 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.274 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.485 -0.769 . . . . 0.0 111.473 -179.575 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.273 . . . . . . . 0 C--O 1.235 0.335 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 111.89 51.64 0.56 Allowed Glycine 0 C--N 1.336 0.541 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.789 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.6 t -139.76 112.66 8.06 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 120.766 0.317 . . . . 0.0 110.517 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.474 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . . . -116.45 149.63 39.15 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.866 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -94.05 168.78 10.73 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.65 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.509 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 24.1 tt0 -62.76 136.54 57.91 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.785 0.326 . . . . 0.0 111.053 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.31 -5.1 81.95 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.956 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -93.71 157.26 16.25 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 122.745 0.418 . . . . 0.0 110.693 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.566 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.1 t -96.95 116.07 28.54 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.082 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.511 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.3 153.95 34.26 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.627 179.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.519 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.0 m-80 -100.76 138.28 38.02 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.766 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.6 m -91.99 20.3 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 120.914 0.388 . . . . 0.0 111.083 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.79 -30.05 7.2 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.835 -178.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.8 -44.97 0.15 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -178.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -115.44 74.07 4.18 Favored Pre-proline 0 CA--C 1.548 0.893 0 O-C-N 123.177 0.298 . . . . 0.0 111.379 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.61 -172.31 0.91 Allowed 'Trans proline' 0 C--N 1.368 1.567 0 C-N-CA 122.792 2.328 . . . . 0.0 112.906 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.511 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 88.8 m -70.21 -177.01 1.29 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 122.414 0.286 . . . . 0.0 111.218 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 16.5 m -84.49 118.36 70.93 Favored Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 122.346 0.258 . . . . 0.0 111.321 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -78.58 157.66 28.55 Favored 'Trans proline' 0 C--N 1.368 1.568 0 C-N-CA 122.727 2.285 . . . . 0.0 113.071 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.66 -32.2 5.7 Favored Glycine 0 C--N 1.338 0.67 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.842 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.5 mt -84.11 -60.92 1.95 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 122.64 0.376 . . . . 0.0 111.016 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 133.03 36.26 0.28 Allowed Glycine 0 C--N 1.342 0.869 0 O-C-N 123.414 0.446 . . . . 0.0 113.217 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.56 155.58 18.77 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.919 0.36 . . . . 0.0 111.392 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.9 t -142.68 129.28 20.27 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.363 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.12 123.77 31.02 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 123.278 0.361 . . . . 0.0 110.785 179.857 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.3 mm -123.28 120.39 27.24 Favored Pre-proline 0 CA--C 1.541 0.629 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.062 -178.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.32 -31.8 4.97 Favored 'Cis proline' 0 C--N 1.372 1.764 0 C-N-CA 124.231 -1.154 . . . . 0.0 113.148 -0.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.642 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.6 -24.86 30.48 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-O 119.358 -0.69 . . . . 0.0 113.815 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -113.65 112.18 48.47 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-N 117.212 0.506 . . . . 0.0 111.035 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.92 -25.17 8.25 Favored 'Cis proline' 0 C--N 1.378 2.084 0 C-N-CA 125.016 -0.827 . . . . 0.0 113.303 -0.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.519 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.35 151.03 29.5 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.798 179.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.17 -168.41 11.34 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.453 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.57 134.47 41.48 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 120.765 0.317 . . . . 0.0 111.476 -179.909 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 85.4 m -80.36 107.72 13.39 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.327 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -112.4 147.79 35.7 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.714 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.439 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.5 m-85 -78.89 129.52 34.63 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.284 -179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.103 -0.951 . . . . 0.0 111.429 -179.526 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.272 . . . . . . . 0 C--O 1.234 0.268 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 100.83 55.11 0.95 Allowed Glycine 0 C--N 1.336 0.529 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.526 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.89 113.15 9.89 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.755 0.312 . . . . 0.0 110.431 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.455 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -117.78 148.17 42.31 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.805 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -92.26 172.09 8.64 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.034 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 24.2 tt0 -65.15 136.92 57.26 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.521 0.328 . . . . 0.0 111.021 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.88 -5.09 80.69 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.983 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -93.66 157.06 16.36 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 122.729 0.412 . . . . 0.0 110.669 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.566 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 52.6 m -96.93 116.09 28.57 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.211 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.505 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.16 155.01 32.4 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.658 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.527 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.5 m-80 -101.7 138.53 38.56 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.78 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.646 HG22 ' O ' ' A' ' 28' ' ' GLY . 35.7 m -91.86 21.22 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 120.91 0.386 . . . . 0.0 111.216 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -113.81 -31.05 6.56 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.931 -178.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -147.54 -44.94 0.17 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -115.69 74.2 4.65 Favored Pre-proline 0 CA--C 1.547 0.864 0 O-C-N 123.175 0.297 . . . . 0.0 111.304 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.67 -172.21 0.9 Allowed 'Trans proline' 0 C--N 1.367 1.537 0 C-N-CA 122.77 2.313 . . . . 0.0 112.8 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.505 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 93.0 m -70.17 -177.5 1.41 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 122.394 0.278 . . . . 0.0 111.152 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.9 m -84.36 118.38 71.03 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 122.222 0.209 . . . . 0.0 111.372 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.5 157.82 28.88 Favored 'Trans proline' 0 C--N 1.369 1.658 0 C-N-CA 122.654 2.236 . . . . 0.0 113.087 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.56 -32.17 5.69 Favored Glycine 0 C--N 1.337 0.598 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.882 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.5 mt -84.25 -60.39 2.1 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.671 0.388 . . . . 0.0 110.97 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.24 36.45 0.3 Allowed Glycine 0 C--N 1.342 0.884 0 O-C-N 123.393 0.433 . . . . 0.0 113.269 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.49 155.8 18.64 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.88 0.372 . . . . 0.0 111.356 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.66 128.79 19.75 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.316 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -84.87 123.76 30.84 Favored 'General case' 0 C--O 1.236 0.381 0 O-C-N 123.226 0.329 . . . . 0.0 110.792 179.853 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.4 mm -122.98 119.84 27.72 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.236 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.12 -31.29 5.28 Favored 'Cis proline' 0 C--N 1.371 1.757 0 C-N-CA 124.147 -1.189 . . . . 0.0 113.129 -0.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.646 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.02 -26.07 25.88 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 115.683 -0.69 . . . . 0.0 113.88 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -115.72 113.37 42.49 Favored Pre-proline 0 CA--C 1.546 0.797 0 CA-C-N 117.211 0.505 . . . . 0.0 111.156 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.59 -27.34 5.92 Favored 'Cis proline' 0 C--N 1.377 2.059 0 CA-C-N 119.323 0.794 . . . . 0.0 113.586 -0.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.527 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p-10 -153.63 151.44 29.71 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.783 179.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -141.37 -168.91 11.68 Favored Glycine 0 C--N 1.336 0.555 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.484 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.51 134.48 41.42 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 120.74 0.305 . . . . 0.0 111.561 -179.839 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 82.8 m -80.3 107.88 13.45 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.361 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -112.55 147.38 36.73 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.693 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.438 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.5 m-85 -78.61 129.62 34.99 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.341 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.057 -0.973 . . . . 0.0 111.45 -179.557 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.269 . . . . . . . 0 C--O 1.235 0.333 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.45 49.47 1.84 Allowed Glycine 0 C--N 1.34 0.791 0 O-C-N 123.348 0.405 . . . . 0.0 112.644 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -138.82 113.47 9.05 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 122.451 0.301 . . . . 0.0 110.411 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.469 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -116.26 148.42 40.5 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.927 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -93.32 169.18 10.57 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.691 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.8 tt0 -62.99 137.21 58.2 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.872 0.368 . . . . 0.0 111.066 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.95 -5.19 80.43 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.999 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -93.66 157.26 16.26 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 122.707 0.403 . . . . 0.0 110.73 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.569 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.1 t -96.89 115.65 27.79 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.074 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -118.8 153.82 33.84 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.604 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.52 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.2 m-80 -100.66 138.25 37.98 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.794 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.7 m -92.01 20.48 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.971 0.415 . . . . 0.0 111.044 -179.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.82 -29.82 7.27 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.857 -178.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -149.06 -45.13 0.14 Allowed 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -115.58 74.15 4.44 Favored Pre-proline 0 CA--C 1.547 0.843 0 O-C-N 123.09 0.244 . . . . 0.0 111.34 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.73 -171.95 0.85 Allowed 'Trans proline' 0 C--N 1.368 1.562 0 C-N-CA 122.769 2.313 . . . . 0.0 112.826 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 94.5 m -70.2 -177.53 1.42 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 122.382 0.273 . . . . 0.0 111.145 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 15.2 m -83.83 118.27 70.91 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 122.231 0.212 . . . . 0.0 111.298 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -78.53 156.95 28.62 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.623 2.215 . . . . 0.0 113.133 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.18 -32.02 5.95 Favored Glycine 0 C--N 1.338 0.657 0 O-C-N 123.682 0.614 . . . . 0.0 112.872 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.7 mt -84.31 -60.84 1.96 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 122.664 0.386 . . . . 0.0 111.045 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 133.09 36.2 0.28 Allowed Glycine 0 C--N 1.342 0.87 0 O-C-N 123.511 0.507 . . . . 0.0 113.243 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.6 155.71 18.67 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.838 0.351 . . . . 0.0 111.346 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.79 129.46 20.33 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.28 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.24 123.79 31.13 Favored 'General case' 0 C--O 1.235 0.334 0 O-C-N 123.237 0.335 . . . . 0.0 110.785 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.7 mm -123.28 120.49 27.21 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.11 -178.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.29 -31.73 5.01 Favored 'Cis proline' 0 C--N 1.371 1.74 0 C-N-CA 124.182 -1.174 . . . . 0.0 113.117 -0.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.643 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.67 -24.9 30.3 Favored Glycine 0 C--N 1.338 0.662 0 CA-C-N 115.788 -0.642 . . . . 0.0 113.859 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.65 112.19 48.46 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 117.225 0.513 . . . . 0.0 111.008 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -69.94 -25.17 8.26 Favored 'Cis proline' 0 C--N 1.378 2.095 0 C-N-CA 125.062 -0.807 . . . . 0.0 113.292 -0.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.52 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p30 -153.4 150.94 29.36 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.811 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.569 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -139.94 -168.34 11.3 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.498 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.46 134.65 41.15 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.76 0.314 . . . . 0.0 111.437 -179.917 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 78.5 m -80.51 107.82 13.63 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.358 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -112.54 147.61 36.25 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.709 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.444 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.4 m-85 -78.81 129.43 34.59 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.269 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.555 -0.736 . . . . 0.0 111.452 -179.552 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.27 . . . . . . . 0 C--O 1.235 0.309 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 126.77 42.0 0.29 Allowed Glycine 0 C--N 1.337 0.591 0 O-C-N 123.716 0.635 . . . . 0.0 112.915 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.6 t -141.96 112.86 7.37 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 120.743 0.306 . . . . 0.0 110.623 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.488 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -115.99 149.82 38.2 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.877 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -94.24 168.67 10.77 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.64 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.512 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 24.6 tt0 -63.07 136.73 57.97 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.747 0.308 . . . . 0.0 111.088 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.02 -4.83 81.95 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.913 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -93.88 157.63 16.04 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 122.725 0.41 . . . . 0.0 110.705 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.567 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.1 t -96.92 116.1 28.59 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.066 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.514 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.3 p -119.39 153.75 34.7 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.609 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.519 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.1 m-80 -100.72 138.22 38.06 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.775 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.5 m -92.03 20.31 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.926 0.394 . . . . 0.0 111.04 -179.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -112.86 -29.9 7.23 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.849 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -148.97 -44.86 0.14 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -115.38 74.07 4.08 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 122.259 0.223 . . . . 0.0 111.36 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.71 -172.41 0.94 Allowed 'Trans proline' 0 C--N 1.367 1.505 0 C-N-CA 122.821 2.347 . . . . 0.0 112.921 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.514 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 88.8 m -70.38 -176.86 1.31 Allowed 'General case' 0 CA--C 1.543 0.692 0 O-C-N 123.168 0.293 . . . . 0.0 111.168 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 17.1 m -84.68 118.36 70.85 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 122.327 0.251 . . . . 0.0 111.348 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.54 157.74 28.7 Favored 'Trans proline' 0 C--N 1.368 1.587 0 C-N-CA 122.705 2.27 . . . . 0.0 113.114 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.64 -32.19 5.7 Favored Glycine 0 C--N 1.337 0.59 0 O-C-N 123.669 0.606 . . . . 0.0 112.853 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 16.7 mt -84.22 -60.2 2.16 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 122.624 0.37 . . . . 0.0 110.991 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.15 36.28 0.31 Allowed Glycine 0 C--N 1.341 0.846 0 O-C-N 123.399 0.437 . . . . 0.0 113.311 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.18 155.7 18.84 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.86 0.33 . . . . 0.0 111.425 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.8 t -142.82 129.08 19.89 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.324 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -84.94 123.72 30.83 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.317 0.386 . . . . 0.0 110.85 179.829 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.2 mm -123.15 120.37 27.38 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.057 -178.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.32 -31.76 4.99 Favored 'Cis proline' 0 C--N 1.371 1.731 0 C-N-CA 124.185 -1.173 . . . . 0.0 113.143 -0.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.642 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.58 -24.88 30.38 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.843 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.65 112.15 48.48 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-N 117.187 0.494 . . . . 0.0 111.012 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -69.88 -25.18 8.23 Favored 'Cis proline' 0 C--N 1.378 2.087 0 C-N-CA 125.036 -0.818 . . . . 0.0 113.34 -0.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.519 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.0 p30 -153.39 150.98 29.41 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.796 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.22 -168.27 11.3 Favored Glycine 0 C--N 1.336 0.531 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.4 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.54 134.33 41.65 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.697 0.284 . . . . 0.0 111.518 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 87.1 m -80.27 107.62 13.22 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.344 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -112.4 147.35 36.62 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.789 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.436 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.3 m-85 -78.61 129.46 34.8 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.259 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 C--O 1.251 1.152 0 CA-C-O 118.533 -0.746 . . . . 0.0 111.389 -179.548 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.272 . . . . . . . 0 C--O 1.235 0.297 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.66 55.6 1.0 Allowed Glycine 0 C--N 1.335 0.523 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.589 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.64 113.3 10.2 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 120.778 0.323 . . . . 0.0 110.416 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.453 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . . . -117.94 148.08 42.53 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.886 179.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -92.2 171.86 8.8 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.059 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.509 ' HA ' ' O ' ' A' ' 34' ' ' CYS . 23.3 tt0 -64.88 137.24 57.64 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.726 0.298 . . . . 0.0 111.108 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.73 -5.02 80.53 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.949 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -93.72 157.04 16.35 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 122.697 0.399 . . . . 0.0 110.662 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.569 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 17.4 t -96.89 115.94 28.3 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.984 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 17' ' ' CYS . 1.4 p -119.06 153.96 33.91 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.62 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.522 ' OD1' ' HB3' ' A' ' 31' ' ' ASP . 6.2 m-80 -100.75 138.23 38.08 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.79 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 28' ' ' GLY . 33.6 m -91.96 20.45 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.961 0.41 . . . . 0.0 111.086 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -112.74 -30.09 7.19 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.736 -178.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.78 -45.02 0.15 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -115.69 74.22 4.66 Favored Pre-proline 0 CA--C 1.548 0.888 0 O-C-N 123.114 0.259 . . . . 0.0 111.294 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.72 -171.84 0.83 Allowed 'Trans proline' 0 C--N 1.368 1.557 0 C-N-CA 122.71 2.273 . . . . 0.0 112.886 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 90.5 m -70.27 -177.55 1.45 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 122.405 0.282 . . . . 0.0 111.069 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.7 m -84.28 118.55 71.47 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 122.249 0.22 . . . . 0.0 111.388 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -78.42 158.18 29.21 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 122.715 2.277 . . . . 0.0 113.094 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.27 -32.1 5.65 Favored Glycine 0 C--N 1.337 0.591 0 O-C-N 123.628 0.58 . . . . 0.0 112.882 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.9 mt -84.34 -61.12 1.88 Allowed 'General case' 0 C--O 1.236 0.36 0 C-N-CA 122.668 0.387 . . . . 0.0 111.024 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.91 36.31 0.28 Allowed Glycine 0 C--N 1.341 0.849 0 O-C-N 123.377 0.423 . . . . 0.0 113.214 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.34 156.2 18.43 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.885 0.343 . . . . 0.0 111.318 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.1 t -143.29 129.61 19.91 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.301 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 33' ' ' THR . 0.1 OUTLIER -85.34 123.79 31.22 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 123.32 0.388 . . . . 0.0 110.848 179.839 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 35.3 mm -123.3 120.36 27.22 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.116 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.41 -31.76 5.0 Favored 'Cis proline' 0 C--N 1.372 1.768 0 C-N-CA 124.155 -1.185 . . . . 0.0 113.142 -0.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.643 ' O ' HG22 ' A' ' 12' ' ' VAL . . . 100.64 -24.71 31.03 Favored Glycine 0 C--N 1.337 0.601 0 CA-C-O 119.386 -0.675 . . . . 0.0 113.874 179.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -113.62 112.13 48.6 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 117.198 0.499 . . . . 0.0 111.06 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -69.95 -25.18 8.25 Favored 'Cis proline' 0 C--N 1.376 2.026 0 CA-C-N 119.416 0.827 . . . . 0.0 113.244 -0.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.522 ' HB3' ' OD1' ' A' ' 11' ' ' ASN . 3.1 p30 -153.25 151.08 29.65 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.836 179.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.569 ' O ' ' HA ' ' A' ' 9' ' ' SER . . . -140.11 -168.43 11.34 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.46 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 0.8 OUTLIER -98.53 134.52 41.37 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 120.77 0.319 . . . . 0.0 111.418 -179.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 80.0 m -80.55 107.78 13.64 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.329 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -112.5 147.73 35.93 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.712 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.445 ' HD2' ' OE2' ' A' ' 6' ' ' GLU . 1.3 m-85 -78.11 128.94 34.57 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.171 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.251 1.18 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.451 -179.19 . . . . . . . . 1 1 . 1 stop_ save_